Processing 00000000.tx.1: Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions J. 

Phrase: "Clearance of IGFs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]
   716   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "insulin from wounds"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "effect of IGF-binding protein interactions J."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.2: Gray Robertson1,2, David A. 

Phrase: "Gray Robertson1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "David A."
Processing 00000000.tx.3: Belford2, and F. 

Phrase: "Belford2,"

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.4: John Ballard2 1Child Health Research Institute, North Adelaide, South Australia 5006; 

Phrase: "John Ballard2 1Child Health Research Institute,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0035172:Research Institute [Organization]
   799   C0018684:Health [Idea or Concept]
   799   C0021622:institute [Organization]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1272753:Institute [Idea or Concept]

Phrase: "North Adelaide,"

Phrase: "South Australia 5006"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0037715:South Australia [Geographic Area]
   827   C0004340:Australia [Geographic Area]
   827   C1710133:South [Spatial Concept]
   755 E C0238711:AUSTRALIAN [Finding]

Phrase: ";"
Processing 00000000.tx.5: and 2Cooperative Research Centre for Tissue Growth and Repair, Adelaide, South Australia 5000,Australia  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES We have examined the role binding proteins have in regulating the clearance of exogenous growth factors from wounds. 

Phrase: "and"

Phrase: "2Cooperative Research Centre for Tissue Growth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0683939:research center [Manufactured Object,Organization]
   753   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Repair,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Repair, NOS [Organism Function]
  1000   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "Adelaide,"

Phrase: "South Australia 5000,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0037715:South Australia [Geographic Area]
   827   C0004340:Australia [Geographic Area]
   827   C1710133:South [Spatial Concept]
   755 E C0238711:AUSTRALIAN [Finding]

Phrase: "Australia  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the role binding proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "have in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C3154893:Have [Idea or Concept]
   833   C3539897:Have [Qualitative Concept]

Phrase: "regulating"

Phrase: "the clearance of exogenous growth factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "from wounds."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021501:wounds [Qualitative Concept]
  1000   C0043250:Wounds [Injury or Poisoning]
Processing 00000000.tx.6: Hunt-Schilling chambers were subcutaneously implanted in rats, and the clearance of insulin-like growth factor (IGF) I from the chamber wound fluid was compared with IGF-II, LR3-IGF-I, which binds poorly to IGF-binding proteins (IGFBP), or insulin. 

Phrase: "Hunt-Schilling chambers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0179874:chambers [Medical Device]
   793 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "subcutaneously"

Phrase: "implanted in rats,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0021102:Implanted [Medical Device]
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]
   756 E C0021107:implant [Therapeutic or Preventive Procedure]
   756 E C0332837:Implant [Injury or Poisoning]
   756 E C1711357:Implant [Functional Concept]

Phrase: "and"

Phrase: "the clearance of insulin-like growth factor (IGF) I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0449297:Clearance [Qualitative Concept]
   744   C1382187:Clearance [Clinical Attribute]
   744   C2825073:Clearance [Natural Phenomenon or Process]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "from the chamber wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   827   C0005889:FLUID [Body Substance]
   827   C0043250:Wound [Injury or Poisoning]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1704353:Fluid [Substance]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "compared with IGF-II,"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   897   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0200396:Factor II [Laboratory Procedure]
   778   C1414504:FACTOR II [Gene or Genome]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0220844:growth [Physiologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1707455:Compared [Activity]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "LR3-IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "which"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "poorly to IGF-binding proteins"
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   909   C0074825:Insulin-Like Growth-Factor-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1149301:insulin-like growth factor binding [Molecular Function]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   800   C1149299:Growth Factor Binding [Molecular Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1623517:insulin binding [Molecular Function]
   750 E C0033618:Protein Binding [Molecular Function]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205169:Poorly [Qualitative Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "(IGFBP"
Meta Candidates (Total=23; Excluded=2; Pruned=0; Remaining=21)
  1000   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1149301:insulin-like growth factor binding [Molecular Function]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   876   C1623517:insulin binding [Molecular Function]
   861   C1149299:Growth Factor Binding [Molecular Function]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0220844:growth [Physiologic Function]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.7: Elimination rate constants of the slow phase of the decay curves did not differ between IGF-I and IGF-II. 

Phrase: "Elimination rate constants of the slow phase of the decay curves"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0221102:Elimination [Physiologic Function]
   738   C0871208:Rate [Activity]
   738   C1521828:Rate [Quantitative Concept]
   737   C2986736:Decay Constant [Quantitative Concept]
   722   C2986811:Rate Constant [Quantitative Concept]
   704   C1547014:*Constant [Quantitative Concept]
   704   C1948059:Constant [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ between IGF-I"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.8: However, LR3-IGF-I and insulin were cleared more rapidly from wound fluid than IGF-I so that the half-lives for IGF-I, IGF-II, LR3-IGF-I, and insulin were 872,861,563,and 324min, respectively. 

Phrase: "However,"

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "cleared"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521097:cleared [Functional Concept]
   966 E C2963144:Clear [Qualitative Concept]

Phrase: "more rapidly from wound fluid"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0005889:FLUID [Body Substance]
   760   C0043250:Wound [Injury or Poisoning]
   760   C0205172:More [Functional Concept]
   760   C0302908:fluid [Substance]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1637379:Rapidly [Qualitative Concept]
   760   C1704353:Fluid [Substance]
   726 E C0016204:Wind NOS [Sign or Symptom]
   726 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "than IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the half-lives for IGF-I,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   742   C0595998:lives [Finding]
   742   C1548795:Live [Qualitative Concept]
   742   C1634625:% live [Qualitative Concept]
   742   C2825407:Half [Quantitative Concept]
   742   C2982691:Live [Activity]
   731   C0018517:Half-Life [Temporal Concept]
   708 E C0376558:Life [Idea or Concept]

Phrase: "IGF-II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "LR3-IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "872,"

Phrase: "861,"

Phrase: "563,"

Phrase: "and"

Phrase: "324min,"

Phrase: "respectively."
Processing 00000000.tx.9: In wound fluid, minimal degradation of the IGFs occurred, whereas insulin was degraded considerably. 

Phrase: "In wound fluid,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "minimal degradation of the IGFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C3547574:insulin degradation [Molecular Function]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "whereas"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "considerably."
Processing 00000000.tx.10: The increased clearance of LR3-IGF-I and insulin equated with a reduced association with wound fluid IGFBPs, and increased amounts of radioactivity of these peptides were detected in the circulation and urine. 

Phrase: "The increased clearance of LR3-IGF-I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0449297:Clearance [Qualitative Concept]
   739   C1382187:Clearance [Clinical Attribute]
   739   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "equated with a reduced association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0004083:Association [Mental Process]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with wound fluid IGFBPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "increased amounts of radioactivity of these peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "detected in the circulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005775:Circulation [Physiologic Function]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1516559:Circulation [Organism Function]

Phrase: "and"

Phrase: "urine."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]
Processing 00000000.tx.11: These results show that this model of wound repair may be of use in examining the kinetics of growth factors and other bioactive molecules in extravascular spaces and support the hypothesis that IGFBPs can be significant regulators of IGF bioavailability in vivo. insulin-like growth factor I analog; 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this model of wound repair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "may"

Phrase: "be of use"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C1524063:Use of [Functional Concept]
   790   C0042153:use [Functional Concept]
   790   C0457083:Use [Functional Concept]
   790   C1947944:Use [Intellectual Product]
   790   C2987476:Be [Conceptual Entity]

Phrase: "in examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "the kinetics of growth factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022702:Kinetics [Natural Phenomenon or Process]
   760   C0220865:kinetics [Functional Concept]
   760   C2825046:Kinetics [Occupation or Discipline]

Phrase: "and"

Phrase: "other bioactive molecules in extravascular spaces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0567416:molecules [Substance]

Phrase: "and"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "significant regulators"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0182953:regulators [Medical Device]
   827 E C1704734:Regulator [Medical Device]
   827 E C1704735:Regulator [Conceptual Entity]

Phrase: "of IGF bioavailability in vivo. insulin-like growth factor I analog"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   890   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   786   C0243071:Analog [Chemical Viewed Structurally]
   724   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   724   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.12: extravascular wound fluid; 

Phrase: "extravascular wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   827   C0005889:FLUID [Body Substance]
   827   C0043250:Wound [Injury or Poisoning]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1704353:Fluid [Substance]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]

Phrase: ";"
Processing 00000000.tx.13: growth factors; 

Phrase: "growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.14: wound healing  INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES WOUND REPAIR is a complex biological process involving diverse biochemical and cellular interactions that result in cellular proliferation and extracellular matrix deposition (33). 

Phrase: "wound healing  INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "WOUND"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]
   966 E C0016204:Wind NOS [Sign or Symptom]
   966 E C0043187:Wind [Natural Phenomenon or Process]
   916 E C0021501:wounds [Qualitative Concept]
   916 E C0332797:Wounded [Functional Concept]

Phrase: "REPAIR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Repair, NOS [Organism Function]
  1000   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a complex biological process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0031845:Biological Process [Physiologic Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "diverse biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "cellular interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "that"

Phrase: "result in cellular proliferation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0020507:Cellular proliferation [Pathologic Function]
   833   C0596290:Cellular Proliferation [Cell Function]
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C0334094:Proliferation [Pathologic Function]
   770   C1274040:Result [Functional Concept]
   770   C1514485:Proliferation [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "and"

Phrase: "extracellular matrix deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333562:Deposition [Functional Concept]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.15: Successful coordination of these events is dependent on extracellular matrix molecules and growth factors with mitogenic and chemotactic properties in the wound environment (28). 

Phrase: "Successful coordination of these events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0242414:Coordination [Physiologic Function]
   760   C0700114:Coordination [Functional Concept]

Phrase: "is"

Phrase: "dependent on extracellular matrix molecules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "growth factors with mitogenic"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   802   C0021756:Mitogenic Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   802   C1522405:Mitogenic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "chemotactic properties in the wound environment"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.16: Research has focused on the application of exogenous growth factors to wounds as a means of improving healing (29) or modifying the healing outcome, such as increased wound strength (31). 

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "has"

Phrase: "focused on the application of exogenous growth factors"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   770   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1516998:Exogenous Factors [Functional Concept]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0185125:Application [Health Care Activity]
   744   C0205101:Exogenous [Spatial Concept]
   744   C0205228:Exogenous [Functional Concept]
   744   C0205234:Focused [Spatial Concept]
   744   C0220844:growth [Physiologic Function]
   744   C1285542:focused [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1947919:Application [Intellectual Product]
   744   C2347934:Application [Intellectual Product]
   744   C2911660:Growth [Activity]
   744   C3539080:APPLICATION [Quantitative Concept]
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]

Phrase: "to wounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021501:wounds [Qualitative Concept]
  1000   C0043250:Wounds [Injury or Poisoning]

Phrase: "as a means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "of improving healing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043240:Healing [Organism Function]
   861   C0205249:Healing [Functional Concept]

Phrase: "(29"

Phrase: ")"

Phrase: "or"

Phrase: "modifying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392747:MODIFY [Functional Concept]

Phrase: "the healing outcome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1274040:Outcome [Functional Concept]

Phrase: "such as increased wound strength"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755 E C0442821:Strong [Qualitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.17: The wound environment contains many proteases (30), some of which may act to alter the interactions between growth factors and cells involved in the healing response. 

Phrase: "The wound environment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "many proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "some of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "may"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the interactions between growth factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "involved in the healing response."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0043240:Healing [Organism Function]
   760   C0205249:Healing [Functional Concept]
   760   C0871261:Response [Organism Attribute]
   760   C1314939:Involved [Functional Concept]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]
Processing 00000000.tx.18: Thus, to improve healing, an exogenous growth factor must be protected from degradation and premature clearance from the wound site so that it can access the appropriate cellular receptors at the required concentrations (4). 

Phrase: "Thus,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "improve"

Phrase: "healing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Healing [Organism Function]
  1000   C0205249:Healing [Functional Concept]

Phrase: "an exogenous growth factor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "must"

Phrase: "be"

Phrase: "protected from degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "premature clearance from the wound site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "it"

Phrase: "can"

Phrase: "access"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444454:Access [Spatial Concept]
  1000   C1554204:access [Idea or Concept]

Phrase: "the appropriate cellular receptors at the required concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0007634:Cellular [Cell]
   744   C0178539:Cellular [Functional Concept]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.19: However, few models that allow examination of the in vivo regulation of growth factor movement between extravascular spaces exist, and consequentially, detailed knowledge of the fate of growth factors after application to wounds and their interactions with components of the wound is limited. 

Phrase: "However,"

Phrase: "few"

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "that"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "examination of the in vivo regulation of growth factor movement"

Phrase: "between extravascular spaces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1883067:Space [Spatial Concept]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ","

Phrase: "and"

Phrase: "consequentially,"

Phrase: "detailed knowledge of the fate of growth factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0376554:Knowledge [Intellectual Product]

Phrase: "after application"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0185125:Application [Health Care Activity]
  1000   C1947919:Application [Intellectual Product]
  1000   C2347934:Application [Intellectual Product]
  1000   C3539080:APPLICATION [Quantitative Concept]

Phrase: "to wounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021501:wounds [Qualitative Concept]
  1000   C0043250:Wounds [Injury or Poisoning]

Phrase: "and"

Phrase: "their interactions with components of the wound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "limited."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.20: The insulin-like growth factors (IGFs) are regulators of tissue growth and differentiation and are normally found associated with six high-affinity IGF-binding proteins (IGFBPs), such that very little unbound peptide exists (for review see Ref. 20). 

Phrase: "The insulin-like growth factors (IGFs)"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
  1000   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   966 E C1753359:insulin-like growth factor [Molecular Function]
   861   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "are"

Phrase: "regulators of tissue growth"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   802   C1817513:growth regulator [Cell Function]
   770   C0182953:regulators [Medical Device]
   737 E C1704734:Regulator [Medical Device]
   737 E C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "normally"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "associated with six high-affinity IGF-binding proteins"
Meta Candidates (Total=32; Excluded=3; Pruned=0; Remaining=29)
   846   C0074825:Insulin-Like Growth-Factor-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   820   C1149301:insulin-like growth factor binding [Molecular Function]
   797   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   797   C1753359:insulin-like growth factor [Molecular Function]
   775   C1149299:Growth Factor Binding [Molecular Function]
   756   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0332281:Associated with [Qualitative Concept]
           Associated
   754   C0020459:high insulin [Disease or Syndrome]
   754   C1623517:insulin binding [Molecular Function]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0205250:High [Qualitative Concept]
   738   C0205452:Six [Quantitative Concept]
   738   C0220844:growth [Physiologic Function]
   738   C0243122:binding [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1299351:High [Qualitative Concept]
   738   C1510827:Affinity [Natural Phenomenon or Process]
   738   C1521761:Factor [Functional Concept]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C2700149:HIGH [Intellectual Product]
   738   C2827422:Factor [Conceptual Entity]
   738   C2911660:Growth [Activity]
   737 E C0033618:Protein Binding [Molecular Function]
   704 E C0750490:Associate [Idea or Concept]
   704 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "such"

Phrase: "that very little unbound peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.21: IGF-I is expressed in granulation tissue (14), whereas several cell types involved in the wound repair response are known to express and produce IGFBPs in vitro (3, 40). 

Phrase: "IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "expressed in granulation tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0018180:Granulation Tissue [Tissue]
   770   C0040300:Tissue [Tissue]
   770   C0518864:granulation [Finding]
   770   C1547928:Tissue [Intellectual Product]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "several cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]

Phrase: "involved in the wound repair response"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0043240:Wound Repair [Organism Function]
           Repair, NOS
   753   C0043250:Wound [Injury or Poisoning]
   753   C0374711:Repair [Therapeutic or Preventive Procedure]
   753   C0871261:Response [Organism Attribute]
   753   C1314939:Involved [Functional Concept]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "and"

Phrase: "produce"

Phrase: "IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.22: Although several studies have demonstrated an enhanced effect of IGF in wounds when coadministered with IGFBPs, the mechanism by which each IGFBP acts is unknown. 

Phrase: "Although"

Phrase: "several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "an enhanced effect of IGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "in wounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021501:wounds [Qualitative Concept]
  1000   C0043250:Wounds [Injury or Poisoning]

Phrase: "when"

Phrase: "coadministered with IGFBPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "each IGFBP acts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   787   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0079613:ACT [Therapeutic or Preventive Procedure]
   747   C1149301:insulin-like growth factor binding [Molecular Function]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.23: Thus IGFBPs may serve to enhance IGF-I bioactivity by maintaining a pool of IGF-I at the site of action and preventing clearance, by protecting IGF-I from degradation, or by targeting IGF-I to cell membranes or receptors. 

Phrase: "Thus IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "IGF-I bioactivity by maintaining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "a pool of IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0337051:Pool [Geographic Area]
   744   C1509144:pool [Clinical Attribute]
   744   C2349200:Pool [Functional Concept]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "at the site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "of action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "and"

Phrase: "preventing clearance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "by protecting IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "from degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "or by targeting IGF-I"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   869   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0021966:I- [Inorganic Chemical]
   744   C0220844:growth [Physiologic Function]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C1521761:Factor [Functional Concept]
   744   C1521840:Targeting [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   739   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   711 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "to cell membranes"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0007603:Cell membranes [Cell Component]
   966 E C3161472:Cell Membrane [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0025255:Membranes [Tissue]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "or"

Phrase: "receptors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.24: Experiments have shown that IGFBP-1 may enhance IGF actions (21, 42) by binding the 5-1-integrin through an Arg-Gly-Asp sequence (13). 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that IGFBP-1"
Meta Candidates (Total=29; Excluded=2; Pruned=0; Remaining=27)
  1000   C0123256:Insulin-Like Growth-Factor Binding Protein 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334092:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1 [Gene or Genome]
   954   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   927   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   927   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   913   C1149301:insulin-like growth factor binding [Molecular Function]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C1623517:insulin binding [Molecular Function]
   845   C1149299:Growth Factor Binding [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "IGF actions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   836   C2911660:Growth action [Activity]
   804   C0441472:actions [Functional Concept]
   771   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1753359:insulin-like growth factor [Molecular Function]
   771 E C3266814:Action [Activity]

Phrase: "(21,"

Phrase: "42"

Phrase: ")"

Phrase: "by binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "the 5-1-integrin through an Arg-Gly-Asp sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.25: IGFBP-3 normally inhibits IGF-I actions, but in the wound this binding protein is proteolyzed (34), a process known to occur in many pathophysiological states (8, 9). 

Phrase: "IGFBP-3 normally"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
   960   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   960   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   923   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   890   C1149301:insulin-like growth factor binding [Molecular Function]
   883   C1416453:INSULIN-LIKE 3 [Gene or Genome]
   861   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1753359:insulin-like growth factor [Molecular Function]
   850   C1623517:insulin binding [Molecular Function]
   835   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   835   C1149299:Growth Factor Binding [Molecular Function]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0220844:growth [Physiologic Function]
   793   C0243122:binding [Functional Concept]
   793   C1145667:Binding [Activity]
   793   C1167622:Binding [Molecular Function]
   793   C1521761:Factor [Functional Concept]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "IGF-I actions,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   841   C2911660:Growth action [Activity]
   799   C0441472:actions [Functional Concept]
   780   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   780   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   766 E C3266814:Action [Activity]
   734   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "but in the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0233535:but [Mental or Behavioral Dysfunction]

Phrase: "wound"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]
   966 E C0016204:Wind NOS [Sign or Symptom]
   966 E C0043187:Wind [Natural Phenomenon or Process]
   916 E C0021501:wounds [Qualitative Concept]
   916 E C0332797:Wounded [Functional Concept]

Phrase: "this binding protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "proteolyzed"

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur in many pathophysiological states"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C1301808:states [Geographic Area]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726 E C1442792:State [Functional Concept]
   726 E C3148680:State [Geographic Area]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.26: The proteolytically modified form of IGFBP-3 has a reduced affinity for IGF-I, a property that may serve to enhance IGF-I actions (6). 

Phrase: "The proteolytically modified form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "of IGFBP-3"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
  1000   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   954   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1149301:insulin-like growth factor binding [Molecular Function]
   900   C1416453:INSULIN-LIKE 3 [Gene or Genome]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C1623517:insulin binding [Molecular Function]
   845   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1149299:Growth Factor Binding [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "a reduced affinity for IGF-I,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "a property"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0871161:Property [Qualitative Concept]
  1000   C1882134:Property [Conceptual Entity]
  1000   C2347695:Property [Entity]

Phrase: "that"

Phrase: "may"

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "IGF-I actions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   841   C2911660:Growth action [Activity]
   799   C0441472:actions [Functional Concept]
   780   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   780   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   766 E C3266814:Action [Activity]
   734   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.27: Several earlier studies have attempted to measure the transfer of growth factors to tissues in vivo, with mixed success (18, 27). 

Phrase: "Several earlier studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the transfer of growth factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0040673:factors transfer [Immunologic Factor]
   797   C1280474:factors transfer [Finding]
   760   C0040671:Transfer [Mental Process]
   760   C1705822:Transfer [Activity]

Phrase: "to tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "with mixed success"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0597535:Success [Social Behavior]
   789 E C1272703:Successful [Qualitative Concept]

Phrase: "(18,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.28: However, most of the data concerning the regulation of the movement of IGFs between extracellular compartments have been derived from plasma pharmacokinetic experiments that identify target organs or tissues but do not provide data on the extravascular kinetics of the IGFs. 

Phrase: "However,"

Phrase: "most of the data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205393:Most [Quantitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the regulation of the movement of IGFs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   777   C1160191:regulation of growth [Organism Function]
           growth regulation
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1327622:Regulation [Biologic Function]

Phrase: "between extracellular compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "derived from plasma pharmacokinetic experiments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0032105:Plasma [Body Substance]
   760   C0201734:PHARMACOKINETIC [Research Activity]
   760   C0681814:Experiments [Research Activity]
   760   C1441547:Derived [Qualitative Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C3245521:derived [Idea or Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "that"

Phrase: "identify"

Phrase: "target organs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0178784:organs [Body Part, Organ, or Organ Component]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]

Phrase: "or"

Phrase: "tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "but"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "data on the extravascular kinetics of the IGFs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1511726:Data [Idea or Concept]
   738   C3245479:data [Medical Device]
Processing 00000000.tx.29: Analogs of IGF-I that exhibit poor binding characteristics to IGFBPs are more potent in vitro compared with native IGF-I (12), a potency that is attributed to reduced interactions with IGFBPs secreted into the media by cells in culture. 

Phrase: "Analogs of IGF-I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0243071:analogs [Chemical Viewed Structurally]
   731   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   731   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "that"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "poor binding characteristics to IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "are"

Phrase: "more potent in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021135:In Vitro [Intellectual Product]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]

Phrase: "compared with native IGF-I"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   869   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0021966:I- [Inorganic Chemical]
   744   C0220844:growth [Physiologic Function]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0302891:Native [Functional Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1707455:Compared [Activity]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   739   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "a potency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   884   C3245505:Potential [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "attributed to reduced interactions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392756:Reduced [Qualitative Concept]
   737   C0449234:Attribute [Idea or Concept]
   737   C1704675:Interaction [Functional Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]

Phrase: "with IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "secreted into the media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1327616:Secreted [Cell Function]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "by cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "in culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.30: However, these analogs are cleared from the circulation more quickly and are degraded to a greater extent than IGF-I (2), suggesting that IGFBPs may regulate the bioavailability of IGFs. 

Phrase: "However,"

Phrase: "these analogs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243071:analogs [Chemical Viewed Structurally]
   893 E C0679213:analogies [Idea or Concept]

Phrase: "are"

Phrase: "cleared from the circulation more quickly"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0005775:Circulation [Physiologic Function]
   753   C0521097:cleared [Functional Concept]
   753   C1516559:Circulation [Organism Function]
   719 E C2963144:Clear [Qualitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "degraded to a greater extent"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1555603:Great extent [Qualitative Concept]
   760   C0439792:Extent [Spatial Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   760   C1881707:DEGRADED [Phenomenon or Process]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "than IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "regulate"

Phrase: "the bioavailability of IGFs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0005508:Bioavailability [Quantitative Concept]
   748   C1706947:BIO-AVAILABILITY [Research Activity]
Processing 00000000.tx.31: The purpose of this study was to determine whether interactions with IGFBPs had any effect on the clearance of IGFs from wound sites. 

Phrase: "The purpose of this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0681832:purpose of study [Research Activity]
   760   C1285529:Purpose [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "interactions with IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704675:Interaction [Functional Concept]

Phrase: "had"

Phrase: "any effect on the clearance of IGFs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "from wound sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.32: We have compared the rates of elimination and breakdown of IGF-I and IGF-II with an IGF analog that binds IGFBPs poorly, LR3-IGF-I (12), and insulin. 

Phrase: "We"

Phrase: "have"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the rates of elimination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "breakdown of IGF-I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C3547574:insulin breakdown [Molecular Function]
   748   C0443161:break down [Qualitative Concept]
   748   C0699900:breakdown [Organism Function]
   748   C1265875:breakdown [Acquired Abnormality]
   731   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   731   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "and"

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with an IGF analog"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   897   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0243071:Analog [Chemical Viewed Structurally]
   771   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1753359:insulin-like growth factor [Molecular Function]
   704 E C0679213:analogies [Idea or Concept]

Phrase: "that"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "IGFBPs poorly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.33: We hypothesize that interactions with IGFBPs significantly decrease the rate of clearance of IGFs from wound sites.  

Phrase: "We"

Phrase: "hypothesize"

Phrase: "that interactions with IGFBPs significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the rate of clearance of IGFs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0025515:clearance rate [Clinical Attribute]
   762   C0449249:Growth rate [Temporal Concept]
   742   C0871208:Rate [Activity]
   742   C1521828:Rate [Quantitative Concept]

Phrase: "from wound sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.34: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Reagents. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Reagents."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.35: Thiobutabarbital (Inactin) was purchased from Research Biochemicals International (Natick, MA). 

Phrase: "Thiobutabarbital"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076448:thiobutabarbital [Organic Chemical,Pharmacologic Substance]

Phrase: "(Inactin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123451:Inactin [Organic Chemical]

Phrase: ")"

Phrase: "was"

Phrase: "purchased from Research Biochemicals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C0869011:purchased [Activity]
   737   C0205474:Biochemical [Functional Concept]

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: "(Natick,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.36: Sodium iodide (Na125I) was obtained from Amersham Australia (Castle Hill, Australia). 

Phrase: "Sodium iodide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0037521:Sodium Iodide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(Na125I"

Phrase: ")"

Phrase: "was"

Phrase: "obtained from Amersham Australia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0004340:Australia [Geographic Area]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "(Castle Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: ")."
Processing 00000000.tx.37: Heparin, Evans Blue dye, recombinant human insulin, and the size exclusion molecular-mass markers were obtained from Sigma (St. Louis, MO). 

Phrase: "Heparin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "Evans Blue dye,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   734   C0015205:Evan's Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "recombinant human insulin,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   913   C1533581:Recombinant Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Insulin
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0086418:Human [Human]
   827   C1514798:recombinant [Organism]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the size exclusion molecular-mass markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0005516:molecular markers [Clinical Attribute]
           Marker

Phrase: "were"

Phrase: "obtained from Sigma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.38: Recombinant human IGF-I, IGF-II, and LR3-IGF-I were obtained from GroPep (Adelaide, Australia). 

Phrase: "Recombinant human IGF-I,"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
  1000   C0904505:Recombinant human insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   911   C1522567:Recombinant Insulin-Like Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   884   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   833   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   829   C1533581:Recombinant Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Insulin
   818   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0021966:I- [Inorganic Chemical]
   795   C0086418:Human [Human]
   795   C0220844:growth [Physiologic Function]
   795   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C1514798:recombinant [Organism]
   795   C1521761:Factor [Functional Concept]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "IGF-II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from GroPep"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Adelaide,"

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: ")."
Processing 00000000.tx.39: Each peptide was 125I-labeled with the chloramine-T method (1) to a specific activity of 75-85 Ci/g and stored at 20C. 

Phrase: "Each peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "125I-"

Phrase: "labeled with the chloramine-T method"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0055332:Chloramin T [Organic Chemical,Pharmacologic Substance]
   753   C0008164:Chloramine [Organic Chemical]
   753   C0025033:Chloramin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C0025663:Method [Intellectual Product]
   753   C0055330:chloramine [Inorganic Chemical]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "to a specific activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0205369:Specific [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1552740:specific [Intellectual Product]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "of 75-85 Ci/g"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C1979839:75 g [Quantitative Concept]
   861   C2348019:Ci/g [Quantitative Concept]
   812   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "stored at 20C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.40: The biological activity of these peptides has been described previously (11, 12, 26). 

Phrase: "The biological activity of these peptides"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0205177:Activity [Functional Concept]
   753   C0205460:biological [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(11,"

Phrase: "12,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.41: Animal surgery. 

Phrase: "Animal surgery."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038894:Surgery [Biomedical Occupation or Discipline]
   861   C0038895:surgery [Functional Concept]
   861   C0543467:Surgery [Health Care Activity]
Processing 00000000.tx.42: All animal procedures were approved by the animal ethics committee of the Adelaide Women's and Children's Hospital, following the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. 

Phrase: "All animal procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "were"

Phrase: "approved by the animal ethics committee of the Adelaide Women's"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C1136115:Ethics Committee, Animal [Professional or Occupational Group]
   760   C0085546:Ethics Committee [Professional or Occupational Group]
   739   C0003062:Animal [Animal]
   739   C0015000:Ethics [Idea or Concept]
   739   C0043210:Women [Population Group]
   739   C0205540:Approved [Qualitative Concept]
   739   C1527243:ethics [Idea or Concept]
   739   C2699414:Committee [Group]

Phrase: "and"

Phrase: "Children's Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0020017:Children's hospital [Health Care Related Organization]
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the Australian Code of Practice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0009219:code [Occupational Activity]
   760   C0805701:Code [Intellectual Product]

Phrase: "for the Care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use of Animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C1524063:Use of [Functional Concept]
   790   C0042153:use [Functional Concept]
   790   C0457083:Use [Functional Concept]
   790   C1947944:Use [Intellectual Product]

Phrase: "for Scientific Purposes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285529:purposes [Functional Concept]
Processing 00000000.tx.43: Male Sprague-Dawley rats (175-200 g) were housed under constant temperature and humidity with 12:12-h light-dark cycles. 

Phrase: "Male Sprague-Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0034715:Rats, Sprague-Dawley [Mammal]
   861   C2699239:Sprague-Dawley [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "(175-200 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "housed under constant temperature"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0005903:temperature [Organism Attribute]
   770   C0020056:Housed [Manufactured Object]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1547014:*Constant [Quantitative Concept]
   770   C1948059:Constant [Qualitative Concept]
   737 E C0442519:house [Conceptual Entity]
   737 E C2003847:House [Manufactured Object]

Phrase: "and"

Phrase: "humidity with 12"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0020167:Humidity [Natural Phenomenon or Process]
   790   C0869465:Humidity [Natural Phenomenon or Process]
   718 E C0205381:Humid [Qualitative Concept]

Phrase: ":"

Phrase: "12-h light-dark cycles."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C2718082:Light-Dark Cycles [Temporal Concept]
           Light Cycles
   804   C0023693:Light [Natural Phenomenon or Process]
   804   C0332582:Dark [Qualitative Concept]
   804   C1306462:Light [Functional Concept]
   804   C1881376:Light [Qualitative Concept]
   771   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.44: Each rat was individually caged, and ad libitum access to food and water was allowed. 

Phrase: "Each rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "was"

Phrase: "individually"

Phrase: "caged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0337189:Cage [Manufactured Object]
   966   C0441239:Cage [Medical Device]

Phrase: ","

Phrase: "and"

Phrase: "ad libitum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879743:ad libitum [Qualitative Concept]

Phrase: "access to food"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016452:Food [Food]
   790   C0444454:Access [Spatial Concept]
   790   C1554204:access [Idea or Concept]

Phrase: "and"

Phrase: "water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "was"

Phrase: "allowed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]
Processing 00000000.tx.45: Hunt-Schilling chambers were constructed from stainless steel mesh as previously described (34). 

Phrase: "Hunt-Schilling chambers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0179874:chambers [Medical Device]
   793 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "constructed from stainless steel mesh"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0038126:Stainless Steel [Biomedical or Dental Material,Inorganic Chemical]
   760   C0038239:Steel [Biomedical or Dental Material,Inorganic Chemical]
   760   C0181805:Mesh [Medical Device]
   760   C1135584:MeSH [Intellectual Product]
   760   C1552983:Mesh [Quantitative Concept]
   726   C2827421:Construct [Classification]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.46: One chamber was implanted subcutaneously per rat and left in situ for 14days. 

Phrase: "One chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "implanted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0021102:Implanted [Medical Device]
   966 E C0021107:implant [Therapeutic or Preventive Procedure]
   966 E C0332837:Implant [Injury or Poisoning]
   966 E C1711357:Implant [Functional Concept]

Phrase: "subcutaneously per rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034693:Rat, NOS [Mammal]
   790   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "left in situ for 14days."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0444498:In situ [Spatial Concept]
Processing 00000000.tx.47: This study was performed 14days after the implantation of the chambers for a number of reasons. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "14days after the implantation of the chambers"

Phrase: "for a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of reasons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:reasons [Idea or Concept]
Processing 00000000.tx.48: First, from the time of implantation there is accumulation of fluid within the lumen of the chamber and an ingrowth of granulation tissue. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "from the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of implantation there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021107:Implantation [Therapeutic or Preventive Procedure]
   861   C0029976:Implantation [Organism Function]
   861   C3244302:Implantation [Functional Concept]

Phrase: "is"

Phrase: "accumulation of fluid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333229:Accumulation of fluid [Functional Concept]
           accumulation fluid

Phrase: "within the lumen"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0524461:Lumen [Body Space or Junction]
  1000   C1282864:Lumen [Body Space or Junction]
  1000   C1301906:Lumen [Qualitative Concept]
  1000   C1551056:Lumen [Quantitative Concept]
   928 E C0524462:Luminal [Spatial Concept]

Phrase: "of the chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "an ingrowth of granulation tissue."
Processing 00000000.tx.49: Second, there was potential for volumetric disturbances caused by injection of tracer or sampling of wound fluid to occur. 

Phrase: "Second, there"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0205436:Second [Quantitative Concept]
   861   C0457385:Second [Temporal Concept]
   861   C0565930:/second [Quantitative Concept]
   861   C1561503:second [Idea or Concept]
   861   C1705190:Second [Qualitative Concept]
   789 E C0027627:secondary [Neoplastic Process]
   789 E C0175668:Secondary [Temporal Concept]

Phrase: "was"

Phrase: "potential for volumetric disturbances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3245505:Potential [Qualitative Concept]

Phrase: "caused by injection of tracer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1522485:Tracer [Indicator, Reagent, or Diagnostic Aid]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "or"

Phrase: "sampling of wound fluid to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441621:Sampling [Diagnostic Procedure]
   760   C0870078:Sampling [Idea or Concept]

Phrase: "occur."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.50: By conducting the experiment 14days after implantation when the wound fluid volume was greatest and by limiting injection or sampling volumes to 10% or less of the wound fluid volume, we aimed to minimize the risk of such problems. 

Phrase: "By conducting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004927:conducting [Individual Behavior]

Phrase: "the experiment 14days after implantation"

Phrase: "when"

Phrase: "the wound fluid volume"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0449971:fluid volume [Quantitative Concept]
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "was"

Phrase: "greatest"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205393:Greatest [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]
   966 E C1704243:Great [Quantitative Concept]

Phrase: "and by limiting injection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021485:injection [Therapeutic or Preventive Procedure]
   770   C0439801:limiting [Functional Concept]
   770   C1272883:Injection [Biomedical or Dental Material]
   770   C1515981:And [Idea or Concept]
   770   C1533685:Injection [Therapeutic or Preventive Procedure]
   770   C1828121:Injection [Functional Concept]

Phrase: "or"

Phrase: "sampling volumes to 10%"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0449468:volumes [Quantitative Concept]
   737 E C1690016:% volume [Qualitative Concept]
   737 E C1705102:Volume [Intellectual Product]
   737 E C2700258:Volume [Laboratory Procedure]

Phrase: "or"

Phrase: "less of the wound fluid volume,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   790   C0449971:fluid volume [Quantitative Concept]
   753   C0005889:FLUID [Body Substance]
   753   C0043250:Wound [Injury or Poisoning]
   753   C0302908:fluid [Substance]
   753   C0439092:less [Intellectual Product]
   753   C0444611:Fluid [Qualitative Concept]
   753   C0449468:*Volume [Quantitative Concept]
   753   C0547044:Less [Qualitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1704353:Fluid [Substance]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]
   719 E C0016204:Wind NOS [Sign or Symptom]
   719 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "we"

Phrase: "aimed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1947946:Aim [Idea or Concept]
   966   C2948600:Aim [Pharmacologic Substance]
   966   C3540471:AIM [Gene or Genome]
   966   C3540472:AIM [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "the risk of such problems."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.51: Finally, the presence of a large and well-perfused vascular structure at this time facilitated the measurement of clearance rates. 

Phrase: "Finally,"

Phrase: "the presence of a large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "well-perfused vascular structure at this time"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0005847:Vascular structure [Body Part, Organ, or Organ Component]
   748   C0678594:Structure [Spatial Concept]

Phrase: "facilitated"

Phrase: "the measurement of clearance rates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0201789:Clearance rate measurement [Laboratory Procedure]
   781   C0201785:Rate measurement [Laboratory Procedure]
   760   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.52: Fourteen days after implantation each rat was weighed and anesthetized with Inactin (60mg/kg ip). 

Phrase: "Fourteen days after implantation"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "each rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "was"

Phrase: "weighed"

Phrase: "and"

Phrase: "anesthetized with Inactin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0123451:Inactin [Organic Chemical]
   790   C1720436:Anesthetized [Finding]

Phrase: "(60mg/kg ip"

Phrase: ")."
Processing 00000000.tx.53: Body temperature was maintained with a heating-pad set so that core body temperature was maintained at 37C. 

Phrase: "Body temperature"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0005903:Body Temperature [Organism Attribute]
           temperature
   861   C0039476:*Temperature [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   777 E C1995017:Bodies [Cell Component]

Phrase: "was"

Phrase: "maintained with a heating-pad"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0181154:heating pad [Medical Device]
   760   C0018851:Heating [Environmental Effect of Humans]
   760   C0182158:pad [Medical Device]
   760   C0332568:Pad [Neoplastic Process]
   760   C1314677:Maintained [Functional Concept]
   760   C3540603:PAD [Gene or Genome]
   726 E C0018837:Heat [Natural Phenomenon or Process]
   726 E C0024501:Maintain [Activity]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that core body temperature"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0456240:Core body temperature [Finding]
   901   C0005903:Body Temperature [Organism Attribute]
           temperature
   827   C0039476:*Temperature [Quantitative Concept]
   827   C0242821:body [Human]
   827   C0444669:Core [Spatial Concept]
   827   C0460148:Body [Anatomical Structure]
   827   C1167518:core [Cell Component]
   827   C1268086:Body [Anatomical Structure]
   827   C1706352:Core [Medical Device]
   827   C1882467:Core [Manufactured Object]
   827   C3274653:Core [Body Substance]
   743 E C1995017:Bodies [Cell Component]

Phrase: "was"

Phrase: "maintained at 37C."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]
Processing 00000000.tx.54: An incision was made through the skin overlying the right jugular vein, and a catheter was aseptically introduced. 

Phrase: "An incision"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0184898:Incision [Therapeutic or Preventive Procedure]
  1000   C2338258:Incision [Body Location or Region]

Phrase: "was"

Phrase: "made through the skin"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0444099:Skin [Body Substance]
   770   C1123023:Skin [Body System]
   770   C1278993:Skin [Body System]
   737   C1881534:Make [Functional Concept]
   715 E C0221912:Cutaneous [Spatial Concept]
   715 E C0221928:Dermal [Qualitative Concept]
   715 E C1522447:Cutaneous [Functional Concept]

Phrase: "overlying"

Phrase: "the right jugular vein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0022427:Jugular vein [Body Part, Organ, or Organ Component]
   901   C1280188:Jugular vein [Body Part, Organ, or Organ Component]
   827   C0042449:Vein [Body Part, Organ, or Organ Component]
   827   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "a catheter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085590:Catheter [Medical Device]
  1000   C1704454:Catheter [Medical Device]

Phrase: "was"

Phrase: "aseptically"

Phrase: "introduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]
Processing 00000000.tx.55: The catheter was immediately flushed with 100l of 0.15M saline containing 10IU/ml heparin. 

Phrase: "The catheter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085590:Catheter [Medical Device]
  1000   C1704454:Catheter [Medical Device]

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "flushed with 100l of 0.15M saline containing 10IU/ml heparin."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   738   C0016382:flushed [Sign or Symptom]
   738   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   738   C0036082:Saline [Substance]
   738   C0332256:Containing [Functional Concept]
   738   C0439526:/mL [Quantitative Concept]
   738   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   738   C1442447:15M [Temporal Concept]
   738   C2700400:Containing [Activity]
   704 E C1696091:Flush [Functional Concept]
Processing 00000000.tx.56: To prevent respiratory problems, a tracheostomy tube was inserted to allow aspiration of secretions. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "respiratory problems,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1659989:Respiratory problems [Sign or Symptom]
   861   C1546466:Problems [Idea or Concept]
   827 E C0033213:Problem [Finding]

Phrase: "a tracheostomy tube"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0184159:Tracheostomy tube [Medical Device]
   861   C0040590:Tracheostomy [Therapeutic or Preventive Procedure]
   861   C0175730:Tube [Medical Device]
   861   C1547937:Tube NOS [Intellectual Product]
   861   C1561954:tube [Conceptual Entity]
   861   C1700189:tracheostomy [Functional Concept]
   861   C1704730:TUBE [Medical Device]
   861   C1875833:TRACHEOSTOMY [Medical Device]

Phrase: "was"

Phrase: "inserted"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441587:Inserted [Health Care Activity]
   966 E C1743766:Insert [Medical Device]
   966 E C1883719:Insert [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "aspiration of secretions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0220787:Aspiration [Health Care Activity]
   790   C0349707:Aspiration [Therapeutic or Preventive Procedure]
   790   C0700198:Aspiration [Pathologic Function]
   790   C2827071:Aspiration [Finding]
Processing 00000000.tx.57: The bladder was catheterized to collect urine, and all incisions were sutured after placement of the catheters to prevent loss of body fluids. 

Phrase: "The bladder"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0005682:Bladder [Body Part, Organ, or Organ Component]
  1000   C1281573:Bladder [Body Part, Organ, or Organ Component]
  1000   C1511200:Bladder [Tissue]
   944 E C0205058:Vesical [Spatial Concept]

Phrase: "was"

Phrase: "catheterized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007430:catheterized [Therapeutic or Preventive Procedure]
  1000   C1548727:Catheterized [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "collect"

Phrase: "urine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "and"

Phrase: "all incisions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0184898:Incisions [Therapeutic or Preventive Procedure]
   966 E C2338258:Incision [Body Location or Region]

Phrase: "were"

Phrase: "sutured after placement of the catheters to"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   793   C0883301:Placement of catheter [Therapeutic or Preventive Procedure]
           catheter placement
   748   C0085590:Catheters [Medical Device]
   748   C0205368:Sutured [Functional Concept]
   748   C0441587:Placement [Health Care Activity]
   748   C1524072:Placement [Qualitative Concept]
   748   C1705834:Sutured [Manufactured Object]
   714 E C0009068:Suture, NOS [Therapeutic or Preventive Procedure]
   714 E C0038969:Suture [Medical Device]
   714 E C0502420:Suture [Body Space or Junction]
   714 E C1704454:Catheter [Medical Device]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "loss of body fluids."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C0235395:LOSS OF FLUIDS [Pathologic Function]
           Fluid loss
   770   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.58: The hair overlying the chamber was clipped, and the skin was disinfected with 70% ethanol. 

Phrase: "The hair"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0018494:Hair [Body Part, Organ, or Organ Component]
  1000   C0444095:Hair [Body Part, Organ, or Organ Component]
   944 E C1539087:PILAR [Gene or Genome]
   928 E C0221958:Hairy [Functional Concept]
   907 E C0031921:pili [Cell Component]
   900 E C0019572:HAIRINESS [Finding]
   900 E C0020555:Hairiness [Disease or Syndrome]

Phrase: "overlying"

Phrase: "the chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "clipped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0175722:Clip [Medical Device]
   966   C1705205:Clip [Medical Device]

Phrase: ","

Phrase: "and"

Phrase: "the skin"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0444099:Skin [Body Substance]
  1000   C1123023:Skin [Body System]
  1000   C1278993:Skin [Body System]
   944 E C0221912:Cutaneous [Spatial Concept]
   944 E C0221928:Dermal [Qualitative Concept]
   944 E C1522447:Cutaneous [Functional Concept]
   877 E C0011646:Dermis [Tissue]

Phrase: "was"

Phrase: "disinfected with 70% ethanol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1381542:70% Ethanol [Clinical Drug]
   770   C0001962:Ethanol [Organic Chemical]
Processing 00000000.tx.59: A sterile 23-gauge needle was inserted percutaneously so that the tip of the needle was approximately in the center of the lumen of the chamber. 

Phrase: "A sterile 23-gauge needle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0027551:Needle [Medical Device]
   812   C1704318:Needle [Medical Device]
   812   C1882041:Needle [Spatial Concept]

Phrase: "was"

Phrase: "inserted"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441587:Inserted [Health Care Activity]
   966 E C1743766:Insert [Medical Device]
   966 E C1883719:Insert [Functional Concept]

Phrase: "percutaneously so"

Phrase: "that"

Phrase: "the tip of the needle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1710425:Tip [Medical Device]
   760   C3282898:Tip [Qualitative Concept]

Phrase: "was"

Phrase: "approximately in the center of the lumen of the chamber."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0205099:Center [Spatial Concept]
   739   C0332232:Approximately [Qualitative Concept]
   739   C0524461:Lumen [Body Space or Junction]
   739   C0935616:Chamber [Body Part, Organ, or Organ Component]
   739   C1282864:Lumen [Body Space or Junction]
   739   C1301906:Lumen [Qualitative Concept]
   739   C1551056:Lumen [Quantitative Concept]
Processing 00000000.tx.60: A microsyringe was then attached to the needle with a short catheter to allow injection of the radiolabeled analogs and subsampling of the wound fluid within the chamber. 

Phrase: "A microsyringe"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "attached to the needle"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0027551:Needle [Medical Device]
   770   C0231441:Attached [Finding]
   770   C1704318:Needle [Medical Device]
   770   C1882041:Needle [Spatial Concept]
   737 E C1314972:ATTACH [Intellectual Product]

Phrase: "with a short catheter to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085590:Catheter [Medical Device]
   827   C1704454:Catheter [Medical Device]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "injection of the radiolabeled analogs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]

Phrase: "and"

Phrase: "subsampling of the wound fluid"

Phrase: "within the chamber."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]
Processing 00000000.tx.61: After placement of the catheters, the rats were allowed to stabilize for 20-30 min. 

Phrase: "After placement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441587:Placement [Health Care Activity]
  1000   C1524072:Placement [Qualitative Concept]

Phrase: "of the catheters,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085590:Catheters [Medical Device]
   966 E C1704454:Catheter [Medical Device]

Phrase: "the rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stabilize for 20-30 min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0456693:/30 min [Temporal Concept]
   806   C1442458:30 min [Temporal Concept]
   760   C0184512:stabilize [Qualitative Concept]
   760   C0702093:/min [Temporal Concept]
Processing 00000000.tx.62: Experiment 1: clearance of radiolabeled IGF-I or 125I from wound fluid. 

Phrase: "Experiment 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ":"

Phrase: "clearance of radiolabeled IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0449297:Clearance [Qualitative Concept]
   744   C1382187:Clearance [Clinical Attribute]
   744   C2825073:Clearance [Natural Phenomenon or Process]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "or"

Phrase: "125I from wound fluid."
Processing 00000000.tx.63: An initial experiment was performed to gain an estimate of the rate at which 125I-IGF-I (n=9rats) or 125I (n=3rats) was eliminated from wound fluid. 

Phrase: "An initial experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "an estimate of the rate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0750572:Estimate [Quantitative Concept]

Phrase: "at which 125I-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(n=9rats"

Phrase: ")"

Phrase: "or"

Phrase: "125I"

Phrase: "(n=3rats"

Phrase: ")"

Phrase: "was"

Phrase: "eliminated from wound fluid."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C0849355:Eliminated [Qualitative Concept]
   770   C1704353:Fluid [Substance]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]
Processing 00000000.tx.64: Preliminary results had indicated that a sampling duration of 6h was required to observe a reasonable decline in the amount of labeled IGF-I remaining in the chamber. 

Phrase: "Preliminary results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1548161:Preliminary results [Idea or Concept]
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "had"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "a sampling duration of 6h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449238:Duration [Temporal Concept]
   760   C2926735:Duration [Pharmacologic Substance]

Phrase: "was"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "observe"

Phrase: "a reasonable decline in the amount"

Phrase: "of labeled IGF-I remaining"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C1527428:Remaining [Qualitative Concept]
   747   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "in the chamber."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]
Processing 00000000.tx.65: Given the long duration of anesthesia and the potential for hemodynamic changes to occur, the packed cell volumes of the IGF-I injected rats were monitored throughout the experiment. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the long duration of anesthesia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0439591:Long duration [Qualitative Concept]
   760   C0449238:Duration [Temporal Concept]
   760   C2926735:Duration [Pharmacologic Substance]

Phrase: "and"

Phrase: "the potential for hemodynamic changes to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "the packed cell volumes"
Meta Candidates (Total=15; Excluded=6; Pruned=0; Remaining=9)
   966   C0018935:Packed cell volume [Laboratory Procedure]
   966   C1318015:Packed cell volume [Laboratory or Test Result]
   901   C0596292:Volumes, Cell [Organism Attribute,Quantitative Concept]
   827   C0007634:Cell [Cell]
   827   C0184967:Packed [Therapeutic or Preventive Procedure]
   827   C0449468:volumes [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1690016:% volume [Qualitative Concept]
   793 E C1705102:Volume [Intellectual Product]
   793 E C1968515:Pack [Medical Device]
   793 E C2700258:Volume [Laboratory Procedure]
   793 E C2825051:Pack [Drug Delivery Device]
   793 E C2828395:Pack [Activity]

Phrase: "of the IGF-I injected rats"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]
   747   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "were"

Phrase: "monitored throughout the experiment."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0681814:Experiment [Research Activity]
   770   C1706386:Experiment [Conceptual Entity]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.66: In this experiment, we found that the hematocrit declined marginally from a mean of 42.1% at the start of the experiment to 41.7% at 6h. 

Phrase: "In this experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the hematocrit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018935:Haematocrit [Laboratory Procedure]
  1000   C0518014:Haematocrit [Laboratory or Test Result]

Phrase: "declined"

Phrase: "marginally from a mean of 42.1%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0444504:Mean [Quantitative Concept]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]

Phrase: "at the start"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Start [Temporal Concept]

Phrase: "of the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "to 41.7%"

Phrase: "at 6h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]
Processing 00000000.tx.67: The body weights of the rats declined by an average of 4.5g or 1.3% of initial body weight. 

Phrase: "The body weights of the rats"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0005910:Weights, Body [Organism Attribute]
       E   weight
   790   C1305866:body weights [Diagnostic Procedure]
       E   weight
   753   C0043100:Weights [Quantitative Concept]
   753   C0242821:body [Human]
   753   C0460148:Body [Anatomical Structure]
   753   C1268086:Body [Anatomical Structure]
   719 E C1705104:Weight [Idea or Concept]

Phrase: "declined by an average of 4.5g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1510992:Average [Quantitative Concept]
   748   C2825518:AVERAGE [Quantitative Concept]

Phrase: "or"

Phrase: "1.3% of initial body weight."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0005910:Body Weight [Organism Attribute]
           weight
   790   C1305866:body weight [Diagnostic Procedure]
           weight
   753   C0043100:Weight [Quantitative Concept]
   753   C0205265:Initial [Temporal Concept]
   753   C0242821:body [Human]
   753   C0460148:Body [Anatomical Structure]
   753   C1268086:Body [Anatomical Structure]
   753   C1279901:Initial [Qualitative Concept]
   753   C1555582:Initial [Idea or Concept]
   753   C1705104:Weight [Idea or Concept]
   753   C1705685:INITIAL [Functional Concept]
   753   C2827734:1+ [Quantitative Concept]
   753   C2981698:1+ [Classification]
Processing 00000000.tx.68: Samples of blood (90l) and wound fluid (19l) were first withdrawn and heparinized to a final concentration of 10IU/ml and then were stored on ice, before 0.35ml of 10mg/ml Evans Blue dye in 0.15M NaCl was injected into the jugular catheter. 

Phrase: "Samples of blood"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0178913:blood samples [Body Substance]
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "(90l"

Phrase: ")"

Phrase: "and"

Phrase: "wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "(19l"

Phrase: ")"

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "withdrawn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0424092:Withdrawn [Finding]
  1000   C2349954:Withdrawn [Activity]
  1000   C2825032:Withdrawn [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "heparinized to a final concentration of 10IU/ml"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0086045:Concentration [Mental Process]
   744   C0205088:Final [Temporal Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1546485:Final [Idea or Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "were"

Phrase: "stored on ice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   756   C1698986:Store [Functional Concept]

Phrase: "before"

Phrase: "0.35ml of 10mg/ml Evans Blue dye"

Phrase: "in 0.15M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "was"

Phrase: "injected into the jugular catheter."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0085590:Catheter [Medical Device]
   760   C1704454:Catheter [Medical Device]
   726   C1720154:Inject [Functional Concept]
Processing 00000000.tx.69: The catheter was washed by several flushings of jugular blood plus a final flush with 100l of heparinized saline. 

Phrase: "The catheter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085590:Catheter [Medical Device]
  1000   C1704454:Catheter [Medical Device]

Phrase: "was"

Phrase: "washed by several flushings of jugular blood"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0016382:Flushings [Sign or Symptom]
   748   C0229664:Blood [Body Substance]
   748   C1548982:Washed [Idea or Concept]
   714 E C0441648:Wash [Activity]
   714 E C1962957:Flushing [Finding]

Phrase: "plus a final flush"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016382:Flush [Sign or Symptom]
   861   C1696091:Flush [Functional Concept]

Phrase: "with 100l"

Phrase: "of heparinized saline."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036082:Saline [Substance]
Processing 00000000.tx.70: Ten minutes after injection of the Evans Blue dye, a second subsample of blood (170l) was withdrawn. 

Phrase: "Ten minutes after injection of the Evans Blue dye,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0439232:minute [Temporal Concept]
   742   C0700321:minute [Quantitative Concept]
   742   C0702093:/minute [Temporal Concept]
   742   C1282918:Minute [Quantitative Concept]
   742   C2347166:Minute [Quantitative Concept]

Phrase: "a second subsample of blood"

Phrase: "(170l"

Phrase: ")"

Phrase: "was"

Phrase: "withdrawn."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0424092:Withdrawn [Finding]
  1000   C2349954:Withdrawn [Activity]
  1000   C2825032:Withdrawn [Mental or Behavioral Dysfunction]
Processing 00000000.tx.71: Additional samples of 40,170,40,200,140,140,140,140,and 140l were similarly withdrawn at 20,30,40,60,120,180,240,300,and 360min, respectively. 

Phrase: "Additional samples of 40,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "170,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "200,"

Phrase: "140,"

Phrase: "140,"

Phrase: "140,"

Phrase: "140,"

Phrase: "and"

Phrase: "140l"

Phrase: "were"

Phrase: "similarly"

Phrase: "withdrawn at 20,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0424092:Withdrawn [Finding]
   790   C2349954:Withdrawn [Activity]
   790   C2825032:Withdrawn [Mental or Behavioral Dysfunction]

Phrase: "30,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "60,"

Phrase: "120,"

Phrase: "180,"

Phrase: "240,"

Phrase: "300,"

Phrase: "and"

Phrase: "360min,"

Phrase: "respectively."
Processing 00000000.tx.72: All samples were heparinized (10IU/ml) and with the exception of the 20-and 40-min samples were treated as follows. 

Phrase: "All samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "heparinized"

Phrase: "(10IU/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "and with the exception of the 20-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1515981:And [Idea or Concept]
   748   C1554961:exception [Idea or Concept]
   748   C1705847:Exception [Conceptual Entity]

Phrase: "and"

Phrase: "40-min samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.73: Triplicate subsamples of 40l were added to tubes containing ice-chilled 10% (wt/vol) TCA, vortexed, and left on ice. 

Phrase: "Triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "subsamples of 40l"

Phrase: "were"

Phrase: "added to tubes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0175730:tubes [Medical Device]
   790   C1524062:Added [Functional Concept]
   790   C1547937:Tubes [Intellectual Product]
   790   C1704474:Tubes [Quantitative Concept]
   756 E C1561954:tube [Conceptual Entity]
   756 E C1704730:TUBE [Medical Device]
   756 E C1883712:Add [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "ice-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "chilled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0085593:Chill [Sign or Symptom]

Phrase: "10%"

Phrase: "(wt/vol) TCA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041405:TCA [Geographic Area]
   827   C0085758:TCA [Congenital Abnormality]
   827   C1415587:TCA [Gene or Genome]
   827   C3536819:TCA [Pharmacologic Substance]

Phrase: "vortexed,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439648:vortexed [Spatial Concept]
  1000   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   966 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "and"

Phrase: "left on ice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020746:Ice [Inorganic Chemical]
   790   C0205091:Left [Spatial Concept]
   790   C1552822:left [Functional Concept]
Processing 00000000.tx.74: The remainder of the blood from the first hour of sampling, including the 20-and 40-min samples, was left at 4C before measurement of the Evans Blue concentration. 

Phrase: "The remainder of the blood"

Phrase: "from the first hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "of sampling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441621:Sampling [Diagnostic Procedure]
  1000   C0870078:Sampling [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the 20-"

Phrase: "and"

Phrase: "40-min samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "left at 4C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205091:Left [Spatial Concept]
   790   C0450376:4c [Intellectual Product]
   790   C1552822:left [Functional Concept]

Phrase: "before measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "of the Evans Blue concentration."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0015205:Evan's Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.75: Any surplus blood from the 120-to 360-min samples inclusive was returned to the rat. 

Phrase: "Any surplus blood from the 120-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0229664:Blood [Body Substance]

Phrase: "to 360-min samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "inclusive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332257:Inclusive [Functional Concept]

Phrase: "was"

Phrase: "returned to the rat."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C0332156:Return to [Qualitative Concept]
           Return
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
Processing 00000000.tx.76: The hematocrit was estimated from the 0-,60-,180-,and 360-min blood samples. 

Phrase: "The hematocrit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018935:Haematocrit [Laboratory Procedure]
  1000   C0518014:Haematocrit [Laboratory or Test Result]

Phrase: "was"

Phrase: "estimated from the 0-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750572:Estimated [Quantitative Concept]

Phrase: "60-,"

Phrase: "180-,"

Phrase: "and"

Phrase: "360-min blood samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0178913:blood samples [Body Substance]
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.77: Immediately after the injection of the dye into the jugular vein, a bolus of 107 counts/min of 125I-IGF-I (40-70 ng of peptide) or 125I and 25l of Evans Blue dye (30mg/ml in 0.15M saline) was injected into the lumen of the chamber. 

Phrase: "Immediately after the injection of the dye"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C0205548:Immediately [Temporal Concept]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1828121:Injection [Functional Concept]

Phrase: "into the jugular vein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022427:Jugular vein [Body Part, Organ, or Organ Component]
  1000   C1280188:Jugular vein [Body Part, Organ, or Organ Component]
   861   C0042449:Vein [Body Part, Organ, or Organ Component]
   861   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "a bolus of 107 counts/min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511237:Bolus [Therapeutic or Preventive Procedure]

Phrase: "of 125I-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(40-70 ng of peptide"

Phrase: ")"

Phrase: "or"

Phrase: "125I"

Phrase: "and"

Phrase: "25l of Evans Blue dye"

Phrase: "(30mg/ml in 0.15M saline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "injected into the lumen of the chamber."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0524461:Lumen [Body Space or Junction]
   748   C0935616:Chamber [Body Part, Organ, or Organ Component]
   748   C1282864:Lumen [Body Space or Junction]
   748   C1301906:Lumen [Qualitative Concept]
   748   C1551056:Lumen [Quantitative Concept]
   714   C1720154:Inject [Functional Concept]
Processing 00000000.tx.78: To ensure a rapid and even distribution of the radiolabel and marker dye within the chamber, the microsyringe was flushed repetitively with wound fluid. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "a rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "even distribution of the radiolabel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "marker dye within the chamber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "the microsyringe"

Phrase: "was"

Phrase: "flushed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016382:flushed [Sign or Symptom]
   966 E C1696091:Flush [Functional Concept]

Phrase: "repetitively with wound fluid."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C1704353:Fluid [Substance]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]
Processing 00000000.tx.79: Subsampling of wound fluid occurred at the same intervals as those for blood but with volumes of 27,19,27,19,and 27l taken at the 10-,20-,30-,40-,and 60-min times, respectively. 

Phrase: "Subsampling of wound fluid"

Phrase: "occurred at the same intervals"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0445247:Same [Qualitative Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C1709305:Occurred [Activity]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "as those for blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "but with volumes of 27,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0449468:volumes [Quantitative Concept]
   726 E C1690016:% volume [Qualitative Concept]
   726 E C1705102:Volume [Intellectual Product]
   726 E C2700258:Volume [Laboratory Procedure]

Phrase: "19,"

Phrase: "27,"

Phrase: "19,"

Phrase: "and"

Phrase: "27l"

Phrase: "taken at the 10-,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1883727:Taken [Conceptual Entity]
   737 E C1515187:Take [Health Care Activity]

Phrase: "20-,"

Phrase: "30-,"

Phrase: "40-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "60-min times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "respectively."
Processing 00000000.tx.80: Thereafter, 7.5l were sampled at each time point. 

Phrase: "Thereafter,"

Phrase: "7.5l"

Phrase: "were"

Phrase: "sampled at each time point."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0441621:sampled [Diagnostic Procedure]
   760   C0870078:sampled [Idea or Concept]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   760   C3541383:Time [Temporal Concept]
   726 E C0370003:Sample [Substance]
   726 E C2347026:Sample [Conceptual Entity]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.81: The samples were also heparinized and triplicate subsamples of 2.5l were immediately added to 10% (wt/vol) TCA, vortexed, and left on ice. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "also"

Phrase: "heparinized"

Phrase: "and"

Phrase: "triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "subsamples of 2.5l"

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "added to 10%"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "(wt/vol) TCA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041405:TCA [Geographic Area]
   827   C0085758:TCA [Congenital Abnormality]
   827   C1415587:TCA [Gene or Genome]
   827   C3536819:TCA [Pharmacologic Substance]

Phrase: "vortexed,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439648:vortexed [Spatial Concept]
  1000   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   966 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "and"

Phrase: "left on ice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020746:Ice [Inorganic Chemical]
   790   C0205091:Left [Spatial Concept]
   790   C1552822:left [Functional Concept]
Processing 00000000.tx.82: Together with the 20-and 40-min samples, the remaining wound fluid of the samples from the first hour was left at 4C for measurement of the Evans Blue concentration. 

Phrase: "Together with the 20-"

Phrase: "and"

Phrase: "40-min samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "the remaining wound fluid of the samples"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   788   C0444182:Wound fluid sample [Body Substance]
   757   C0438734:Fluid sample [Body Substance]
   748   C0005889:FLUID [Body Substance]
   748   C0043250:Wound [Injury or Poisoning]
   748   C0302908:fluid [Substance]
   748   C0444611:Fluid [Qualitative Concept]
   748   C1704353:Fluid [Substance]
   714 E C0016204:Wind NOS [Sign or Symptom]
   714 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "from the first hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "was"

Phrase: "left at 4C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205091:Left [Spatial Concept]
   790   C0450376:4c [Intellectual Product]
   790   C1552822:left [Functional Concept]

Phrase: "for measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "of the Evans Blue concentration."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0015205:Evan's Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.83: Excretion of the radiolabeled tracer into urine was monitored by collecting urine hourly for the duration of the experiment. 

Phrase: "Excretion of the radiolabeled tracer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0221102:Excretion [Physiologic Function]
   760   C0504085:Excretion [Body Substance]
   760   C2699704:EXCRETION [Regulation or Law]

Phrase: "into urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "was"

Phrase: "monitored by collecting urine hourly"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0042036:Urine [Body Substance]
   760   C0042037:urine [Functional Concept]
   760   C0558292:Hourly [Temporal Concept]
   760   C1516698:Collecting [Functional Concept]
   760   C2963137:Urine [Body Substance]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1704646:Monitor [Manufactured Object]

Phrase: "for the duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]

Phrase: "of the experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.84: An equivalent volume of Hartmann's saline containing 10% (wt/vol) glucose was injected intravenously to help maintain intravascular volume. 

Phrase: "An equivalent volume of Hartmann's saline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0449468:*Volume [Quantitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10%"

Phrase: "(wt/vol) glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravenously to"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "intravascular volume."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0442123:Intravascular [Spatial Concept]
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]
   861   C2960476:Intravascular [Functional Concept]
Processing 00000000.tx.85: Triplicate subsamples (50l) of the hourly urine collections were added to 10% (wt/vol) TCA, vortexed, and left on ice. 

Phrase: "Triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "subsamples"

Phrase: "(50l"

Phrase: ")"

Phrase: "of the hourly urine collections"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0200354:Urine Collection [Laboratory Procedure]
   827   C0600644:Collections [Intellectual Product]
   827   C1516698:Collection [Functional Concept]
   827   C1704814:Collection [Idea or Concept]
   743 E C1516695:Collected [Idea or Concept]

Phrase: "were"

Phrase: "added to 10%"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "(wt/vol) TCA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041405:TCA [Geographic Area]
   827   C0085758:TCA [Congenital Abnormality]
   827   C1415587:TCA [Gene or Genome]
   827   C3536819:TCA [Pharmacologic Substance]

Phrase: "vortexed,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439648:vortexed [Spatial Concept]
  1000   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   966 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "and"

Phrase: "left on ice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020746:Ice [Inorganic Chemical]
   790   C0205091:Left [Spatial Concept]
   790   C1552822:left [Functional Concept]
Processing 00000000.tx.86: The blood, wound fluid, and urine samples treated with TCA were kept on ice for at least 30min and centrifuged, and the radioactivity in the TCA-soluble and TCA-insoluble fractions was measured. 

Phrase: "The blood,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "wound fluid,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "and"

Phrase: "urine samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444180:Urine sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "treated with TCA"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0041405:TCA [Geographic Area]
   790   C0085758:TCA [Congenital Abnormality]
   790   C1415587:TCA [Gene or Genome]
   790   C1522326:Treated [Functional Concept]
   790   C3536819:TCA [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "were"

Phrase: "kept on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   756   C0333118:Keep [Functional Concept]

Phrase: "for"

Phrase: "at least 30min"

Phrase: "and"

Phrase: "centrifuged,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "and"

Phrase: "the radioactivity in the TCA-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "TCA-insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.87: At the completion of the experiment, the anesthetized rat was killed and weighed. 

Phrase: "At the completion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205197:Completion [Qualitative Concept]
  1000   C1554962:completion [Qualitative Concept]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "the anesthetized rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]

Phrase: "was"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "weighed."
Processing 00000000.tx.88: The volume of wound fluid remaining in the chamber was measured after aspiration and used to calculate the total amount of radioactivity remaining. 

Phrase: "The volume of wound fluid remaining"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0449971:fluid volume [Quantitative Concept]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: "in the chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "measured after aspiration"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0220787:Aspiration [Health Care Activity]
   790   C0349707:Aspiration [Therapeutic or Preventive Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C0700198:Aspiration [Pathologic Function]
   790   C2827071:Aspiration [Finding]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "the total amount of radioactivity remaining."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.89: Experiment 2: comparison of the rates of clearance of IGF-I, IGF-II, LR3-IGF-I, and insulin from wound fluid. 

Phrase: "Experiment 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ":"

Phrase: "comparison of the rates of clearance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "of IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "IGF-II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "LR3-IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin from wound fluid."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.90: The injection and sampling procedures of experiment 1were utilized in a second experiment in which the rate of elimination of labeled IGF-I from wound fluid was compared with rates of IGF-II, LR3-IGF-I, or insulin (n=8rats/treatment). 

Phrase: "The injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "and"

Phrase: "sampling procedures of experiment 1were"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0025664:procedures [Intellectual Product]
   760   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C2700391:procedures [Activity]
   726 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   726 E C3274430:PROCEDURE [Health Care Activity]
   726 E C3538935:Procedure [Idea or Concept]
   726 E C3539779:Procedure [Intellectual Product]

Phrase: "utilized in a second experiment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C0681814:Experiment [Research Activity]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]
   760   C1706386:Experiment [Conceptual Entity]

Phrase: "in which"

Phrase: "the rate of elimination of labeled IGF-I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0449249:Growth rate [Temporal Concept]
   738   C0871208:Rate [Activity]
   738   C1521828:Rate [Quantitative Concept]

Phrase: "from wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "compared with rates of IGF-II,"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   849   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   818   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   818   C1753359:insulin-like growth factor [Molecular Function]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C0200396:Factor II [Laboratory Procedure]
   764   C1414504:FACTOR II [Gene or Genome]
   762   C0449249:growth rates [Temporal Concept]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0220844:growth [Physiologic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1707455:Compared [Activity]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   734   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   708   C0871208:Rate [Activity]
   708   C1521828:Rate [Quantitative Concept]

Phrase: "LR3-IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(n=8rats/treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: ")."
Processing 00000000.tx.91: In addition, after each rat was killed and weighed, the wound fluid was aspirated, and the chamber and tissue immediately surrounding the chamber were removed by dissection and added to 25ml of 0.5M NaOH. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "after"

Phrase: "each rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "was"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "weighed,"

Phrase: "the wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "aspirated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0700198:Aspirated [Pathologic Function]
   966 E C0370199:Aspirate [Body Substance]

Phrase: ","

Phrase: "and"

Phrase: "the chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "tissue immediately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed by dissection"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0012737:Dissection [Therapeutic or Preventive Procedure]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "added to 25ml of 0.5M NaOH."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1524062:Added [Functional Concept]
   714 E C1883712:Add [Functional Concept]
Processing 00000000.tx.92: The rat carcass was homogenized in 0.5M NaOH and digested at room temperature. 

Phrase: "The rat carcass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0229961:Carcass [Fully Formed Anatomical Structure]

Phrase: "was"

Phrase: "homogenized in 0.5M NaOH"

Phrase: "and"

Phrase: "digested at room temperature."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0868946:digested [Physiologic Function]
   770   C1547703:Room [Spatial Concept]
Processing 00000000.tx.93: Radioactivity was measured in the tissue or carcass extracts after digestion. 

Phrase: "Radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "measured in the tissue"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0040300:Tissue [Tissue]
   770   C0444706:Measured [Qualitative Concept]
   770   C1547928:Tissue [Intellectual Product]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "or"

Phrase: "carcass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0229961:Carcass [Fully Formed Anatomical Structure]

Phrase: "extracts after digestion."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0012238:Digestion [Organism Function]
   790   C2349986:Digestion [Research Activity]
   790   C2828366:Extract [Substance]
   734 E C0443277:Peptic [Functional Concept]
Processing 00000000.tx.94: Measurement of blood and wound fluid volumes. 

Phrase: "Measurement of blood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0242485:Measurement [Functional Concept]

Phrase: "and"

Phrase: "wound fluid volumes."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   867   C0449971:fluid volume [Quantitative Concept]
   827   C0449468:volumes [Quantitative Concept]
   793 E C1690016:% volume [Qualitative Concept]
   793 E C1705102:Volume [Intellectual Product]
   793 E C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.95: To estimate the total blood or wound fluid volume, a dye marker dilution technique (22) was modified for use with a microplate reader. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "the total blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "or"

Phrase: "wound fluid volume,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0449971:fluid volume [Quantitative Concept]
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "a dye marker dilution technique"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C0013341:Dye Dilution Technique [Diagnostic Procedure]
   861   C0079240:Dilution technique [Laboratory Procedure]
           Dilution
   812   C0449851:Technique [Functional Concept]
   812   C1948037:Dilution [Functional Concept]
   729 E C0025664:techniques [Intellectual Product]

Phrase: "(22"

Phrase: ")"

Phrase: "was"

Phrase: "modified for use"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0042153:use [Functional Concept]
   790   C0392747:Modified [Functional Concept]
   790   C0457083:Use [Functional Concept]
   790   C1947944:Use [Intellectual Product]

Phrase: "with a microplate reader."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182258:Microplate Reader [Medical Device]
   861   C1514743:Reader [Professional or Occupational Group]
   861   C1706461:Reader [Manufactured Object]
Processing 00000000.tx.96: Samples of plasma or wound fluid collected during the first hour after injection of the respective dye solutions were centrifuged at 10,000g and 4C for 10min to sediment cells and cellular debris. 

Phrase: "Samples of plasma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   841   C0444263:Plasma sample [Body Substance]
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "or"

Phrase: "wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "collected during the first hour"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205435:First [Quantitative Concept]
   760   C0439227:Hour [Temporal Concept]
   760   C0564385:/hour [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]

Phrase: "after injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of the respective dye solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "centrifuged at 10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g"

Phrase: "and"

Phrase: "4C for 10min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0450376:4c [Intellectual Product]

Phrase: "to sediment cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cellular debris."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0440266:Debris [Substance]
Processing 00000000.tx.97: Supernatant samples of 5l were diluted in 95l of 0.15M NaCl, the absorbances were measured at 600nm, and the dye concentrations were obtained by reference to a standard curve. 

Phrase: "Supernatant samples of 5l"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "diluted in 95l of 0.15M NaCl,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C1442447:15M [Temporal Concept]
   748   C1959973:% NaCl [Quantitative Concept]
   714   C1720119:Dilute [Functional Concept]
   714   C1948037:Dilute [Functional Concept]

Phrase: "the absorbances"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1268822:Absorbance [Clinical Attribute]
   966   C2825050:Absorbance [Phenomenon or Process]

Phrase: "were"

Phrase: "measured at 600nm,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "the dye concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "obtained by reference"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C1301820:Obtained [Functional Concept]
   790   C1514811:Reference [Idea or Concept]
   790   C1706462:Reference [Conceptual Entity]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "to a standard curve."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]
Processing 00000000.tx.98: The dye concentration at time 0(t0) was extrapolated, and fluid volumes were calculated according to the formula: volume (ml)=(mg of dye injected)/(dye concentration at t0 in mg/ml). 

Phrase: "The dye concentration at time 0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "(t0)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475371:T0 [Finding]

Phrase: "was"

Phrase: "extrapolated"

Phrase: ","

Phrase: "and"

Phrase: "fluid volumes"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0449971:fluid volume [Quantitative Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C0449468:volumes [Quantitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C1690016:% volume [Qualitative Concept]
   827 E C1705102:Volume [Intellectual Product]
   827 E C2700258:Volume [Laboratory Procedure]

Phrase: "were"

Phrase: "calculated according to the formula"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0444686:Calculated [Functional Concept]
   760   C0489829:Formula [Intellectual Product]
   760   C0680240:according [Social Behavior]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1705501:Formula [Intellectual Product]

Phrase: ":"

Phrase: "volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0449468:*Volume [Quantitative Concept]
  1000   C1690016:% volume [Qualitative Concept]
  1000   C1705102:Volume [Intellectual Product]
  1000   C2700258:Volume [Laboratory Procedure]

Phrase: "(ml)=(mg of dye"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0439294:ml mg [Quantitative Concept]
   770   C0439269:mg% [Quantitative Concept]
   770   C1960952:mg % [Quantitative Concept]
   770   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: ")"

Phrase: "/"

Phrase: "(dye concentration at t0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "in mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439294:mg ml [Quantitative Concept]
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.99: Neutral-gel chromatography. 

Phrase: "Neutral-gel chromatography."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0008559:Gel Chromatography [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]
   727 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.100: Subsamples of wound fluid (200l) collected from each rat at the completion of experiment 2were thawed, defatted, and centrifuged, and the supernatant was subjected to size-exclusion chromatography as previously described (34). 

Phrase: "Subsamples of wound fluid"

Phrase: "(200l"

Phrase: ")"

Phrase: "collected from each rat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "at the completion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205197:Completion [Qualitative Concept]
  1000   C1554962:completion [Qualitative Concept]

Phrase: "of experiment 2were thawed,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710378:Thaw [Laboratory Procedure]

Phrase: "defatted"

Phrase: ","

Phrase: "and"

Phrase: "centrifuged,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "subjected to size-exclusion chromatography"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   862   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0456389:size [Spatial Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C2828389:Exclusion [Activity]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.101: The column was calibrated with molecular-mass standards of 150kDa (human IgG), 66kDa (BSA), 30kDa (carbonic anhydrase), and 12.5kDa (cytochrome c), as well as the radiolabeled peptides (IGF-I and IGF-II, 7.5kDa; LR3-IGF-I, 9.1kDa; and insulin, 5.8kDa). 

Phrase: "The column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "calibrated with molecular-mass standards of 150kDa"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   748   C0038137:standards [Intellectual Product]
   748   C0175675:Standards [Qualitative Concept]
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1521991:Molecular [Qualitative Concept]
   714 E C1442989:Standard [Qualitative Concept]
   714 E C2828392:Standard [Intellectual Product]

Phrase: "(human IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2702333:Human IgG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "66kDa"

Phrase: "(BSA"

Phrase: ")"

Phrase: ","

Phrase: "30kDa"

Phrase: "(carbonic anhydrase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007028:Carbonic Anhydrase [Amino Acid, Peptide, or Protein,Enzyme]
   789   C0007009:Carbon [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "12.5kDa"

Phrase: "(cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "the radiolabeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "7.5kDa"

Phrase: "; LR3-IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "9.1kDa"

Phrase: ";"

Phrase: "and"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "5.8kDa"

Phrase: ")."
Processing 00000000.tx.102: Data analysis. 

Phrase: "Data analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.103: All radioactivity measurements were corrected for radioactive decay back to the day the experiment was performed. 

Phrase: "All radioactivity measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "corrected for radioactive decay"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0034553:radioactive [Natural Phenomenon or Process]
   770   C0205202:Corrected [Qualitative Concept]
   770   C1265875:Decay [Acquired Abnormality]
   770   C2700592:Decay [Phenomenon or Process]
   737 E C2349182:Correct [Qualitative Concept]

Phrase: "back to the day"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004600:Back [Body Location or Region]
   770   C0205095:Back [Spatial Concept]
   770   C0460009:Back [Body Location or Region]
   770   C1995000:Back [Body Location or Region]

Phrase: "the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.104: The amount of TCA-precipitable peptide remaining in the wound fluid at each time point was expressed as a percentage of the initial amount of TCA-precipitable peptide injected into the chamber. 

Phrase: "The amount of TCA-precipitable peptide remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "in the wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "at each time point"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "expressed as a percentage of the initial amount of TCA-precipitable peptide"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   736   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   736   C0041405:TCA [Geographic Area]
   736   C0085758:TCA [Congenital Abnormality]
   736   C0205265:Initial [Temporal Concept]
   736   C0439165:Percentage [Quantitative Concept]
   736   C1265611:Amount [Quantitative Concept]
   736   C1279901:Initial [Qualitative Concept]
   736   C1415587:TCA [Gene or Genome]
   736   C1549488:Percentage [Idea or Concept]
   736   C1555582:Initial [Idea or Concept]
   736   C1561533:Percentage [Idea or Concept]
   736   C1705685:INITIAL [Functional Concept]
   736   C3536819:TCA [Pharmacologic Substance]

Phrase: "injected into the chamber."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0935616:Chamber [Body Part, Organ, or Organ Component]
   737   C1720154:Inject [Functional Concept]
Processing 00000000.tx.105: The data were then fitted to a biexponential equation (2) with a nonlinear curve-fitting program (TableCurve 2D version 3.0,Jandel Scientific, Corte Madeira, CA). 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fitted to a biexponential equation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0036572:Fit [Sign or Symptom]
   760   C0424576:Fit [Finding]
   760   C0552449:Equation [Conceptual Entity]
   760   C2349186:Fit [Activity]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "with a nonlinear curve-fitting program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1709697:Program [Conceptual Entity]
   812   C2728259:Program [Pharmacologic Substance]
   812   C3484370:Program [Functional Concept]

Phrase: "(TableCurve 2D version 3.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0333052:Version [Functional Concept]
   804   C1705052:2D [Spatial Concept]
   804   C2607870:Version [Spatial Concept]
   804   C2986796:2D [Functional Concept]

Phrase: "Jandel Scientific, Corte Madeira,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0024444:Madeira [Geographic Area]
   812   C0684316:madeira [Food]

Phrase: "CA)."
Processing 00000000.tx.106: Elimination rate constants (Kd) of the slow phase of the curves were calculated with the 120-to 360-min data. 

Phrase: "Elimination rate constants"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C2986811:Rate Constant [Quantitative Concept]
   827   C0221102:Elimination [Physiologic Function]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   793   C1547014:*Constant [Quantitative Concept]
   793   C1948059:Constant [Qualitative Concept]

Phrase: "(Kd) of the slow phase of the curves"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0026691:KD [Disease or Syndrome]
   744   C1705240:KD [Gene or Genome]
   744   C1839259:KD [Disease or Syndrome]

Phrase: "were"

Phrase: "calculated with the 120-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444686:Calculated [Functional Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]

Phrase: "to 360-min data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
Processing 00000000.tx.107: The half-lives of decay for each curve were calculated from the equation t1/2=ln 2/Kd. 

Phrase: "The half-lives of decay"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   773   C0018517:Half-Life [Temporal Concept]
   760   C0595998:lives [Finding]
   760   C1548795:Live [Qualitative Concept]
   760   C1634625:% live [Qualitative Concept]
   760   C2825407:Half [Quantitative Concept]
   760   C2982691:Live [Activity]
   726 E C0376558:Life [Idea or Concept]

Phrase: "for each curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205134:Curve [Spatial Concept]

Phrase: "were"

Phrase: "calculated from the equation t1/2=ln 2/Kd."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0026691:KD [Disease or Syndrome]
   742   C0444686:Calculated [Functional Concept]
   742   C0552449:Equation [Conceptual Entity]
   742   C0861352:LN [Neoplastic Process]
   742   C1413227:T1 [Gene or Genome]
   742   C1428884:ln [Gene or Genome]
   742   C1441506:Calculated [Activity]
   742   C1443182:Calculated [Laboratory Procedure]
   742   C1705240:KD [Gene or Genome]
   742   C1839259:KD [Disease or Syndrome]
Processing 00000000.tx.108: All data are presented as meansSE. 

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as meansSE."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449450:Presented [Idea or Concept]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.109: Analysis of the wound fluid decay rate constants and distribution of radioactivity was achieved by one-way ANOVA, whereas post hoc pair-wise multiple comparisons were made with Fisher's protected least square differences procedure (SuperANOVA, 1989,Abacus Concepts, Berkeley, CA). 

Phrase: "Analysis of the wound fluid decay rate constants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "distribution of radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520511:distribution [Idea or Concept]
   790   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "achieved by one-way ANOVA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   862   C1709320:One-way ANOVA [Quantitative Concept]
   760   C0205447:One [Quantitative Concept]

Phrase: "whereas"

Phrase: "post hoc pair-wise multiple comparisons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   822   C0086766:Paired Comparisons [Quantitative Concept]
   766   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "made with Fisher's"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0325045:Fisher [Mammal]
   756   C1881534:Make [Functional Concept]

Phrase: "protected"

Phrase: "least square differences procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C1948041:Procedure [Therapeutic or Preventive Procedure]
   812   C2700391:Procedure [Activity]
   812   C3274430:PROCEDURE [Health Care Activity]
   812   C3538935:Procedure [Idea or Concept]
   812   C3539779:Procedure [Intellectual Product]

Phrase: "(SuperANOVA,"

Phrase: "1989,"

Phrase: "Abacus Concepts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178566:concepts [Idea or Concept]

Phrase: "Berkeley,"

Phrase: "CA)."
Processing 00000000.tx.110: Differences that give P<0.05were considered to be statistically significant.  

Phrase: "Differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "that"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "P<0.05were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.111: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Experiment 1: clearance of radiolabeled IGF-I or 125I from wound fluid. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Experiment 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ":"

Phrase: "clearance of radiolabeled IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0449297:Clearance [Qualitative Concept]
   744   C1382187:Clearance [Clinical Attribute]
   744   C2825073:Clearance [Natural Phenomenon or Process]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "or"

Phrase: "125I from wound fluid."
Processing 00000000.tx.112: Preliminary data on the decay profiles of IGF-I or 125I in wound fluid were derived from an initial experiment in which tracer was injected into the chamber and the elimination of radioactivity from the wound fluid was monitored. 

Phrase: "Preliminary data on the decay profiles of IGF-I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1511726:Data [Idea or Concept]
   736   C3245479:data [Medical Device]

Phrase: "or"

Phrase: "125I in wound fluid"

Phrase: "were"

Phrase: "derived from an initial experiment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205265:Initial [Temporal Concept]
   760   C0681814:Experiment [Research Activity]
   760   C1279901:Initial [Qualitative Concept]
   760   C1441547:Derived [Qualitative Concept]
   760   C1555582:Initial [Idea or Concept]
   760   C1705685:INITIAL [Functional Concept]
   760   C1706386:Experiment [Conceptual Entity]
   760   C3245521:derived [Idea or Concept]

Phrase: "in which tracer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522485:Tracer [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "injected into the chamber"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0935616:Chamber [Body Part, Organ, or Organ Component]
   737   C1720154:Inject [Functional Concept]

Phrase: "and"

Phrase: "the elimination of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0221102:Elimination [Physiologic Function]

Phrase: "from the wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "monitored."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.113: The volume of wound fluid collected from the chamber at the completion of the experiment was added to the volume of wound fluid removed by sampling and was compared with the volume calculated from the Evans Blue dye dilution assay. 

Phrase: "The volume of wound fluid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0449971:fluid volume [Quantitative Concept]
   760   C0449468:*Volume [Quantitative Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "collected from the chamber"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0935616:Chamber [Body Part, Organ, or Organ Component]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "at the completion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205197:Completion [Qualitative Concept]
  1000   C1554962:completion [Qualitative Concept]

Phrase: "of the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "added to the volume of wound fluid"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   774   C0449971:fluid volume [Quantitative Concept]
   748   C0005889:FLUID [Body Substance]
   748   C0043250:Wound [Injury or Poisoning]
   748   C0302908:fluid [Substance]
   748   C0444611:Fluid [Qualitative Concept]
   748   C0449468:*Volume [Quantitative Concept]
   748   C1524062:Added [Functional Concept]
   748   C1690016:% volume [Qualitative Concept]
   748   C1704353:Fluid [Substance]
   748   C1705102:Volume [Intellectual Product]
   748   C2700258:Volume [Laboratory Procedure]
   714 E C0016204:Wind NOS [Sign or Symptom]
   714 E C0043187:Wind [Natural Phenomenon or Process]
   714 E C1883712:Add [Functional Concept]

Phrase: "removed by sampling"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0441621:Sampling [Diagnostic Procedure]
   790   C0849355:Removed [Qualitative Concept]
   790   C0870078:Sampling [Idea or Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "compared with the volume"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0449468:*Volume [Quantitative Concept]
   770   C1690016:% volume [Qualitative Concept]
   770   C1705102:Volume [Intellectual Product]
   770   C1707455:Compared [Activity]
   770   C2700258:Volume [Laboratory Procedure]

Phrase: "calculated from the Evans Blue dye dilution assay."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   793   C1875083:DYE EVANS BLUE [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0015205:Evan's Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   744   C0079240:Dilution [Laboratory Procedure]
   744   C0243073:assay [Qualitative Concept]
   744   C0444686:Calculated [Functional Concept]
   744   C1260957:Blue [Qualitative Concept]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.114: Because the two procedures gave similar results, subsequent calculations of the amount of tracer remaining in the chamber were made with the volume calculated by the Evans Blue method. 

Phrase: "Because"

Phrase: "the two procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "similar results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "subsequent calculations of the amount of tracer remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1441506:Calculation [Activity]

Phrase: "in the chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "made with the volume"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0449468:*Volume [Quantitative Concept]
   770   C1690016:% volume [Qualitative Concept]
   770   C1705102:Volume [Intellectual Product]
   770   C2700258:Volume [Laboratory Procedure]
   737   C1881534:Make [Functional Concept]

Phrase: "calculated by the Evans Blue method."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0015205:Evan's Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0025663:Method [Intellectual Product]
   753   C0444686:Calculated [Functional Concept]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
   753   C1260957:Blue [Qualitative Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.115: After injection of tracer into the chamber, the radioactivity remaining in the wound fluid, the amount present in the circulation, and the amount of radioactivity accumulating in urine were measured over time and expressed as the percentage of the administered dose. 

Phrase: "After injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of tracer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522485:Tracer [Indicator, Reagent, or Diagnostic Aid]

Phrase: "into the chamber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "the radioactivity remaining in the wound fluid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1527428:Remaining [Qualitative Concept]

Phrase: "the amount present in the circulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "the amount of radioactivity accumulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "in urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "were"

Phrase: "measured over time"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   790   C0040223:Time [Temporal Concept]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541383:Time [Temporal Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "expressed as the percentage of the administered dose."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0178602:Dose [Quantitative Concept]
   744   C0439165:Percentage [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]
   744   C1521801:Administered [Functional Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   711 E C1621583:Administer [Functional Concept]
Processing 00000000.tx.116: The use of radiolabeled peptides with the TCA-precipitation assay provided a simple and rapid method for measuring total and degraded peptides. 

Phrase: "The use of radiolabeled peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "with the TCA-precipitation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "a simple"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205352:Simple [Qualitative Concept]

Phrase: "and"

Phrase: "rapid method for measuring total"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0872257:rapid method [Diagnostic Procedure]
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "degraded peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.117: Sampling volumes were also minimized. 

Phrase: "Sampling volumes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449468:volumes [Quantitative Concept]
   827 E C1690016:% volume [Qualitative Concept]
   827 E C1705102:Volume [Intellectual Product]
   827 E C2700258:Volume [Laboratory Procedure]

Phrase: "were"

Phrase: "also"

Phrase: "minimized."
Processing 00000000.tx.118: The amount of intact (TCA insoluble) radiolabeled IGF-I present in the chamber decreased over time (Fig. 1A). 

Phrase: "The amount of intact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "(TCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0041405:TCA [Geographic Area]
  1000   C0085758:TCA [Congenital Abnormality]
  1000   C1415587:TCA [Gene or Genome]
  1000   C3536819:TCA [Pharmacologic Substance]

Phrase: "insoluble"

Phrase: ")"

Phrase: "radiolabeled IGF-I present in the chamber"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0150312:Present [Quantitative Concept]
   739   C0449450:Present [Idea or Concept]

Phrase: "decreased over time"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0040223:Time [Temporal Concept]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0547047:Decrease [Quantitative Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.119: After 1h, ~22% of the original amount of peptide had been eliminated. 

Phrase: "After 1h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "~22% of the original amount of peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0205313:Original [Idea or Concept]
   748   C1265611:Amount [Quantitative Concept]
   748   C2347409:Original [Occupational Activity]

Phrase: "had"

Phrase: "been"

Phrase: "eliminated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]
Processing 00000000.tx.120: However, from 1h until the end of the experiment, the rate of elimination of intact IGF-I from wound fluid was slower, with a decline of ~20% occurring in this time. 

Phrase: "However,"

Phrase: "from 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "until the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "the rate of elimination of intact IGF-I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0449249:Growth rate [Temporal Concept]
   738   C0871208:Rate [Activity]
   738   C1521828:Rate [Quantitative Concept]

Phrase: "from wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "slower,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439834:Slow [Qualitative Concept]

Phrase: "with a decline of ~20%"

Phrase: "occurring in this time."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   737   C1709305:Occur [Activity]
   737   C2745955:OCCUR [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.121: In contrast to labeled IGF-I, 125I was rapidly eliminated from the chamber (Fig. 1A), such that by 1h after injection only 45% of the original material was present. 

Phrase: "In contrast to labeled IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "125I"

Phrase: "was"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "eliminated from the chamber"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0849355:Eliminated [Qualitative Concept]
   770   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "such"

Phrase: "that by 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442450:1H [Temporal Concept]

Phrase: "after injection only 45%"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0021485:injection [Therapeutic or Preventive Procedure]
   827   C0205171:Only [Quantitative Concept]
   827   C1272883:Injection [Biomedical or Dental Material]
   827   C1533685:Injection [Therapeutic or Preventive Procedure]
   827   C1720467:Only [Intellectual Product]
   827   C1828121:Injection [Functional Concept]

Phrase: "of the original material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "was"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.122: Furthermore, the rapid rate of elimination of 125I continued after 1h, with <5% of the administered dose remaining after 6h. 

Phrase: "Furthermore,"

Phrase: "the rapid rate of elimination of 125I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "continued after 1h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0549178:Continued [Idea or Concept]
   790   C1442450:1H [Temporal Concept]

Phrase: "with"

Phrase: "<5% of the administered dose remaining"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0178602:Dose [Quantitative Concept]
   753   C0439084:>5 [Quantitative Concept]
   753   C0728893:+5 [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1521801:Administered [Functional Concept]
   753   C1527428:Remaining [Qualitative Concept]
   719 E C1621583:Administer [Functional Concept]

Phrase: "after 6h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]
Processing 00000000.tx.123: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.124: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.125: Clearance of tracer from wound fluid (experiment 1). 

Phrase: "Clearance of tracer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C2986829:Tracer Clearance [Functional Concept]
   790   C0449297:Clearance [Qualitative Concept]
   790   C1382187:Clearance [Clinical Attribute]
   790   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "from wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "(experiment 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.126: TCA-insoluble insulin-like growth factor (IGF) I (; n=9rats) or total 125I (; n=3rats) radioactivity was measured in wound fluid (A), blood (B), and urine (C) over 6h after injection into chamber. 

Phrase: "TCA-insoluble insulin-like growth factor"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0220844:growth [Physiologic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IGF) I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "; n=9rats"

Phrase: ")"

Phrase: "or"

Phrase: "total 125I"

Phrase: "("

Phrase: "; n=3rats"

Phrase: ")"

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "measured in wound fluid"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1704353:Fluid [Substance]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "blood (B),"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "(C) over 6h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1553033:[c] [Quantitative Concept]

Phrase: "after injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "into chamber."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]
Processing 00000000.tx.127: Amount of radioactivity remaining was calculated as a percentage of that injected into chamber. 

Phrase: "Amount of radioactivity remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "calculated as a percentage of that"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0439165:Percentage [Quantitative Concept]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "injected into chamber."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0935616:Chamber [Body Part, Organ, or Organ Component]
   756   C1720154:Inject [Functional Concept]
Processing 00000000.tx.128: All values are meansSE. 

Phrase: "All values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "meansSE."
Processing 00000000.tx.129: The amount of intact IGF-I peptide in the circulation was at all times very low compared with the amount injected into the chamber (Fig. 1B). 

Phrase: "The amount of intact IGF-I peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1265611:Amount [Quantitative Concept]

Phrase: "in the circulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005775:Circulation [Physiologic Function]
  1000   C1516559:Circulation [Organism Function]

Phrase: "was at all times"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0040223:times [Temporal Concept]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "very low"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442811:Very low [Finding]
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "compared with the amount"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1265611:Amount [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "injected into the chamber"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0935616:Chamber [Body Part, Organ, or Organ Component]
   737   C1720154:Inject [Functional Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.130: Thus 10min after injection, <0.1% of that injected was present in blood, and by 6h this had risen to only 0.6%. 

Phrase: "Thus 10min after injection,"

Phrase: "<0.1% of that"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "was"

Phrase: "present in blood,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "and by 6h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292428:6H [Temporal Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "this"

Phrase: "had"

Phrase: "risen"

Phrase: "to only 0.6%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205171:Only [Quantitative Concept]
   812   C1720467:Only [Intellectual Product]
   812   C1883351:To [Qualitative Concept]
Processing 00000000.tx.131: By comparison, 125I radioactivity in the circulation had risen to ~5% of the administered dose at 1h, but by the end of the experiment this had fallen to 3.5%. 

Phrase: "By comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "125I radioactivity in the circulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "had"

Phrase: "risen"

Phrase: "to ~5% of the administered dose"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0178602:Dose [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1521801:Administered [Functional Concept]
   753   C1883351:To [Qualitative Concept]
   719 E C1621583:Administer [Functional Concept]

Phrase: "at 1h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "but by the end of the experiment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0233535:but [Mental or Behavioral Dysfunction]
   748   C0444930:End [Spatial Concept]
   748   C0681814:Experiment [Research Activity]
   748   C1706386:Experiment [Conceptual Entity]
   748   C2746065:End [Temporal Concept]

Phrase: "this"

Phrase: "had"

Phrase: "fallen to 3.5%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0085639:Fall [Finding]
   737   C0238715:Fall [Temporal Concept]
Processing 00000000.tx.132: Similarly, the accumulation of IGF-I radioactivity in urine over the duration of the experiment was <3% of the total radioactivity injected (Fig. 1C), whereas ~16% of the 125I radioactivity accumulated in the urine by 6h. 

Phrase: "Similarly,"

Phrase: "the accumulation of IGF-I radioactivity"

Phrase: "in urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "over the duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]

Phrase: "of the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was <"

Phrase: "3% of the total radioactivity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]
   760   C0439086:<3 [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C2827736:3+ [Quantitative Concept]
   760   C2981702:3+ [Classification]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "(Fig. 1C"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "~16% of the 125I radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "accumulated in the urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0042036:Urine [Body Substance]
   770   C0042037:urine [Functional Concept]
   770   C2963137:Urine [Body Substance]

Phrase: "by 6h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]
Processing 00000000.tx.133: Experiment 2: comparison of the rates of clearance of IGF-I, IGF-II, LR3-IGF-I, and insulin from wound fluid. 

Phrase: "Experiment 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ":"

Phrase: "comparison of the rates of clearance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "of IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "IGF-II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "LR3-IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin from wound fluid."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.134: After establishment of the decay profile of IGF-I in wound fluid, a second experiment was performed to compare the rate of elimination of IGF-I with rates of IGF-II and LR3-IGF-I, an analog that interacts poorly with IGFBPs (12). 

Phrase: "After establishment"

Phrase: "of the decay profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "of IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in wound fluid,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "a second experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the rate of elimination of IGF-I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0449249:Growth rate [Temporal Concept]
   739   C0871208:Rate [Activity]
   739   C1521828:Rate [Quantitative Concept]

Phrase: "with rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871208:Rate [Activity]
   966   C1521828:Rate [Quantitative Concept]

Phrase: "of IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "LR3-IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "an analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243071:Analog [Chemical Viewed Structurally]
   900 E C0679213:analogies [Idea or Concept]

Phrase: "that"

Phrase: "interacts"

Phrase: "poorly with IGFBPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205169:Poorly [Qualitative Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.135: The experiment also included insulin, which is of a similar molecular weight to the IGFs but does not interact with the IGFBPs, to establish whether the rate of elimination from the wound fluid was a function of molecular size. 

Phrase: "The experiment also included insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "which"

Phrase: "is of a similar molecular weight"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0026385:Molecular Weight [Quantitative Concept]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705104:Weight [Idea or Concept]
   753   C2348205:Similar [Qualitative Concept]

Phrase: "to the IGFs"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
  1000   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   966 E C1753359:insulin-like growth factor [Molecular Function]
   861   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with the IGFBPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "whether"

Phrase: "the rate of elimination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "from the wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "a function of molecular size."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1148560:molecular function [Molecular Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.136: The decline of the total amount of radioactivity present in wound fluid was biphasic for each peptide (Fig. 2A). 

Phrase: "The decline of the total amount of radioactivity present"

Phrase: "in wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "biphasic for each peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205184:Biphasic [Temporal Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.137: In the first hour after injection, ~20% of the radioactivity of labeled IGF-I or IGF-II was eliminated in contrast to ~30% of the LR3-IGF-I or insulin radioactivity. 

Phrase: "In the first hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "after injection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "~20% of the radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "of labeled IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "eliminated in contrast to ~30%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0849355:Eliminated [Qualitative Concept]
   760   C1979874:Contrast [Qualitative Concept]

Phrase: "of the LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin radioactivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]
Processing 00000000.tx.138: A slow phase of elimination then occurred from 1h until the end of the experiment, by which time approximately a further 15% of the radioactivity of the IGF peptides had been eliminated from the wound fluid. 

Phrase: "A slow phase of elimination then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205390:Phase [Temporal Concept]

Phrase: "occurred from 1h"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1442450:1H [Temporal Concept]
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "until the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "by which time approximately"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "a further 15% of the radioactivity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0034553:Radioactivity [Natural Phenomenon or Process]
   753   C1517331:Further [Spatial Concept]
   719 E C0205108:far [Spatial Concept]

Phrase: "of the IGF peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   924   C0037657:Insulin-like growth peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
           Insulin-like growth factor
   804   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   771   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "had"

Phrase: "been"

Phrase: "eliminated from the wound fluid."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0005889:FLUID [Body Substance]
   760   C0043250:Wound [Injury or Poisoning]
   760   C0302908:fluid [Substance]
   760   C0444611:Fluid [Qualitative Concept]
   760   C0849355:Eliminated [Qualitative Concept]
   760   C1704353:Fluid [Substance]
   726 E C0016204:Wind NOS [Sign or Symptom]
   726 E C0043187:Wind [Natural Phenomenon or Process]
Processing 00000000.tx.139: Total insulin radioactivity declined by ~28% from 1to 6h (Fig. 2A). 

Phrase: "Total insulin radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "declined by ~28%"

Phrase: "from 1to 6h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1292428:6H [Temporal Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.140: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.141: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.142: Clearance of 125I-labeled proteins from wound fluid (experiment 2). 

Phrase: "Clearance of 125I-labeled proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "from wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "(experiment 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.143: Radiolabeled IGF-I (), IGF-II (), LR3-IGF-I [an IGF analog that binds poorly to IGF-binding proteins (IGFBPs); ], or insulin () was injected into chambers, and total radioactivity (A) or TCA-insoluble radioactivity (B) was measured over a 6-h period. 

Phrase: "Radiolabeled IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "["

Phrase: "an IGF analog"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   897   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0243071:Analog [Chemical Viewed Structurally]
   771   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1753359:insulin-like growth factor [Molecular Function]
   704 E C0679213:analogies [Idea or Concept]

Phrase: "that"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "poorly to IGF-binding proteins"
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   909   C0074825:Insulin-Like Growth-Factor-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1149301:insulin-like growth factor binding [Molecular Function]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   800   C1149299:Growth Factor Binding [Molecular Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1623517:insulin binding [Molecular Function]
   750 E C0033618:Protein Binding [Molecular Function]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205169:Poorly [Qualitative Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "(IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ";"

Phrase: "],"

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: "was"

Phrase: "injected into chambers,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0179874:chambers [Medical Device]
   756 E C0935616:Chamber [Body Part, Organ, or Organ Component]
   756   C1720154:Inject [Functional Concept]

Phrase: "and"

Phrase: "total radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "(A)"

Phrase: "or"

Phrase: "TCA-insoluble radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "(B"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "measured over a 6-h period."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   783   C0444953:H 6 [Intellectual Product]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439531:/period [Temporal Concept]
   753   C0441932:H+ [Classification]
   753   C0444706:Measured [Qualitative Concept]
   753   C0564385:/h [Quantitative Concept]
   753   C1948053:Period [Temporal Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.144: Radioactivity is expressed as a percentage of that injected. 

Phrase: "Radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "expressed as a percentage of that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "injected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]
Processing 00000000.tx.145: Values are meansSE; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "meansSE"

Phrase: ";"
Processing 00000000.tx.146: n=8rats/treatment (see Table 1 for statistical summary). 

Phrase: "n=8rats/treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table 1 for statistical summary"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0038215:Statistical [Occupation or Discipline]
   760   C0039224:Table [Manufactured Object]
   760   C1552616:summary [Intellectual Product]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]
   760   C1706244:Summary [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.147: cpm, Counts/min. 

Phrase: "cpm,"

Phrase: "Counts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439157:counts [Quantitative Concept]
  1000   C0750480:Count [Activity]
  1000   C1705566:Count [Quantitative Concept]

Phrase: "/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]
Processing 00000000.tx.148: The amount of intact IGF-I present in wound fluid declined in a biphasic manner (Fig. 2B). 

Phrase: "The amount of intact IGF-I present"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1265611:Amount [Quantitative Concept]

Phrase: "in wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "declined in a biphasic manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205184:Biphasic [Temporal Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.149: TCA-insoluble radioactivity for IGF-II and LR3-IGF-I (Fig. 2B) showed a similar biphasic pattern of decay to IGF-I. 

Phrase: "TCA-insoluble radioactivity for IGF-II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a similar biphasic pattern of decay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1332555:Biphasic Pattern [Finding]
   753   C0449774:Pattern [Spatial Concept]

Phrase: "to IGF-I."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.150: However, the amount of intact LR3-IGF-I remaining after 1h was 70% of the injected dose compared with 82% for IGF-I (Fig. 2B). 

Phrase: "However,"

Phrase: "the amount of intact LR3-IGF-I remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1265611:Amount [Quantitative Concept]

Phrase: "after 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "was"

Phrase: "70% of the injected dose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2986768:Injected Dose [Functional Concept]
   760   C0178602:Dose [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   726   C1720154:Inject [Functional Concept]

Phrase: "compared with 82%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "for IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.151: By 6h, this difference was greater, with 55% of intact LR3-IGF-I remaining compared with 68% of intact IGF-I. 

Phrase: "By 6h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]

Phrase: "this difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "greater,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0443228:greater [Quantitative Concept]
  1000   C1704243:Greater [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]

Phrase: "with 55%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "of intact LR3-IGF-I remaining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1527428:Remaining [Qualitative Concept]
   723   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   723   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "compared with 68% of intact IGF-I."
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   833   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   806   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   806   C1753359:insulin-like growth factor [Molecular Function]
   760   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0021966:I- [Inorganic Chemical]
   739   C0205266:Intact [Qualitative Concept]
   739   C0220844:growth [Physiologic Function]
   739   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0450387:68 [Intellectual Product]
   739   C1521761:Factor [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1554187:Intact [Idea or Concept]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1707455:Compared [Activity]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   730   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.152: Insulin showed the fastest decline of TCA-insoluble radioactivity remaining in the chamber, declining rapidly in the first hour to 70% of that injected. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the fastest decline of TCA-insoluble radioactivity remaining"

Phrase: "in the chamber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "declining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511741:Declining [Qualitative Concept]

Phrase: "rapidly in the first hour"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205435:First [Quantitative Concept]
   760   C0439227:Hour [Temporal Concept]
   760   C0564385:/hour [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1637379:Rapidly [Qualitative Concept]

Phrase: "to 70%"

Phrase: "of that"

Phrase: "injected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]
Processing 00000000.tx.153: Only 35% remained at 6h (Fig. 2B). 

Phrase: "Only 35%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "remained at 6h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292428:6H [Temporal Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.154: The slopes of the slow phases of the TCA-insoluble curves were used to calculate the elimination rate constant (Kd) and half-lives for each peptide (Table 1). 

Phrase: "The slopes of the slow phases of the TCA-insoluble curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0807955:slopes [Quantitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "the elimination rate constant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C2986811:Rate Constant [Quantitative Concept]
   827   C0221102:Elimination [Physiologic Function]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1547014:*Constant [Quantitative Concept]
   827   C1948059:Constant [Qualitative Concept]

Phrase: "(Kd)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: "and"

Phrase: "half-lives for each peptide"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   773   C0018517:Half-Life [Temporal Concept]
   760   C0595998:lives [Finding]
   760   C1548795:Live [Qualitative Concept]
   760   C1634625:% live [Qualitative Concept]
   760   C2825407:Half [Quantitative Concept]
   760   C2982691:Live [Activity]
   726 E C0376558:Life [Idea or Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.155: The Kd for IGF-I did not significantly differ from that of IGF-II (P>0.05). 

Phrase: "The Kd for IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0026691:KD [Disease or Syndrome]
   744   C1705240:KD [Gene or Genome]
   744   C1839259:KD [Disease or Syndrome]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "differ from that of IGF-II"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   849   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   818   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   818   C1753359:insulin-like growth factor [Molecular Function]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C0200396:Factor II [Laboratory Procedure]
   764   C1414504:FACTOR II [Gene or Genome]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0220844:growth [Physiologic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   734   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(P>0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.156: This was in contrast to LR3-IGF-I or insulin, which had significantly greater rates of elimination than IGF-I (P<0.05and P<0.001,respectively).  

Phrase: "This"

Phrase: "was in contrast to LR3-IGF-I"
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   833   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   806   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   806   C1753359:insulin-like growth factor [Molecular Function]
   760   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0021966:I- [Inorganic Chemical]
   739   C0043194:WAS [Disease or Syndrome]
   739   C0220844:growth [Physiologic Function]
   739   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0450768:LR3 [Body Location or Region]
   739   C1416917:LR3 [Gene or Genome]
   739   C1421478:WAS [Gene or Genome]
   739   C1521761:Factor [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1979874:Contrast [Qualitative Concept]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   739   C2987131:LR3 [Gene or Genome]
   730   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "which"

Phrase: "had"

Phrase: "significantly greater rates of elimination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "than IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(P<0.05and P<0.001,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.157: View this table: [in this window] [in a new window]  Table 1.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.158: Elimination rate constants of intact peptides in wound fluid Degradation of the labeled peptides in wound fluid was evaluated by measuring the proportion of intact material present over time (Fig. 3). 

Phrase: "Elimination rate constants of intact peptides"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C2986811:Rate Constant [Quantitative Concept]
   753   C0221102:Elimination [Physiologic Function]
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]
   719   C1547014:*Constant [Quantitative Concept]
   719   C1948059:Constant [Qualitative Concept]

Phrase: "in wound fluid Degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "of the labeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "in wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "evaluated by measuring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0220825:Evaluated [Functional Concept]
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the proportion of intact material present"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.159: Each of the IGF peptides remained >89% intact in the wound fluid throughout the experiment, whereas insulin, being 94% TCA insoluble at the beginning of the experiment, declined to be only 73% intact by 6h. 

Phrase: "Each of the IGF peptides"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
           Insulin-like growth peptide
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   744   C0220844:growth [Physiologic Function]
   744   C1457900:Each [Quantitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "remained"

Phrase: ">89% intact in the wound fluid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205266:Intact [Qualitative Concept]
   753   C1554187:Intact [Idea or Concept]

Phrase: "throughout the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "whereas"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "being"

Phrase: "94% TCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0041405:TCA [Geographic Area]
   861   C0085758:TCA [Congenital Abnormality]
   861   C1415587:TCA [Gene or Genome]
   861   C3536819:TCA [Pharmacologic Substance]

Phrase: "insoluble at the beginning of the experiment,"

Phrase: "declined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "only 73% intact by 6h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205266:Intact [Qualitative Concept]
   760   C1554187:Intact [Idea or Concept]
Processing 00000000.tx.160: In accordance with this observation, there was an increased rate of elimination of the TCA-insoluble radioactivity in wound fluid (Fig. 2B) compared with the rate of elimination of the total radioactivity (Fig. 2A). 

Phrase: "In accordance with this observation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "there"

Phrase: "was"

Phrase: "an increased rate of elimination of the TCA-insoluble radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0871208:Rate [Activity]
   739   C1521828:Rate [Quantitative Concept]

Phrase: "in wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "compared with the rate of elimination of the total radioactivity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0034553:Radioactivity [Natural Phenomenon or Process]
   739   C0221102:Elimination [Physiologic Function]
   739   C0439175:% total [Quantitative Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C0871208:Rate [Activity]
   739   C1521828:Rate [Quantitative Concept]
   739   C1707455:Compared [Activity]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.161: In contrast, the rates of elimination of the TCA-insoluble material and total radioactivity for LR3-IGF-I were more similar (Fig. 2, A and B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the rates of elimination of the TCA-insoluble material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C0871208:Rate [Activity]
   708   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "total radioactivity for LR3-IGF-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "more similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.162: We recognize that the TCA-precipitation assay may underestimate tracer degradation because some peptide fragments may be precipitable yet functionally inactive (10). 

Phrase: "We"

Phrase: "recognize"

Phrase: "that"

Phrase: "the TCA-precipitation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "may"

Phrase: "underestimate"

Phrase: "tracer degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "because"

Phrase: "some peptide fragments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0030935:Peptide Fragments [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "precipitable yet functionally inactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205254:Inactive [Qualitative Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.163: This assay was chosen in preference to other techniques, such as radioimmunoassay, which not only may not distinguish between active and inactive fragments, but also would be incapable of distinguishing added from endogenous peptides and may suffer from interference by IGFBPs. 

Phrase: "This assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "chosen in preference"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0558295:preference [Idea or Concept]
   790   C1549513:Preference [Idea or Concept]
   790   C1707391:Chosen [Activity]

Phrase: "to other techniques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025664:techniques [Intellectual Product]
  1000   C0449851:Techniques [Functional Concept]

Phrase: "such as radioimmunoassay,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034580:Radioimmunoassay [Laboratory Procedure]

Phrase: "which"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "distinguish between active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205177:Active [Functional Concept]

Phrase: "and"

Phrase: "inactive fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "but"

Phrase: "also"

Phrase: "would"

Phrase: "be"

Phrase: "incapable of distinguishing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1550518:incapable [Idea or Concept]

Phrase: "added from endogenous peptides"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0205227:Endogenous [Functional Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "may"

Phrase: "suffer from interference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0521102:Interference [Qualitative Concept]
   790   C0683278:suffer [Mental or Behavioral Dysfunction]

Phrase: "by IGFBPs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.164: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.165: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.166: TCA insolubility of radiolabeled peptides in wound fluid (experiment 2). 

Phrase: "TCA insolubility of radiolabeled peptides"

Phrase: "in wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "(experiment 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.167: Samples of wound fluid were diluted in 10% TCA, and the proportion of intact radiolabeled IGF-I (), IGF-II (), LR3-IGF-I (), or insulin () was measured over time. 

Phrase: "Samples of wound fluid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C0444182:Wound fluid sample [Body Substance]
   802   C0438734:Fluid sample [Body Substance]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "diluted in 10% TCA,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0041405:TCA [Geographic Area]
   770   C0085758:TCA [Congenital Abnormality]
   770   C1415587:TCA [Gene or Genome]
   770   C3536819:TCA [Pharmacologic Substance]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "the proportion of intact radiolabeled IGF-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1709707:Proportion [Quantitative Concept]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: "was"

Phrase: "measured over time."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   790   C0040223:Time [Temporal Concept]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541383:Time [Temporal Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.168: Values are meansSE; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "meansSE"

Phrase: ";"
Processing 00000000.tx.169: n=8rats/treatment. 

Phrase: "n=8rats/treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.170: Samples of wound fluid collected from each rat at the end of the experiment were chromatographed under neutral conditions to evaluate the capacity of the respective labeled peptides to bind IGFBPs. 

Phrase: "Samples of wound fluid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C0444182:Wound fluid sample [Body Substance]
   802   C0438734:Fluid sample [Body Substance]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "collected from each rat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "chromatographed under neutral conditions to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1882074:Neutral [Qualitative Concept]
   760   C2825492:Neutral [Phenomenon or Process]
   726   C0012634:condition [Disease or Syndrome]
   726   C0302647:chromatograph [Medical Device]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the capacity of the respective labeled peptides to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1516240:Capacity [Quantitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "IGFBPs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.171: IGF-I eluted in three regions corresponding to 150,30-50, and 7.5kDa, respectively (Fig. 4A). 

Phrase: "IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "eluted in three regions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205449:Three [Quantitative Concept]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "corresponding to 150,"

Phrase: "30-50,"

Phrase: "and"

Phrase: "7.5kDa,"

Phrase: "respectively"

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.172: This profile is similar to that seen after incubating wound fluid with 125I-IGF-I in vitro at 4C (34). 

Phrase: "This profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979963:Profile [Laboratory Procedure]
  1000   C2003903:Profile [Functional Concept]

Phrase: "is"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "seen after incubating wound fluid"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   760   C0005889:FLUID [Body Substance]
   760   C0043250:Wound [Injury or Poisoning]
   760   C0205397:Seen [Qualitative Concept]
   760   C0302908:fluid [Substance]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1439852:incubating [Laboratory Procedure]
   760   C1704353:Fluid [Substance]
   726 E C0016204:Wind NOS [Sign or Symptom]
   726 E C0042789:see [Organism Function]
   726 E C0043187:Wind [Natural Phenomenon or Process]
   726 E C1947903:See [Activity]

Phrase: "with 125I-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in vitro at 4C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.173: IGF-II showed a similar pattern of elution to IGF-I, although the relative amount of radioactivity recovered in the 150-kDa region was substantially greater, and there was a corresponding reduction in the 30-to 50-and 7.5-kDa peaks. 

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a similar pattern of elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "to IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "although"

Phrase: "the relative amount of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "recovered in the 150-kDa region"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0521108:recovered [Qualitative Concept]
   753   C1532717:kDa [Quantitative Concept]
   719 E C2004454:recover [Organism Function]

Phrase: "was"

Phrase: "substantially greater,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0443228:greater [Quantitative Concept]
   861   C1704243:Greater [Quantitative Concept]
   827 E C0549177:Great [Quantitative Concept]

Phrase: "and"

Phrase: "there"

Phrase: "was"

Phrase: "a corresponding reduction in the 30-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "to 50-"

Phrase: "and"

Phrase: "7.5-kDa peaks."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0444505:peaks [Quantitative Concept]
Processing 00000000.tx.174: Chromatography of insulin or LR3-IGF-I revealed two small peaks of radioactivity at ~50-70 kDa (Fig. 4, C and D), but the greatest amounts, representing unbound peptide, were recovered in each case as a single peak at ~7 kDa. 

Phrase: "Chromatography of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0008550:Chromatography [Laboratory Procedure]

Phrase: "or"

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "two small peaks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0442820:Small peak [Finding]
   827   C0444505:peaks [Quantitative Concept]

Phrase: "of radioactivity at ~50-70 kDa (Fig. 4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0034553:Radioactivity [Natural Phenomenon or Process]
   795   C0349966:Fig [Food]
   795   C1337208:FIG [Food]
   795   C1532717:kDa [Quantitative Concept]

Phrase: "C"

Phrase: "and"

Phrase: "D)"

Phrase: ","

Phrase: "but"

Phrase: "the greatest amounts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "unbound peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "recovered in each case"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0521108:recovered [Qualitative Concept]
   770   C0868928:Case [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]
   737 E C2004454:recover [Organism Function]

Phrase: "as a single peak at ~7 kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.175: Although the IGFBP- and receptor-binding abilities of the tracers after incubation in wound fluid were not assessed, the binding properties of similarly prepared labeled peptides have been described previously (11, 12, 26). 

Phrase: "Although"

Phrase: "the IGFBP-"
Meta Candidates (Total=23; Excluded=2; Pruned=0; Remaining=21)
  1000   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1149301:insulin-like growth factor binding [Molecular Function]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   876   C1623517:insulin binding [Molecular Function]
   861   C1149299:Growth Factor Binding [Molecular Function]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0220844:growth [Physiologic Function]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "receptor-binding abilities of the tracers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Abilities [Organism Attribute]

Phrase: "after incubation"

Phrase: "in wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: ","

Phrase: "the binding properties of similarly"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "labeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(11,"

Phrase: "12,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.176: The neutral-gel filtration chromatography profiles also suggest that the endogenous IGF-binding capacity of wound fluid was not exceeded by the amount of tracer added, which was calculated to be <10% of the total IGF-I present (34, 43). 

Phrase: "The neutral-gel filtration chromatography profiles also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C1979963:Profile [Laboratory Procedure]
   766   C2003903:Profile [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the endogenous IGF-binding capacity of wound fluid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   820   C1149301:insulin-like growth factor binding [Molecular Function]
   775   C1149299:Growth Factor Binding [Molecular Function]
   756   C0439155:Binding capacity [Quantitative Concept]
   754   C1623517:insulin binding [Molecular Function]
   738   C0243122:binding [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1516240:Capacity [Quantitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exceeded by the amount of tracer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1265611:Amount [Quantitative Concept]
   753   C1522485:Tracer [Indicator, Reagent, or Diagnostic Aid]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be <"

Phrase: "10% of the total IGF-I present"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   833   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   806   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   806   C1753359:insulin-like growth factor [Molecular Function]
   760   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0021966:I- [Inorganic Chemical]
   739   C0150312:Present [Quantitative Concept]
   739   C0220844:growth [Physiologic Function]
   739   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0439175:% total [Quantitative Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C0449450:Present [Idea or Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   730   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(34,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.177: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.178: 4.  

Phrase: "4."
Processing 00000000.tx.179: Assessment of association of radiolabeled peptides with IGFBPs (experiment 2). 

Phrase: "Assessment of association of radiolabeled peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261322:Assessment [Health Care Activity]
   753   C1516048:Assessment [Activity]

Phrase: "with IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(experiment 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.180: Wound fluid containing IGF-I (A), IGF-II (B), insulin (C), or LR3-IGF-I (D) was collected at end of experiment and applied to a Superose-12 column equilibrated in PBS, pH 7.2.

Phrase: "Wound fluid containing IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   890   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   890   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   861   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1753359:insulin-like growth factor [Molecular Function]
   822   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0021966:I- [Inorganic Chemical]
   793   C0220844:growth [Physiologic Function]
   793   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C1521761:Factor [Functional Concept]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "D)"

Phrase: "was"

Phrase: "collected at end of experiment"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0444930:End [Spatial Concept]
   760   C0681814:Experiment [Research Activity]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C1706386:Experiment [Conceptual Entity]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "applied to a Superose-12 column"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0075646:Superose 12 [Carbohydrate]
   753   C0185125:Applied [Health Care Activity]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]

Phrase: "equilibrated in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "pH 7.2."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.181: Samples were eluted at 0.5ml/min with the same buffer, and radioactivity was determined in 0.5-ml fractions. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "eluted at 0.5ml/min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]

Phrase: "with the same buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "determined in 0.5-ml fractions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.182: Column was standardized with molecular-mass markers of 150kDa (human IgG), 66kDa (BSA), 30kDa (carbonic anhydrase), and 12.5kDa (cytochrome c), as well as 125I-labeled peptides (IGF-I and IGF-II, 7.5kDa; LR3-IGF-I, 9.1kDa; and insulin, 5.8kDa). 

Phrase: "Column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "standardized with molecular-mass markers of 150kDa"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   774   C0005516:molecular markers [Clinical Attribute]
           Marker
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1521991:Molecular [Qualitative Concept]

Phrase: "(human IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2702333:Human IgG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "66kDa"

Phrase: "(BSA"

Phrase: ")"

Phrase: ","

Phrase: "30kDa"

Phrase: "(carbonic anhydrase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007028:Carbonic Anhydrase [Amino Acid, Peptide, or Protein,Enzyme]
   789   C0007009:Carbon [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "12.5kDa"

Phrase: "(cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "125I-labeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "7.5kDa"

Phrase: "; LR3-IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "9.1kDa"

Phrase: ";"

Phrase: "and"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "5.8kDa"

Phrase: ")."
Processing 00000000.tx.183: Values are meansSE; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "meansSE"

Phrase: ";"
Processing 00000000.tx.184: n=8rats/treatment. 

Phrase: "n=8rats/treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.185: Radioactivity in blood and urine was measured to determine whether the increased rates of clearance from the wound fluid were reflected in the amount of each appearing in these fluids (Figs. 5 and 6). 

Phrase: "Radioactivity in blood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the increased rates of clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0025515:clearance rate [Clinical Attribute]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "from the wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "were"

Phrase: "reflected in the amount of each"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0558058:reflected [Mental Process]
   753   C1265611:Amount [Quantitative Concept]

Phrase: "appearing in these fluids"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0005889:Fluids [Body Substance]
   770   C0302908:fluids [Substance]
   770   C1521806:Fluids [Tissue]
   737 E C0444611:Fluid [Qualitative Concept]
   737   C0700364:APPEAR [Qualitative Concept]
   737 E C1704353:Fluid [Substance]

Phrase: "(Figs. 5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.186: LR3-IGF-I or insulin showed similar and increasing amounts of intact peptide in blood throughout the experiment (Fig. 5). 

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "increasing amounts of intact peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "in blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "throughout the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.187: This was in contrast to the IGF-I or IGF-II radioactivity, which was lower and constant from 120min onward. 

Phrase: "This"

Phrase: "was in contrast to the IGF-I"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   833   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   806   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   806   C1753359:insulin-like growth factor [Molecular Function]
   760   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0021966:I- [Inorganic Chemical]
   739   C0043194:WAS [Disease or Syndrome]
   739   C0220844:growth [Physiologic Function]
   739   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1421478:WAS [Gene or Genome]
   739   C1521761:Factor [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1979874:Contrast [Qualitative Concept]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   730   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "IGF-II radioactivity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0034553:Radioactivity [Natural Phenomenon or Process]
   780   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   780   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   734   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "which"

Phrase: "was"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "and"

Phrase: "constant from 120min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1547014:*Constant [Quantitative Concept]
   790   C1948059:Constant [Qualitative Concept]

Phrase: "onward."
Processing 00000000.tx.188: For IGF-I, 45% of the total radioactivity present in the blood throughout the experiment was TCA insoluble. 

Phrase: "For IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "45% of the total radioactivity present"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0034553:Radioactivity [Natural Phenomenon or Process]
   753   C0150312:Present [Quantitative Concept]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "in the blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "throughout the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "TCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0041405:TCA [Geographic Area]
  1000   C0085758:TCA [Congenital Abnormality]
  1000   C1415587:TCA [Gene or Genome]
  1000   C3536819:TCA [Pharmacologic Substance]

Phrase: "insoluble."
Processing 00000000.tx.189: Approximately similar values were recorded for LR3-IGF-I, IGF-II, and insulin. 

Phrase: "Approximately similar values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "recorded for LR3-IGF-I,"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   869   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0021966:I- [Inorganic Chemical]
   744   C0220844:growth [Physiologic Function]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0450768:LR3 [Body Location or Region]
   744   C1416917:LR3 [Gene or Genome]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C2987131:LR3 [Gene or Genome]
   739   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   711   C0034869:Record [Intellectual Product]

Phrase: "IGF-II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.190: Accumulation of radioactivity in urine (Fig. 6) showed similar patterns of appearance as for blood in that by the end of the trial more LR3-IGF-I or insulin radioactivity accumulated than that observed with IGF-I or IGF-II. 

Phrase: "Accumulation of radioactivity"

Phrase: "in urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar patterns of appearance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Patterns [Spatial Concept]

Phrase: "as for blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "in that"

Phrase: "by the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the trial more LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   890   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   890   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   861   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1753359:insulin-like growth factor [Molecular Function]
   822   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0021966:I- [Inorganic Chemical]
   793   C0220844:growth [Physiologic Function]
   793   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C1521761:Factor [Functional Concept]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "accumulated than that"

Phrase: "observed with IGF-I"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1441672:Observed [Functional Concept]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "IGF-II."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.191: However, for the duration of the experiment, 5% of the total radioactivity of each peptide injected into the chamber was excreted into the urine (Fig. 6). 

Phrase: "However,"

Phrase: "for the duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "5% of the total radioactivity of each peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0034553:Radioactivity [Natural Phenomenon or Process]
   744   C0439084:>5 [Quantitative Concept]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0728893:+5 [Quantitative Concept]

Phrase: "injected into the chamber"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0935616:Chamber [Body Part, Organ, or Organ Component]
   737   C1720154:Inject [Functional Concept]

Phrase: "was"

Phrase: "excreted into the urine"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0042036:Urine [Body Substance]
   770   C0042037:urine [Functional Concept]
   770   C1688651:% excreted [Quantitative Concept]
   770   C2963137:Urine [Body Substance]
   737 E C0221102:excrete [Physiologic Function]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.192: View larger version (22K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.193: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.194: Total (A) or TCA-insoluble (B) radioactivity in blood after injection of IGF-I (), IGF-II (), LR3-IGF-I (), or insulin () into chambers (experiment 2). 

Phrase: "Total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "(A)"

Phrase: "or"

Phrase: "TCA-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0041405:TCA [Geographic Area]
  1000   C0085758:TCA [Congenital Abnormality]
  1000   C1415587:TCA [Gene or Genome]
  1000   C3536819:TCA [Pharmacologic Substance]

Phrase: "insoluble"

Phrase: "(B"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: ")"

Phrase: "radioactivity in blood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "after injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: "into chambers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "(experiment 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.195: Radioactivity is expressed as a percentage of that injected. 

Phrase: "Radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "expressed as a percentage of that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "injected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]
Processing 00000000.tx.196: Values are meansSE; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "meansSE"

Phrase: ";"
Processing 00000000.tx.197: n=8rats/treatment. 

Phrase: "n=8rats/treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.198: View larger version (23K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.199: 6.  

Phrase: "6."
Processing 00000000.tx.200: Accumulation of radioactivity in urine (experiment 2). 

Phrase: "Accumulation of radioactivity"

Phrase: "in urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "(experiment 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.201: Radiolabeled-IGF-I (), IGF-II (), LR3-IGF-I (), or insulin () was injected into chambers, and total radioactivity is expressed as a percentage of that injected. 

Phrase: "Radiolabeled-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527121:Radiolabeled [Qualitative Concept]
   966 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: "was"

Phrase: "injected into chambers,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0179874:chambers [Medical Device]
   756 E C0935616:Chamber [Body Part, Organ, or Organ Component]
   756   C1720154:Inject [Functional Concept]

Phrase: "and"

Phrase: "total radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "expressed as a percentage of that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "injected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]
Processing 00000000.tx.202: Values are meansSE; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "meansSE"

Phrase: ";"
Processing 00000000.tx.203: n=8rats/treatment. 

Phrase: "n=8rats/treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.204: At completion of the experiment, radioactivity present in the wound fluid, chamber and associated tissue, and rat carcass was measured (Table 2). 

Phrase: "At completion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205197:Completion [Qualitative Concept]
  1000   C1554962:completion [Qualitative Concept]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "radioactivity present in the wound fluid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "associated tissue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "rat carcass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0229961:Carcass [Fully Formed Anatomical Structure]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.205: Radioactivity present in urine or that removed by blood or wound fluid sampling was also measured to complete the mass balance. 

Phrase: "Radioactivity present in urine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "that"

Phrase: "removed by blood"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   790   C0005767:Blood [Tissue]
   790   C0005768:blood [Body Substance]
   790   C0229664:Blood [Body Substance]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]
   718 E C0333275:Bloody [Qualitative Concept]
   706 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   706 E C0392895:Bloods [Population Group]
   706 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   706 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "or"

Phrase: "wound fluid sampling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441621:Sampling [Diagnostic Procedure]
   827   C0870078:Sampling [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "the mass balance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014653:Balance [Organism Function]
   861   C0205415:Balance [Functional Concept]
   861   C0560184:Balance [Finding]
Processing 00000000.tx.206: For each of the peptide treatments, >92% of the administered dose was recovered with no significant difference occurring between treatments (P>0.05). 

Phrase: "For each"

Phrase: "of the peptide treatments,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: ">92% of the administered dose"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0178602:Dose [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1521801:Administered [Functional Concept]
   726 E C1621583:Administer [Functional Concept]

Phrase: "was"

Phrase: "recovered with no significant difference"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0237881:significant [Quantitative Concept]
   760   C0521108:recovered [Qualitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]
   726 E C2004454:recover [Organism Function]

Phrase: "occurring between treatments"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0087111:Treatments [Therapeutic or Preventive Procedure]
   756 E C0039798:treatment [Functional Concept]
   756 E C1522326:Treatment [Functional Concept]
   756 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   756 E C1705169:Treatment [Conceptual Entity]
   756   C1709305:Occur [Activity]
   756   C2745955:OCCUR [Temporal Concept]
   756 E C3538994:TREATMENT [Research Activity]

Phrase: "(P>0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.207: Additionally, no significant differences in the tracer distribution were found between IGF-I- and IGF-II-injected rats. 

Phrase: "Additionally,"

Phrase: "no significant differences in the tracer distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "found between IGF-I-"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0150312:Found [Quantitative Concept]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   714 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "IGF-II-injected rats."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]
   747   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]
Processing 00000000.tx.208: Compared with the IGF-I group, there was significantly more radioactivity recovered in the carcasses of LR3-IGF-I- or insulin-treated rats (P<0.0001). 

Phrase: "Compared with the IGF-I group,"
Meta Candidates (Total=27; Excluded=1; Pruned=0; Remaining=26)
   849   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   818   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   818   C1753359:insulin-like growth factor [Molecular Function]
   764   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1959640:I group [Clinical Attribute]
   762 E C0441843:Group I [Intellectual Product]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0021966:I- [Inorganic Chemical]
   742   C0220844:growth [Physiologic Function]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441833:Group [Idea or Concept]
   742   C0687744:group [Population Group]
   742   C1257890:Group [Population Group]
   742   C1521761:Factor [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1552516:Group [Health Care Related Organization]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1705428:Group [Conceptual Entity]
   742   C1705429:Group [Population Group]
   742   C1707455:Compared [Activity]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   734   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "there"

Phrase: "was"

Phrase: "significantly more radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "recovered in the carcasses"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0229961:Carcasses [Fully Formed Anatomical Structure]
   770   C0521108:recovered [Qualitative Concept]
   737 E C2004454:recover [Organism Function]

Phrase: "of LR3-IGF-I-"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin-treated rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "(P<0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.209: In contrast, the amount of radioactivity recovered from tissue associated with the chambers of insulin-treated rats was approximately one-half of that recovered for the other treatments (P<0.0001). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the amount of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "recovered from tissue"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0040300:Tissue [Tissue]
   790   C0521108:recovered [Qualitative Concept]
   790   C1547928:Tissue [Intellectual Product]
   756 E C2004454:recover [Organism Function]

Phrase: "associated with the chambers of insulin-treated rats"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   767   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0179874:chambers [Medical Device]
   744   C1522326:Treated [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   711 E C0750490:Associate [Idea or Concept]
   711 E C0935616:Chamber [Body Part, Organ, or Organ Component]
   711 E C1292734:TREAT [Functional Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "approximately one-half of that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2825407:Half [Quantitative Concept]

Phrase: "recovered for the"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0521108:recovered [Qualitative Concept]
   756 E C2004454:recover [Organism Function]

Phrase: "other treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0087111:Treatments [Therapeutic or Preventive Procedure]
   966 E C0039798:treatment [Functional Concept]
   966 E C1522326:Treatment [Functional Concept]
   966 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   966 E C1705169:Treatment [Conceptual Entity]
   966 E C3538994:TREATMENT [Research Activity]

Phrase: "(P<0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.210: At 6h, as inferred from the rates of elimination of tracer from wound fluid, significantly more radioactivity was present in the wound fluid of rats injected with IGF-I than in that injected with LR3-IGF-I or insulin (P<0.0001). 

Phrase: "At 6h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]

Phrase: "as"

Phrase: "inferred from the rates of elimination of tracer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0221102:Elimination [Physiologic Function]
   744   C0679201:Inferred [Mental Process]
   744   C1522485:Tracer [Indicator, Reagent, or Diagnostic Aid]
   744   C3245504:inferred [Idea or Concept]
   711   C0871208:Rate [Activity]
   711   C1521828:Rate [Quantitative Concept]

Phrase: "from wound fluid,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "significantly more radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "present in the wound fluid of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "injected with IGF-I"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   714   C1720154:Inject [Functional Concept]

Phrase: "than"

Phrase: "in that"

Phrase: "injected with LR3-IGF-I"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   869   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0021966:I- [Inorganic Chemical]
   744   C0220844:growth [Physiologic Function]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0450768:LR3 [Body Location or Region]
   744   C1416917:LR3 [Gene or Genome]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C2987131:LR3 [Gene or Genome]
   739   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   711   C1720154:Inject [Functional Concept]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(P<0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.211: Similarly, more radioactivity was recovered from the urine of LR3-IGF-I- or insulin-treated rats than IGF-I- treated rats (P<0.01and P<0.0001,respectively).  

Phrase: "Similarly,"

Phrase: "more radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "recovered from the urine"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0042036:Urine [Body Substance]
   770   C0042037:urine [Functional Concept]
   770   C0521108:recovered [Qualitative Concept]
   770   C2963137:Urine [Body Substance]
   737 E C2004454:recover [Organism Function]

Phrase: "of LR3-IGF-I-"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin-treated rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "than IGF-I- treated rats"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]
   747   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "(P<0.01and P<0.0001,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.212: View this table: [in this window] [in a new window]  Table 2.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.213: Analysis of the final distribution of radioactivity for each peptide  DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Few studies have investigated the role IGFBPs have in regulating the actions of IGFs in the extravascular environment, and as such, the behavior of IGF peptides is mostly derived from in vitro or circulatory studies. 

Phrase: "Analysis of the final distribution of radioactivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597748:radioactivity analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "for each peptide  DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Few studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the role IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C3154893:Have [Idea or Concept]
   833   C3539897:Have [Qualitative Concept]

Phrase: "regulating"

Phrase: "the actions of IGFs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C2911660:Growth action [Activity]
   748   C0441472:actions [Functional Concept]
   714 E C3266814:Action [Activity]

Phrase: "in the extravascular environment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]

Phrase: "and as such,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "the behavior of IGF peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0004927:Behavior [Individual Behavior]
   744   C2707008:Behavior [Clinical Attribute]

Phrase: "is"

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "derived from in vitro"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "or"

Phrase: "circulatory studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.214: In the present study, we have adapted the Hunt-Schilling chamber model of wound repair (19) to allow repeated sampling of extravascular wound fluid from the same chamber, with minimal risk of contamination with plasma. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "adapted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2937289:adapted [Organic Chemical]

Phrase: "the Hunt-Schilling chamber model of wound repair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Model [Intellectual Product]

Phrase: "(19"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "repeated sampling of extravascular wound fluid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441621:Sampling [Diagnostic Procedure]
   753   C0870078:Sampling [Idea or Concept]

Phrase: "from the same chamber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "with minimal risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "of contamination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0259846:contamination [Human-caused Phenomenon or Process]
  1000   C1881659:CONTAMINATION [Event]
  1000   C2349974:Contamination [Idea or Concept]

Phrase: "with plasma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
Processing 00000000.tx.215: The results showed that interactions with IGFBPs retarded the elimination from the wound environment of IGF-I and IGF-II, both of which significantly interact with IGFBPs, compared with an analog of IGF-I, LR3-IGF-I, which has a greatly reduced affinity. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that interactions with IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "retarded"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0521111:Retarded [Qualitative Concept]
   928 E C0311403:Inhibited [Qualitative Concept]
   928 E C3463820:Inhibiting [Activity]
   907 E C0018790:arrested [Disease or Syndrome]
   907 E C0237477:Arrest [Temporal Concept]
   907 E C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "the elimination from the wound environment of IGF-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0221102:Elimination [Physiologic Function]

Phrase: "and"

Phrase: "IGF-II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "both of which significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "interact with IGFBPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "compared with an analog of IGF-I,"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   833   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   806   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   806   C1753359:insulin-like growth factor [Molecular Function]
   760   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0021966:I- [Inorganic Chemical]
   739   C0220844:growth [Physiologic Function]
   739   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0243071:Analog [Chemical Viewed Structurally]
   739   C1521761:Factor [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1707455:Compared [Activity]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   730   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "LR3-IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "which"

Phrase: "has"

Phrase: "a greatly reduced affinity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.216: All the peptides tested were eliminated from the chamber in a biphasic manner with an initial rapid phase in the first hour followed by a slower phase for the remainder of the experiment. 

Phrase: "All"

Phrase: "the peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "eliminated from the chamber"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0849355:Eliminated [Qualitative Concept]
   770   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "in a biphasic manner"

Phrase: "with an initial rapid phase in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205390:Phase [Temporal Concept]

Phrase: "the first hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "followed by a slower phase"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0205390:Phase [Temporal Concept]
   726   C0439834:Slow [Qualitative Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "for the remainder"

Phrase: "of the experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.217: Although few studies have attempted to measure clearance of growth factors from extravascular sites, the patterns of elimination in this study are consistent with those observations. 

Phrase: "Although"

Phrase: "few studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "clearance of growth factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "from extravascular sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "the patterns of elimination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0231360:ELIMINATION PATTERNS [Finding]
   770   C0449774:Patterns [Spatial Concept]

Phrase: "in this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "consistent with those observations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.218: Thus radiolabeled insulin injected into the wound fluid of Hunt-Schilling chambers that had been implanted in diabetic rats was cleared in a similar manner to the peptides of this study (15). 

Phrase: "Thus radiolabeled insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "injected into the wound fluid of Hunt-Schilling chambers"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   742   C0005889:FLUID [Body Substance]
   742   C0043250:Wound [Injury or Poisoning]
   742   C0179874:chambers [Medical Device]
   742   C0302908:fluid [Substance]
   742   C0444611:Fluid [Qualitative Concept]
   742   C1704353:Fluid [Substance]
   708 E C0016204:Wind NOS [Sign or Symptom]
   708 E C0043187:Wind [Natural Phenomenon or Process]
   708 E C0935616:Chamber [Body Part, Organ, or Organ Component]
   708   C1720154:Inject [Functional Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "implanted in diabetic rats"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0021102:Implanted [Medical Device]
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0241863:DIABETIC [Finding]
   737 E C0021107:implant [Therapeutic or Preventive Procedure]
   737 E C0332837:Implant [Injury or Poisoning]
   737 E C1711357:Implant [Functional Concept]

Phrase: "was"

Phrase: "cleared in a similar manner"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0521097:cleared [Functional Concept]
   760   C2348205:Similar [Qualitative Concept]
   726 E C2963144:Clear [Qualitative Concept]

Phrase: "to the peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "of this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.219: It was also reported that 125I-labeled epidermal growth factor rapidly disappeared from implanted sponges, with only 10% of the radioactivity remaining after 4h (7). 

Phrase: "It"

Phrase: "was"

Phrase: "also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that 125I-labeled epidermal growth factor rapidly"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   861   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1323367:epidermal growth factor [Molecular Function]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0014520:Epidermal [Tissue]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0221920:Epidermal [Spatial Concept]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]

Phrase: "disappeared from implanted sponges,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0021102:Implanted [Medical Device]
   770   C0032699:Sponges [Eukaryote]
   770   C0441126:Sponges [Medical Device]
   737 E C0021107:implant [Therapeutic or Preventive Procedure]
   737 E C0332837:Implant [Injury or Poisoning]
   737 E C1711357:Implant [Functional Concept]

Phrase: "with only 10%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "of the radioactivity remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527428:Remaining [Qualitative Concept]

Phrase: "after 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.220: In another study, radiolabeled transforming growth factor-, platelet-derived growth factor, or basic fibroblast growth factor was emulsified in collagen, and the clearance of each from the chambers over 10days was examined (37). 

Phrase: "In another study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "radiolabeled transforming growth factor-,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "platelet-derived growth factor,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "or"

Phrase: "basic fibroblast growth factor"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0380603:Fibroblast Growth Factor, Basic [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0919506:FIBROBLAST GROWTH FACTOR, BASIC [Gene or Genome]
  1000   C1522505:Basic Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0016026:Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0016030:Fibroblast [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1527178:Basic [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   741 E C0920750:basicity [Quantitative Concept]

Phrase: "was"

Phrase: "emulsified in collagen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   790   C1167364:collagen [Cell Component]
   718 E C0439689:Collagenous [Qualitative Concept]

Phrase: "and"

Phrase: "the clearance of each"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "from the chambers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "over 10days"

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.221: A biphasic clearance of the growth factors was observed, with ~30-35% of the peptides remaining after 6h. 

Phrase: "A biphasic clearance of the growth factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449297:Clearance [Qualitative Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "with ~30-35%"

Phrase: "of the peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "remaining after 6h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292428:6H [Temporal Concept]
   790   C1527428:Remaining [Qualitative Concept]
Processing 00000000.tx.222: However, the initial phase of decay lasted up to 24h, and some radioactivity was recoverable after 10days. 

Phrase: "However,"

Phrase: "the initial phase of decay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205390:Phase [Temporal Concept]

Phrase: "lasted up to 24h,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0456696:/24h [Temporal Concept]
   770   C1442770:24H [Temporal Concept]
   737   C1517741:Last [Qualitative Concept]

Phrase: "and"

Phrase: "some radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "recoverable after 10days."
Processing 00000000.tx.223: The long duration of that study may be due to the chambers being filled with collagen, which could have impeded clearance of the growth factors, and as such the results may not be directly comparable with ours. 

Phrase: "The long duration of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0439591:Long duration [Qualitative Concept]
   770   C0449238:Duration [Temporal Concept]
   770   C2926735:Duration [Pharmacologic Substance]

Phrase: "that study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "be due to the chambers"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0179874:chambers [Medical Device]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]
   726 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "being"

Phrase: "filled with collagen,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   790   C1167364:collagen [Cell Component]
   790   C1708059:Filled [Activity]
   718 E C0439689:Collagenous [Qualitative Concept]

Phrase: "which"

Phrase: "could"

Phrase: "have"

Phrase: "impeded"

Phrase: "clearance of the growth factors,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "as"

Phrase: "such the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "directly comparable with ours."
Processing 00000000.tx.224: Interaction and binding to components of the extracellular matrix, which may occur with growth factors, would be one mechanism by which the clearance of growth factors could be regulated. 

Phrase: "Interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "binding to components of the extracellular matrix,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1323260:extracellular matrix binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "which"

Phrase: "may"

Phrase: "occur with growth factors,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   770   C2911660:Growth [Activity]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "would"

Phrase: "be"

Phrase: "one mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "the clearance of growth factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "could"

Phrase: "be"

Phrase: "regulated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.225: However, the results of Sprugel et al. 

Phrase: "However,"

Phrase: "the results of Sprugel et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]
Processing 00000000.tx.226: (37), derived with growth factors that are capable of binding to matrix, suggest that such interactions may not be sufficient to increase the tissue half-lives of exogenous growth factors. 

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "derived with growth factors"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1441547:Derived [Qualitative Concept]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
   770   C3245521:derived [Idea or Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "capable of binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "to matrix,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "such interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the tissue half-lives of exogenous growth factors."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0595998:lives [Finding]
   744   C1548795:Live [Qualitative Concept]
   744   C1634625:% live [Qualitative Concept]
   744   C2825407:Half [Quantitative Concept]
   744   C2982691:Live [Activity]
   737   C0018517:Half-Life [Temporal Concept]
   711 E C0376558:Life [Idea or Concept]
Processing 00000000.tx.227: In contrast, our experiments suggest the presence of a pool of specific carrier proteins, in the form of the IGFBPs in wound fluid, is sufficient to alter the kinetics of an exogenous IGF provided it is capable of interacting with the IGFBPs. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "our experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of a pool of specific carrier proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "of the IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in wound fluid,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the kinetics of an exogenous IGF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0022702:Kinetics [Natural Phenomenon or Process]
   742   C0220865:kinetics [Functional Concept]
   742   C2825046:Kinetics [Occupation or Discipline]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "it"

Phrase: "is"

Phrase: "capable of interacting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "with the IGFBPs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.228: We evaluated the clearance of LR3-IGF-I, an analog of IGF-I with a 13-amino acid NH2-terminal extension and a substitution of Arg for the Glu at position 3(12). 

Phrase: "We"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the clearance of LR3-IGF-I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0449297:Clearance [Qualitative Concept]
   742   C1382187:Clearance [Clinical Attribute]
   742   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "an analog of IGF-I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0243071:Analog [Chemical Viewed Structurally]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "with a 13-amino acid NH2-terminal extension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0231448:Extension [Functional Concept]
   799   C1880641:Extension [Conceptual Entity]

Phrase: "and"

Phrase: "a substitution of Arg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1555721:Substitution [Idea or Concept]
   770   C1706204:Substitution [Activity]

Phrase: "for the Glu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at position 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.229: Its affinity for IGFBPs, compared with IGF-I, is greatly reduced, a property that increases its potency in vitro and in vivo (12, 41). 

Phrase: "Its affinity for IGFBPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "compared with IGF-I,"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1707455:Compared [Activity]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "is"

Phrase: "greatly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ","

Phrase: "a property"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0871161:Property [Qualitative Concept]
  1000   C1882134:Property [Conceptual Entity]
  1000   C2347695:Property [Entity]

Phrase: "that"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "its potency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   884   C3245505:Potential [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(12,"

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.230: In an earlier study, LR3-IGF-I was shown to be cleared from plasma more rapidly than IGF-I (2), a finding consistent with the present results. 

Phrase: "In an earlier study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "cleared from plasma more rapidly"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0032105:Plasma [Body Substance]
   760   C0521097:cleared [Functional Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1637379:Rapidly [Qualitative Concept]
   726 E C2963144:Clear [Qualitative Concept]

Phrase: "than IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "consistent with the present results."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.231: We also demonstrated that, in contrast to IGF-I and IGF-II, LR3-IGF-I was not able to significantly interact with IGFBPs in wound fluid, as chromatographed samples of wound fluid containing LR3-IGF-I eluted as a single peak in the region expected for unbound peptide. 

Phrase: "We also"

Phrase: "demonstrated"

Phrase: "that,"

Phrase: "in contrast to IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "not able to significantly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0085732:Able [Organism Attribute]
   812   C1299581:Able [Finding]
   812   C1518422:Not [Functional Concept]

Phrase: "interact with IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in wound fluid,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "as"

Phrase: "chromatographed samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "of wound fluid containing LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   873   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   849   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   849   C1753359:insulin-like growth factor [Molecular Function]
   814   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   807   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   807   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0018270:'growth' NOS [Organism Function]
   791   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   791   C0021966:I- [Inorganic Chemical]
   791   C0220844:growth [Physiologic Function]
   791   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   791   C1521761:Factor [Functional Concept]
   791   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   791   C1579433:Insulin [Pharmacologic Substance]
   791   C1621966:Growth [Organ or Tissue Function]
   791   C2827422:Factor [Conceptual Entity]
   791   C2911660:Growth [Activity]
   735 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   708 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "eluted as a single peak"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0444505:Peak [Quantitative Concept]

Phrase: "in the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "expected for unbound peptide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C1517001:Expected [Idea or Concept]
Processing 00000000.tx.232: Given the in vitro IGFBP-binding characteristics of LR3-IGF-I, it may also be expected that this peptide would also interact to a lesser extent with tissue- or matrix-associated IGFBPs than IGF-I or IGF-II. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the in vitro IGFBP-binding characteristics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1521970:Characteristics [Qualitative Concept]
   717   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of LR3-IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "it"

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "that"

Phrase: "this peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "would"

Phrase: "also"

Phrase: "interact to a lesser extent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]

Phrase: "with tissue-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "or"

Phrase: "matrix-associated IGFBPs than IGF-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "IGF-II."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.233: However, the amount of radioactivity present in the chamber tissue at the end of the experiment did not differ between the IGF peptides, whereas the amount of radioactivity found in the carcass was greater for LR3-IGF-I, consistent with a more rapid transfer of this peptide from the chamber wound fluid to other tissues compared with IGF-I and IGF-II. 

Phrase: "However,"

Phrase: "the amount of radioactivity present"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "in the chamber tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ between the IGF peptides,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
           Insulin-like growth peptide
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   744   C0220844:growth [Physiologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "whereas"

Phrase: "the amount of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "found in the carcass"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0150312:Found [Quantitative Concept]
   770   C0229961:Carcass [Fully Formed Anatomical Structure]
   737 E C0243095:Find [Finding]

Phrase: "was"

Phrase: "greater for LR3-IGF-I,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0443228:greater [Quantitative Concept]
   744   C1704243:Greater [Quantitative Concept]
   711 E C0549177:Great [Quantitative Concept]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "consistent with a more rapid transfer of this peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "from the chamber wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   827   C0005889:FLUID [Body Substance]
   827   C0043250:Wound [Injury or Poisoning]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1704353:Fluid [Substance]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]

Phrase: "to other tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "compared with IGF-I"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1707455:Compared [Activity]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.234: Although the actual sites of binding were not determined in this study, the data suggest that despite LR3-IGF-I being more rapidly cleared from the chamber, this peptide was still able to interact with wound tissue to the same extent as IGF-I and IGF-II. 

Phrase: "Although"

Phrase: "the actual sites of binding"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0005456:Binding Sites [Receptor]
   790   C2945843:Site of [Qualitative Concept]
   781 E C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "determined in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that despite LR3-IGF-I"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   869   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0021966:I- [Inorganic Chemical]
   744   C0220844:growth [Physiologic Function]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0450768:LR3 [Body Location or Region]
   744   C1416917:LR3 [Gene or Genome]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C2987131:LR3 [Gene or Genome]
   739   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "being"

Phrase: "more rapidly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C1637379:Rapidly [Qualitative Concept]

Phrase: "cleared from the chamber,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0521097:cleared [Functional Concept]
   770   C0935616:Chamber [Body Part, Organ, or Organ Component]
   737 E C2963144:Clear [Qualitative Concept]

Phrase: "this peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "still able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "interact with wound tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0040300:Tissue [Tissue]
   770   C0043250:Wound [Injury or Poisoning]
   770   C1547928:Tissue [Intellectual Product]

Phrase: "to the same extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]

Phrase: "as IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.235: It has been reported that IGF-I present in the 150-kDa complex of IGFBP-3 is cleared more slowly from plasma than that present in the 30-to 50-kDa form (25). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that IGF-I present"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0150312:Present [Quantitative Concept]
   799   C0449450:Present [Idea or Concept]
   780   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   780   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   734   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "in the 150-kDa complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "of IGFBP-3"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
  1000   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   954   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1149301:insulin-like growth factor binding [Molecular Function]
   900   C1416453:INSULIN-LIKE 3 [Gene or Genome]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C1623517:insulin binding [Molecular Function]
   845   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1149299:Growth Factor Binding [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "cleared"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521097:cleared [Functional Concept]
   966 E C2963144:Clear [Qualitative Concept]

Phrase: "more slowly from plasma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0032105:Plasma [Body Substance]
   770   C0205172:More [Functional Concept]
   770   C0439834:Slowly [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "than"

Phrase: "that present in the 30-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "to 50-kDa form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.236: Additionally, IGFBP-3 in wound fluid is proteolyzed, after which it exhibits a reduced ability to bind radiolabeled IGF-I (6, 34), leading to a greater amount of the labeled IGF-I associating with lower- molecular-weight binding proteins. 

Phrase: "Additionally,"

Phrase: "IGFBP-3 in wound fluid"
Meta Candidates (Total=26; Excluded=1; Pruned=0; Remaining=25)
   893   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   893   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   862   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1149301:insulin-like growth factor binding [Molecular Function]
   806   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   806   C1753359:insulin-like growth factor [Molecular Function]
   782   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C1149299:Growth Factor Binding [Molecular Function]
   777   C1416453:INSULIN-LIKE 3 [Gene or Genome]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0033618:Protein Binding [Molecular Function]
   757   C1623517:insulin binding [Molecular Function]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0220844:growth [Physiologic Function]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1521761:Factor [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "proteolyzed"

Phrase: ","

Phrase: "after"

Phrase: "which it"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a reduced ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "radiolabeled IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(6,"

Phrase: "34"

Phrase: ")"

Phrase: ","

Phrase: "leading to a greater amount"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0332152:Leading [Temporal Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C1265611:Amount [Quantitative Concept]
   760   C1522538:Leading [Functional Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C0549177:Great [Quantitative Concept]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "of the labeled IGF-I associating"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   795   C0332281:associating [Qualitative Concept]
   762 E C0750490:Associate [Idea or Concept]
   762 E C1706221:Associate [Professional or Occupational Group]
   747   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "with lower- molecular-weight binding proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
Processing 00000000.tx.237: As an extension of this finding, it might be expected that IGF-II would exhibit a lower rate of elimination from wound fluid than IGF-I because a greater proportion of IGF-II was present in the 150-kDa complex compared with IGF-I. 

Phrase: "As an extension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extension [Functional Concept]
  1000   C1880641:Extension [Conceptual Entity]

Phrase: "of this finding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "it"

Phrase: "might"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "that IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "would"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a lower rate of elimination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "from wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "than IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "because"

Phrase: "a greater proportion of IGF-II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709707:Proportion [Quantitative Concept]

Phrase: "was"

Phrase: "present in the 150-kDa complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "compared with IGF-I."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1707455:Compared [Activity]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.238: Our finding is consistent with the preferential binding of IGF-II to unoccupied, proteolytically nicked IGFBP-3 to form a ternary complex (24). 

Phrase: "Our finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "consistent with the preferential binding of IGF-II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "to unoccupied, proteolytically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1548224:Unoccupied [Idea or Concept]

Phrase: "nicked"

Phrase: "IGFBP-3 to"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
   960   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   960   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   923   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   890   C1149301:insulin-like growth factor binding [Molecular Function]
   883   C1416453:INSULIN-LIKE 3 [Gene or Genome]
   861   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1753359:insulin-like growth factor [Molecular Function]
   850   C1623517:insulin binding [Molecular Function]
   835   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   835   C1149299:Growth Factor Binding [Molecular Function]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0220844:growth [Physiologic Function]
   793   C0243122:binding [Functional Concept]
   793   C1145667:Binding [Activity]
   793   C1167622:Binding [Molecular Function]
   793   C1521761:Factor [Functional Concept]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a ternary complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.239: Why no difference was observed is not obvious from the data, but may, in part, be due to the increased permeability of the capillary barrier in granulation tissue. 

Phrase: "Why"

Phrase: "no difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "is"

Phrase: "not obvious from the data,"

Phrase: "but"

Phrase: "may"

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "be due to the increased permeability of the capillary barrier"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   775   C0232377:CAPILLARY PERMEABILITY INCREASED [Finding]
   775   C1382398:Increased capillary permeability [Finding]
   775   C2825070:Increased Capillary Permeability [Organ or Tissue Function]
   760   C0678226:Due to [Functional Concept]
           due
   757   C0006906:Capillary Permeability [Organ or Tissue Function]
   739   C0006901:Capillary [Body Part, Organ, or Organ Component]
   739   C0031164:Permeability [Natural Phenomenon or Process]
   739   C0205217:Increased [Quantitative Concept]
   739   C0442805:Increased [Functional Concept]
   739   C0935624:Capillary [Body Part, Organ, or Organ Component]
   739   C1280521:Capillary [Body Part, Organ, or Organ Component]
   739   C1706912:BARRIER [Medical Device]
   739   C2987476:Be [Conceptual Entity]
   739   C3146286:Due [Idea or Concept]

Phrase: "in granulation tissue."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018180:Granulation Tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C0518864:granulation [Finding]
   861   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.240: Nevertheless, we were not able to demonstrate any significant difference between the clearances of IGF-I and IGF-II. 

Phrase: "Nevertheless,"

Phrase: "we"

Phrase: "were"

Phrase: "not able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1518422:Not [Functional Concept]

Phrase: "demonstrate"

Phrase: "any significant difference between the clearances of IGF-I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C1705241:*Difference [Quantitative Concept]
   736   C1705242:Difference [Qualitative Concept]
   715   C2752783:differential growth [Organism Function]

Phrase: "and"

Phrase: "IGF-II."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.241: Insulin, which is of a similar molecular weight to LR3-IGF-I and does not associate with binding proteins, was eliminated more rapidly from wound fluid. 

Phrase: "Insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "which"

Phrase: "is of a similar molecular weight"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0026385:Molecular Weight [Quantitative Concept]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705104:Weight [Idea or Concept]
   753   C2348205:Similar [Qualitative Concept]

Phrase: "to LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associate with binding proteins,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   802 E C0033618:Protein Binding [Molecular Function]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243122:binding [Functional Concept]
   770   C0750490:Associate [Idea or Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "more rapidly from wound fluid."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0005889:FLUID [Body Substance]
   760   C0043250:Wound [Injury or Poisoning]
   760   C0205172:More [Functional Concept]
   760   C0302908:fluid [Substance]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1637379:Rapidly [Qualitative Concept]
   760   C1704353:Fluid [Substance]
   726 E C0016204:Wind NOS [Sign or Symptom]
   726 E C0043187:Wind [Natural Phenomenon or Process]
Processing 00000000.tx.242: However, the process of insulin elimination was complex due to degradation of the hormone in wound fluid. 

Phrase: "However,"

Phrase: "the process of insulin elimination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "complex due to degradation of the hormone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in wound fluid."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.243: In other experiments (15), the half-life of intact radiolabeled insulin in 14-day-old wounds of diabetic rats was calculated as 150min. 

Phrase: "In other experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "the half-life of intact radiolabeled insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0018517:Half-Life [Temporal Concept]
   748   C0376558:Life [Idea or Concept]
   748   C2825407:Half [Quantitative Concept]

Phrase: "in 14-day-old wounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021501:wounds [Qualitative Concept]
   812   C0043250:Wounds [Injury or Poisoning]

Phrase: "of diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "was"

Phrase: "calculated as 150min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.244: The smaller estimate, compared with our data, is reasonable given the well-described disturbances to healing that occur in diabetic rats (15). 

Phrase: "The smaller estimate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750572:Estimate [Quantitative Concept]

Phrase: "compared with our data,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511726:Data [Idea or Concept]
   770   C1707455:Compared [Activity]
   770   C3245479:data [Medical Device]

Phrase: "is"

Phrase: "reasonable given"

Phrase: "the well-described disturbances to healing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C2699787:Disturbance [Qualitative Concept]

Phrase: "that"

Phrase: "occur in diabetic rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0241863:DIABETIC [Finding]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.245: The degradation of insulin in wound fluid has been attributed to the action of a specific extracellular protease which, in accordance with our own results, was also shown not to proteolyze either IGF-I or IGF-II (36). 

Phrase: "The degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "in wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "attributed to the action of a specific extracellular protease"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   745   C3266814:Action attribute [Activity]
           Action
   742   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C0205369:Specific [Qualitative Concept]
   742   C0441472:Action [Functional Concept]
   742   C0521119:Extracellular [Cell Component]
   742   C1552740:specific [Intellectual Product]
   742   C1947941:Protease [Enzyme]
   708   C0449234:Attribute [Idea or Concept]
   708   C1704772:Attribute [Conceptual Entity]
   708   C1882133:Attribute [Qualitative Concept]

Phrase: "which,"

Phrase: "in accordance with our own results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "was"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "proteolyze"

Phrase: "either IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.246: However, another study showed that the insulin-degrading enzyme degraded IGF-I slightly in vitro, as assessed by either TCA precipitation or by the loss of ability to bind type-1 IGF receptors (35). 

Phrase: "However,"

Phrase: "another study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "slightly in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]

Phrase: ","

Phrase: "as"

Phrase: "assessed by either TCA precipitation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C0041405:TCA [Geographic Area]
   760   C0085758:TCA [Congenital Abnormality]
   760   C1415587:TCA [Gene or Genome]
   760   C1516048:Assessed [Activity]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]
   760   C3536819:TCA [Pharmacologic Substance]

Phrase: "or by the loss of ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0085732:Ability [Organism Attribute]
   748   C1517945:Loss [Quantitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "type-1 IGF receptors"
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   913   C0140079:Insulin-Like Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   845   C0206454:Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   845 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0441729:Type 1 [Classification]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0332307:Type [Qualitative Concept]
   795   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1547052:*Type [Quantitative Concept]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.247: Furthermore, Roth et al. 

Phrase: "Furthermore,"

Phrase: "Roth et al."
Processing 00000000.tx.248: (35) observed that IGF-II was more susceptible than IGF-I to proteolysis of the IGFs by the human insulin-degrading enzyme. 

Phrase: "(35"

Phrase: ")"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "more susceptible than IGF-I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0231204:Susceptible [Functional Concept]
   744   C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "to proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "of the IGFs"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
  1000   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   966 E C1753359:insulin-like growth factor [Molecular Function]
   861   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by the human insulin-degrading enzyme."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   861   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.249: It is plausible that some degradation of the IGF peptides may have occurred in our experiments, but no breakdown products accumulated because of rapid clearance of such products. 

Phrase: "It"

Phrase: "is"

Phrase: "plausible"

Phrase: "that"

Phrase: "some degradation of the IGF peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C3547574:insulin degradation [Molecular Function]
   745   C1523817:peptide degradation [Molecular Function]
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]

Phrase: "may"

Phrase: "have"

Phrase: "occurred in our experiments,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1709305:Occurred [Activity]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C2745955:OCCUR [Temporal Concept]

Phrase: "but"

Phrase: "no breakdown products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "accumulated because of rapid clearance of such products."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0439831:Rapid [Qualitative Concept]
   744   C0449297:Clearance [Qualitative Concept]
   744   C1382187:Clearance [Clinical Attribute]
   744   C1514468:Products [Entity]
   744   C2825073:Clearance [Natural Phenomenon or Process]
   711 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.250: Although rates of elimination of the degraded (TCA soluble) fractions could not be calculated in our experiments, 125I was rapidly cleared from the chamber such that by 6h, <5% of the original material remained. 

Phrase: "Although"

Phrase: "rates of elimination of the degraded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "(TCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0041405:TCA [Geographic Area]
  1000   C0085758:TCA [Congenital Abnormality]
  1000   C1415587:TCA [Gene or Genome]
  1000   C3536819:TCA [Pharmacologic Substance]

Phrase: "soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: ")"

Phrase: "fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "calculated in our experiments,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0444686:Calculated [Functional Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "125I"

Phrase: "was"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "cleared from the chamber"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0521097:cleared [Functional Concept]
   770   C0935616:Chamber [Body Part, Organ, or Organ Component]
   737 E C2963144:Clear [Qualitative Concept]

Phrase: "such"

Phrase: "that by 6h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292428:6H [Temporal Concept]

Phrase: "<5% of the original material"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205313:Original [Idea or Concept]
   760   C0439084:>5 [Quantitative Concept]
   760   C0520510:Material [Substance]
   760   C0728893:+5 [Quantitative Concept]
   760   C2347409:Original [Occupational Activity]

Phrase: "remained."
Processing 00000000.tx.251: The labeled IGFs were 88-92% intact before injection into the chambers, with the range of values attributed to varying specific activities. 

Phrase: "The labeled IGFs"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   937   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   904 E C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "88-92% intact before injection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205266:Intact [Qualitative Concept]
   760   C1554187:Intact [Idea or Concept]

Phrase: "into the chambers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "with the range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "of values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "attributed to varying specific activities."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   764   C1879549:Activity Attribute [Qualitative Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C0441655:Activities [Activity]
   760   C1552740:specific [Intellectual Product]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726   C0449234:Attribute [Idea or Concept]
   726 E C1561536:*Activity [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]
Processing 00000000.tx.252: Over time the TCA insolubility of the IGF peptides in wound fluid increased. 

Phrase: "Over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "the TCA insolubility of the IGF peptides"

Phrase: "in wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.253: A potential bias may exist here because radioactivity could reenter the wound chamber from the circulation. 

Phrase: "A potential bias"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "may"

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "here"

Phrase: "because"

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "could"

Phrase: "reenter"

Phrase: "the wound chamber from the circulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0935616:Chamber [Body Part, Organ, or Organ Component]
Processing 00000000.tx.254: No allowance for this possibility was made in this model. 

Phrase: "No allowance for this possibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0556660:Allowance [Quantitative Concept]
   760   C1524004:Allowance [Intellectual Product]

Phrase: "was"

Phrase: "made in this model."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C3161035:Model [Intellectual Product]
   737   C1881534:Make [Functional Concept]
Processing 00000000.tx.255: However, in other work in our laboratory, <0.1% of an intravenously administered bolus of IGF-I was detected in wound fluid after 4h (Bastian, S.E., P.E.Walton, D.L.Andress, and D.A.Belford, unpublished observations). 

Phrase: "However,"

Phrase: "in other work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "in our laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "<0.1% of an intravenously administered bolus"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   774   C1737200:ADMINISTERED INTRAVENOUSLY [Finding]
   748   C1511237:Bolus [Therapeutic or Preventive Procedure]
   748   C1521801:Administered [Functional Concept]
   714 E C1621583:Administer [Functional Concept]

Phrase: "of IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "detected in wound fluid"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0442726:Detected [Finding]
   770   C0444611:Fluid [Qualitative Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1704353:Fluid [Substance]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "after 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "(Bastian,"

Phrase: "S."

Phrase: "E.,"

Phrase: "P.E.Walton,"

Phrase: "D."

Phrase: "L.Andress,"

Phrase: "and"

Phrase: "D.A.Belford,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "unpublished observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.256: This result, together with the observation that Na125I is rapidly cleared from the chamber, supports the view that reentry contributes little to the total chamber radioactivity. 

Phrase: "This result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "together with the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that Na125I"

Phrase: "is"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "cleared from the chamber,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0521097:cleared [Functional Concept]
   770   C0935616:Chamber [Body Part, Organ, or Organ Component]
   737 E C2963144:Clear [Qualitative Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that reentry"

Phrase: "contributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "little to the total chamber radioactivity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   753   C0700321:Little [Quantitative Concept]
   753   C2700395:Little [Quantitative Concept]
Processing 00000000.tx.257: Against the view that IGFBPs protect IGFs from proteolytic action, LR3-IGF-I did not appear to be significantly degraded in wound fluid. 

Phrase: "Against the view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protect"

Phrase: "IGFs from proteolytic action,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   853   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   820 E C1753359:insulin-like growth factor [Molecular Function]
   778   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C2911660:Growth action [Activity]
           Growth
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0220844:growth [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "LR3-IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "significantly"

Phrase: "degraded in wound fluid."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C1704353:Fluid [Substance]
   770   C1881707:DEGRADED [Phenomenon or Process]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]
Processing 00000000.tx.258: Interestingly, the greater breakdown of insulin in wound fluid was not reflected in an increase in the proportion of TCA-soluble radioactivity in blood. 

Phrase: "Interestingly,"

Phrase: "the greater breakdown of insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C3547574:insulin breakdown [Molecular Function]
   760   C0443161:break down [Qualitative Concept]
   760   C0699900:breakdown [Organism Function]
   760   C1265875:breakdown [Acquired Abnormality]

Phrase: "in wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reflected in an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C0558058:reflected [Mental Process]

Phrase: "in the proportion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709707:Proportion [Quantitative Concept]
   928 E C0205351:Proportional [Qualitative Concept]

Phrase: "of TCA-soluble radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "in blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.259: Presumably, this is due to the rapid removal of these products from the blood, which was reflected in the higher accumulation of insulin radioactivity in urine. 

Phrase: "Presumably,"

Phrase: "this"

Phrase: "is due to the rapid removal of these products"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0015252:Removal [Therapeutic or Preventive Procedure]
   742   C0439831:Rapid [Qualitative Concept]
   742   C0728940:Removal [Therapeutic or Preventive Procedure]
   742   C1514468:Products [Entity]
   742   C3146286:Due [Idea or Concept]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "from the blood,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "reflected in the higher accumulation of insulin radioactivity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   750   C0020459:high insulin [Disease or Syndrome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0034553:Radioactivity [Natural Phenomenon or Process]
   744   C0558058:reflected [Mental Process]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "in urine."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]
Processing 00000000.tx.260: Constitutive expression of IGFs and most IGFBPs by cells of the repair response strongly suggests a role for IGFs in wound repair (14, 38, 40). 

Phrase: "Constitutive expression of IGFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "most IGFBPs by cells of the repair response strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role for IGFs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in wound repair"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043240:Wound Repair [Organism Function]
           Repair, NOS
   861   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "(14,"

Phrase: "38,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.261: Furthermore, the potent in vitro stimulatory activity of IGF analogs with low IGFBP affinity on cells that are principal components of the repair process enhances the prospect of IGFs as agents that may have therapeutic value in wound healing. 

Phrase: "Furthermore,"

Phrase: "the potent in vitro stimulatory activity of IGF analogs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C1753359:insulin-like growth factor activity [Molecular Function]
   767   C1149472:growth factor activity [Molecular Function]
   751   C1145751:insulin activity [Molecular Function]
   736   C0205177:Activity [Functional Concept]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C1561536:*Activity [Idea or Concept]

Phrase: "with low IGFBP affinity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1510827:Affinity [Natural Phenomenon or Process]
   756   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   723   C1149301:insulin-like growth factor binding [Molecular Function]
   711   C0242972:low protein [Therapeutic or Preventive Procedure]
   711   C0748025:low protein [Finding]

Phrase: "on cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "principal components of the repair process"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   773   C1882460:Principal Component [Quantitative Concept]
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the prospect of IGFs"

Phrase: "as agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "have"

Phrase: "therapeutic value in wound healing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1522609:Value [Quantitative Concept]
Processing 00000000.tx.262: Yet, positive responses to exogenous IGF-I have been equivocal and generally limited to those studies where an IGFBP was administered conjointly (16, 21, 42), pertubations of the growth hormone-IGF-IGFBP system exist (39, 42), or where the IGF is present at persistently increased levels (5, 7, 39). 

Phrase: "Yet,"

Phrase: "positive responses to exogenous IGF-I"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0871261:responses [Organism Attribute]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "have"

Phrase: "been"

Phrase: "equivocal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332241:Equivocal [Qualitative Concept]

Phrase: "and"

Phrase: "generally"

Phrase: "limited to those studies where"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0439801:Limited [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C3542948:Limited [Intellectual Product]
   726 E C0557651:Study [Manufactured Object]
   726 E C1549649:Limit [Idea or Concept]
   726 E C2349209:Limit [Conceptual Entity]
   726 E C2603343:Study [Research Activity]

Phrase: "an IGFBP"
Meta Candidates (Total=23; Excluded=2; Pruned=0; Remaining=21)
  1000   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1149301:insulin-like growth factor binding [Molecular Function]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   876   C1623517:insulin binding [Molecular Function]
   861   C1149299:Growth Factor Binding [Molecular Function]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0220844:growth [Physiologic Function]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "conjointly"

Phrase: "(16,"

Phrase: "21,"

Phrase: "42"

Phrase: ")"

Phrase: ","

Phrase: "pertubations"

Phrase: "of the growth hormone-IGF-IGFBP system"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   845   C0014136:Hormonal System [Body System]
   786   C0449913:System [Functional Concept]
   786   C1553451:System [Manufactured Object]
   786   C1704459:System [Medical Device]
   718   C0074898:growth hormone-binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   718   C1415063:growth hormone binding protein [Gene or Genome]
   715 E C0205373:Systemic [Functional Concept]
   709   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0596714:hormone binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   707   C1149299:Growth Factor Binding [Molecular Function]
   706   C0682768:hormone protein [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "(39,"

Phrase: "42"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "where"

Phrase: "the IGF"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1753359:insulin-like growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "present at persistently increased levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.263: The roles of the IGFBPs that are present during wound repair and the parts they play in regulating IGF bioavailability are unclear. 

Phrase: "The roles of the IGFBPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "present during wound repair"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "the parts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:parts [Spatial Concept]
  1000   C1709471:PARTS [Quantitative Concept]

Phrase: "they"

Phrase: "play in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0032214:Play [Daily or Recreational Activity]
   833   C0600138:play [Finding]

Phrase: "regulating"

Phrase: "IGF bioavailability"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0005508:Bioavailability [Quantitative Concept]
   804   C1706947:BIO-AVAILABILITY [Research Activity]
   771   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1753359:insulin-like growth factor [Molecular Function]
   733 E C0935763:Bioavailable [Qualitative Concept]

Phrase: "are"

Phrase: "unclear."
Processing 00000000.tx.264: Nevertheless, some insight has been gained from observations of the effects of application of IGFBPs with IGF-I to wounds. 

Phrase: "Nevertheless,"

Phrase: "some insight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233820:Insight [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "gained from observations of the effects of application of IGFBPs"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   739   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0185125:Application [Health Care Activity]
   739   C0302523:observations [Research Activity]
   739   C0700325:observations [Health Care Activity]
   739   C1280500:effects [Qualitative Concept]
   739   C1947919:Application [Intellectual Product]
   739   C2347934:Application [Intellectual Product]
   739   C3244290:observations [Functional Concept]
   739   C3539080:APPLICATION [Quantitative Concept]
   722   C0595938:effects increased [Pathologic Function]
   706   C1517378:Gain [Quantitative Concept]
   706 E C1964257:Observation [Diagnostic Procedure]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "with IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "to wounds."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021501:wounds [Qualitative Concept]
  1000   C0043250:Wounds [Injury or Poisoning]
Processing 00000000.tx.265: Thus IGFBP-1 in the phosphorylated form has been shown to enhance wound epithelialization and granulation tissue formation when administered with IGF-I (21, 42), an effect that has been attributed to the ability of this IGFBP to associate with tissue integrins (13). 

Phrase: "Thus IGFBP-1"
Meta Candidates (Total=29; Excluded=2; Pruned=0; Remaining=27)
   960   C0123256:Insulin-Like Growth-Factor Binding Protein 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   960   C1334092:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1 [Gene or Genome]
   923   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   904   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   904   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   890   C1149301:insulin-like growth factor binding [Molecular Function]
   861   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1753359:insulin-like growth factor [Molecular Function]
   850   C1623517:insulin binding [Molecular Function]
   835   C1149299:Growth Factor Binding [Molecular Function]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0220844:growth [Physiologic Function]
   793   C0243122:binding [Functional Concept]
   793   C1145667:Binding [Activity]
   793   C1167622:Binding [Molecular Function]
   793   C1521761:Factor [Functional Concept]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the phosphorylated form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "wound epithelialization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3266038:Wound Epithelialization [Finding]
   861   C0334029:Epithelialisation [Organ or Tissue Function]
   861   C1317977:Epithelialisation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "granulation tissue formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0018180:Granulation Tissue [Tissue]

Phrase: "when"

Phrase: "administered with IGF-I"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1521761:Factor [Functional Concept]
   748   C1521801:Administered [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   714 E C1621583:Administer [Functional Concept]

Phrase: "(21,"

Phrase: "42"

Phrase: ")"

Phrase: ","

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "attributed to the ability"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0085732:Ability [Organism Attribute]
   737   C0449234:Attribute [Idea or Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]

Phrase: "of this IGFBP to"
Meta Candidates (Total=23; Excluded=2; Pruned=0; Remaining=21)
   954   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1149301:insulin-like growth factor binding [Molecular Function]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C1623517:insulin binding [Molecular Function]
   845   C1149299:Growth Factor Binding [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "associate with tissue integrins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   770   C0040300:Tissue [Tissue]
   770   C0750490:Associate [Idea or Concept]
   770   C1547928:Tissue [Intellectual Product]
   770   C1706221:Associate [Professional or Occupational Group]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.266: Also, proteolytic fragments of IGFBP-3 have a reduced affinity for IGF-I and are thought to enhance IGF-I bioactivity by localizing IGF-I to the cell membrane (23, 32). 

Phrase: "Also,"

Phrase: "proteolytic fragments of IGFBP-3"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   741   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   739   C0332255:fragments [Functional Concept]
   739   C0486805:Fragments [Body Substance]
   726   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   726   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   706 E C1708096:Fragment [Qualitative Concept]

Phrase: "have"

Phrase: "a reduced affinity for IGF-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "IGF-I bioactivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   780   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   780   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   734   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "by localizing IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "to the cell membrane"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0007603:Cell Membrane [Cell Component]
  1000   C3161472:Cell Membrane [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1706182:Membrane [Manufactured Object]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.267: This process has yet to be confirmed in vivo, although IGFBP-3 is proteolyzed in wound fluid (34), suggesting that such a mechanism does exist. 

Phrase: "This process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "has"

Phrase: "yet to"

Phrase: "be"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "although"

Phrase: "IGFBP-3"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
  1000   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   954   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1149301:insulin-like growth factor binding [Molecular Function]
   900   C1416453:INSULIN-LIKE 3 [Gene or Genome]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C1623517:insulin binding [Molecular Function]
   845   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1149299:Growth Factor Binding [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "proteolyzed in wound fluid"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C1704353:Fluid [Substance]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "such a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "does"

Phrase: "exist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.268: A role for other IGFBPs in dermal wound repair is also postulated on the basis of their expression by components of normal skin (3) and the presence of glycosaminoglycan-binding domains in IGFBP sequences (17). 

Phrase: "A role for other IGFBPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in dermal wound repair"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0043240:Wound Repair [Organism Function]
           Repair, NOS
   885   C0580646:skin repair [Therapeutic or Preventive Procedure]
   827   C0374711:Repair [Therapeutic or Preventive Procedure]
   706   C0564444:skin wound [Injury or Poisoning]

Phrase: "is"

Phrase: "also"

Phrase: "postulated on the basis of their expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: "by components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "of normal skin"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C0558145:Normal skin [Finding]
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C0444099:Skin [Body Substance]
   861   C1123023:Skin [Body System]
   861   C1278993:Skin [Body System]
   861   C2347086:% Normal [Quantitative Concept]
   805 E C0221912:Cutaneous [Spatial Concept]
   805 E C0221928:Dermal [Qualitative Concept]
   805 E C1522447:Cutaneous [Functional Concept]
   738 E C0011646:Dermis [Tissue]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "the presence of glycosaminoglycan-binding domains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in IGFBP sequences"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   818   C0002518:protein sequences [Amino Acid Sequence]
   795   C0162326:Sequences [Nucleotide Sequence]
   787   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C0004793:Sequence [Nucleotide Sequence]
   762 E C0162327:Sequence [Nucleotide Sequence]
   762 E C1519249:Sequence [Functional Concept]
   747   C1149301:insulin-like growth factor binding [Molecular Function]
   712 E C1548958:Sequential [Idea or Concept]
   712 E C1705294:Sequential [Qualitative Concept]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.269: However, not all IGFBPs are expressed in skin, and the expression of each IGFBP is localized to different components of the integument (3), indicating that the activity of IGFs may be regulated according to the target cells involved. 

Phrase: "However,"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "expressed in skin,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0444099:Skin [Body Substance]
   790   C1123023:Skin [Body System]
   790   C1278993:Skin [Body System]
   734 E C0221912:Cutaneous [Spatial Concept]
   734 E C0221928:Dermal [Qualitative Concept]
   734 E C1522447:Cutaneous [Functional Concept]

Phrase: "and"

Phrase: "the expression of each IGFBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "localized to different components of the integument"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0037267:Integument [Body System]
   748   C0392752:Localized [Spatial Concept]
   748   C0449432:Components [Manufactured Object]
   748   C1123023:Integument [Body System]
   748   C1705242:Different [Qualitative Concept]
   714 E C1705248:Component [Conceptual Entity]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the activity of IGFs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   863   C1753359:insulin-like growth factor activity [Molecular Function]
   788   C1149472:growth factor activity [Molecular Function]
   774   C1145751:insulin activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "regulated according to the target cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0221284:Target cells [Cell]
   790   C3272919:Target Cells [Laboratory Procedure]
   753   C0007634:Cells [Cell]
   753   C0680240:according [Social Behavior]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.270: In conclusion, our observations that IGF analogs with reduced affinity for the IGFBPs are cleared from wound fluid at a greater rate than native IGF-I or IGF-II emphasize the importance of IGFBPs in maintaining a pool of IGF at the wound site. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that IGF analogs with reduced affinity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0243071:analogs [Chemical Viewed Structurally]

Phrase: "for the IGFBPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074825:IGFBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "cleared from wound fluid"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   802   C0453847:Clear fluid [Food]
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C0521097:cleared [Functional Concept]
   770   C1704353:Fluid [Substance]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]
   737 E C2963144:Clear [Qualitative Concept]

Phrase: "at a greater rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "than native IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "emphasize"

Phrase: "the importance of IGFBPs"

Phrase: "in maintaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0024501:Maintain [Activity]

Phrase: "a pool of IGF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0337051:Pool [Geographic Area]
   748   C1509144:pool [Clinical Attribute]
   748   C2349200:Pool [Functional Concept]

Phrase: "at the wound site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.271: Furthermore, the clearance experiments may serve as a general model for measuring the regulation of the bioactivity and transfer of growth factors and other bioactive molecules from one extravascular compartment to another. 

Phrase: "Furthermore,"

Phrase: "the clearance experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "may"

Phrase: "serve as a general model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205246:General [Spatial Concept]
   760   C1553889:General [Idea or Concept]
   760   C3161035:Model [Intellectual Product]

Phrase: "for measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the regulation of the bioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "transfer of growth factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0040673:factors transfer [Immunologic Factor]
   819   C1280474:factors transfer [Finding]
   770   C0040671:Transfer [Mental Process]
   770   C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "other bioactive molecules from one extravascular compartment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0567416:molecules [Substance]

Phrase: "to another."
Processing 00000000.tx.272: Nevertheless, whether manipulation of IGF/IGFBP associations can be used as a means to alter the healing processes in wounds has yet to be determined.  

Phrase: "Nevertheless,"

Phrase: "whether"

Phrase: "manipulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185111:Manipulation, NOS [Therapeutic or Preventive Procedure]
  1000   C0947647:Manipulation [Therapeutic or Preventive Procedure]

Phrase: "of IGF/IGFBP associations"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   788   C0004083:Associations [Mental Process]
   755 E C0439849:Association [Qualitative Concept]
   755 E C0596306:Association [Phenomenon or Process]
   755 E C0699792:association [Social Behavior]
   730   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1149301:insulin-like growth factor binding [Molecular Function]
   703   C1623517:insulin binding [Molecular Function]

Phrase: "can"

Phrase: "be"

Phrase: "used as a means to"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   760   C1273517:used [Finding]
   760   C1704970:Means [Conceptual Entity]
   726 E C0042153:use [Functional Concept]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the healing processes in wounds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1999265:Healing Process [Organism Function]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "has"

Phrase: "yet to"

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.273: ACKNOWLEDGEMENTS The authors wish to thank Paul Rogers for skilled technical assistance provided during these experiments.  

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "wish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1423524:WISH [Gene or Genome]
  1000   C3273411:WISH [Gene or Genome]
  1000   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Paul Rogers for skilled technical assistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C3463939:Roger [Eukaryote]

Phrase: "provided during these experiments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1999230:Provided [Activity]
   737 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.274: FOOTNOTES The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.275: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.276: 1734 solely to indicate this fact. 

Phrase: "1734 solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.277: Address for reprint requests and other correspondence to: G.

Phrase: "Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0376649:Address [Intellectual Product]
   770   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.278: Robertson, Child Health Research Institute, 72King William Road, North Adelaide, South Australia 5006,Australia. 

Phrase: "Robertson,"

Phrase: "Child Health Research Institute,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0008078:Child Health [Health Care Activity]
   861   C0035172:Research Institute [Organization]
   812   C0018684:Health [Idea or Concept]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "72King William Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442650:Road [Manufactured Object]

Phrase: "North Adelaide,"

Phrase: "South Australia 5006,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0037715:South Australia [Geographic Area]
   827   C0004340:Australia [Geographic Area]
   827   C1710133:South [Spatial Concept]
   755 E C0238711:AUSTRALIAN [Finding]

Phrase: "Australia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]
Processing 00000000.tx.279: Received 3 June 1998; 

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "3 June 1998"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: ";"
Processing 00000000.tx.280: accepted in final form 10 December 1998.  

Phrase: "accepted in final form 10 December 1998."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205088:Final [Temporal Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1546485:Final [Idea or Concept]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.281: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1.  

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.282: Ballard, F. 

Phrase: "Ballard,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.283: J., S. 

Phrase: "J.,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.284: E. 

Phrase: "E."
Processing 00000000.tx.285: Knowles, P. 

Phrase: "Knowles,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.286: E. 

Phrase: "E."
Processing 00000000.tx.287: Walton, K. 

Phrase: "Walton,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.288: Edson, P. 

Phrase: "Edson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.289: C. 

Phrase: "C."
Processing 00000000.tx.290: Owens, M. 

Phrase: "Owens,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.291: A. 

Phrase: "A."
Processing 00000000.tx.292: Mohler, and B. 

Phrase: "Mohler,"

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.293: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.294: Ferraiolo. 

Phrase: "Ferraiolo."
Processing 00000000.tx.295: Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats. 

Phrase: "Plasma clearance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0032105:Plasma [Body Substance]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "tissue distribution of labelled insulin-like growth factor-I"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0040287:Tissue Distribution [Quantitative Concept]
   764   C0220927:tissue distribution [Functional Concept]
   762   C0040048:Tissue Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1333522:TISSUE FACTOR [Gene or Genome]
   762   C1621966:Tissue Growth [Organ or Tissue Function]
   742   C0040300:Tissue [Tissue]
   742   C0520511:distribution [Idea or Concept]
   742   C1547928:Tissue [Intellectual Product]
   742   C1704711:Distribution [Functional Concept]

Phrase: "(IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "des(1-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1539265:Des-1 [Gene or Genome]
   901   C3539688:Des-1 [Gene or Genome]

Phrase: ")"

Phrase: "IGF-I in rats."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.296: J. 

Phrase: "J."
Processing 00000000.tx.297: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.298: 128: 197-204, 1991[Abstract]. 

Phrase: "128"

Phrase: ":"

Phrase: "197-204,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.299: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.300: Bastian, S. 

Phrase: "Bastian,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.301: E., P. 

Phrase: "E.,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.302: E. 

Phrase: "E."
Processing 00000000.tx.303: Walton, J. 

Phrase: "Walton,"

Phrase: "J."
Processing 00000000.tx.304: C. 

Phrase: "C."
Processing 00000000.tx.305: Wallace, and F. 

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.306: J. 

Phrase: "J."
Processing 00000000.tx.307: Ballard. 

Phrase: "Ballard."
Processing 00000000.tx.308: Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats. 

Phrase: "Plasma clearance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0032105:Plasma [Body Substance]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "tissue distribution of labelled insulin-like growth factor-I"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0040287:Tissue Distribution [Quantitative Concept]
   764   C0220927:tissue distribution [Functional Concept]
   762   C0040048:Tissue Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1333522:TISSUE FACTOR [Gene or Genome]
   762   C1621966:Tissue Growth [Organ or Tissue Function]
   742   C0040300:Tissue [Tissue]
   742   C0520511:distribution [Idea or Concept]
   742   C1547928:Tissue [Intellectual Product]
   742   C1704711:Distribution [Functional Concept]

Phrase: "(IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "an analogue LR3IGF-I in pregnant rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.309: J. 

Phrase: "J."
Processing 00000000.tx.310: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.311: 138: 327-336, 1993[Abstract]. 

Phrase: "138"

Phrase: ":"

Phrase: "327-336,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.312: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.313: Batch, J. 

Phrase: "Batch,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550176:Batch [Idea or Concept]
  1000   C1948031:Batch [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.314: A., F. 

Phrase: "A.,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.315: A. 

Phrase: "A."
Processing 00000000.tx.316: Mercuri, S. 

Phrase: "Mercuri,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.317: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.318: Edmondson, and G. 

Phrase: "Edmondson,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.319: A. 

Phrase: "A."
Processing 00000000.tx.320: Werther. 

Phrase: "Werther."
Processing 00000000.tx.321: Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization. 

Phrase: "Localization of messenger ribonucleic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "for insulin-like growth factor-binding proteins"
Meta Candidates (Total=23; Excluded=2; Pruned=0; Remaining=21)
  1000   C0074825:Insulin-Like Growth-Factor-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1149301:insulin-like growth factor binding [Molecular Function]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   876   C1623517:insulin binding [Molecular Function]
   861   C1149299:Growth Factor Binding [Molecular Function]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0220844:growth [Physiologic Function]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in human skin"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0444099:Skin [Body Substance]
   861   C1123023:Skin [Body System]
   861   C1278993:Skin [Body System]
   805 E C0221912:Cutaneous [Spatial Concept]
   805 E C0221928:Dermal [Qualitative Concept]
   805 E C1522447:Cutaneous [Functional Concept]
   738 E C0011646:Dermis [Tissue]

Phrase: "by in situ hybridization."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]
Processing 00000000.tx.322: J. 

Phrase: "J."
Processing 00000000.tx.323: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.324: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.325: Metab. 

Phrase: "Metab."
Processing 00000000.tx.326: 79: 1444-1449, 1994[Abstract]. 

Phrase: "79"

Phrase: ":"

Phrase: "1444-1449,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.327: 4.  

Phrase: "4."
Processing 00000000.tx.328: Bennett, N. 

Phrase: "Bennett,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.329: T., and G. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.330: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.331: Schultz. 

Phrase: "Schultz."
Processing 00000000.tx.332: Growth factors and wound healing: part II. 

Phrase: "Growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "wound healing"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: ":"

Phrase: "part II."
Processing 00000000.tx.333: Role in normal and chronic wound healing. 

Phrase: "Role in normal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "chronic wound healing."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0043240:Wound Healing [Organism Function]
           Healing
   827   C0043250:Wound [Injury or Poisoning]
   827   C0205249:Healing [Functional Concept]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.334: Am. 

Phrase: "Am."
Processing 00000000.tx.335: J.Surg. 

Phrase: "J.Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.336: 166: 74-81, 1993[Medline]. 

Phrase: "166"

Phrase: ":"

Phrase: "74-81,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.337: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.338: Bitar, M. 

Phrase: "Bitar,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.339: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.340: Insulin-like growth factor-I reverses diabetes-induced wound healing impairment in rats. 

Phrase: "Insulin-like growth factor-I reverses diabetes-induced wound healing impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0684336:Impairment [Pathologic Function]

Phrase: "in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.341: Horm. 

Phrase: "Horm."
Processing 00000000.tx.342: Metab. 

Phrase: "Metab."
Processing 00000000.tx.343: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.344: 29: 383-386, 1997[Medline]. 

Phrase: "29"

Phrase: ":"

Phrase: "383-386,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.345: 6.  

Phrase: "6."
Processing 00000000.tx.346: Blat, C., J. 

Phrase: "Blat"

Phrase: ","

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.347: Villaudy, and M. 

Phrase: "Villaudy,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.348: Binoux. 

Phrase: "Binoux."
Processing 00000000.tx.349: In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. 

Phrase: "In vivo proteolysis of serum insulin-like growth factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0597304:Proteolysis [Molecular Function]

Phrase: "(IGF) binding protein-3 results"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   793   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   756   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   723   C1149301:insulin-like growth factor binding [Molecular Function]
   717   C1416453:INSULIN-LIKE 3 [Gene or Genome]

Phrase: "in increased availability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Availability [Functional Concept]

Phrase: "of IGF to target cells."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   876   C0030281:Insulin Cell [Cell]
   845   C0007595:growth cell [Cell Function]
   818   C0221284:Target cells [Cell]
   818   C3272919:Target Cells [Laboratory Procedure]
   795   C0007634:Cells [Cell]
   795   C1521840:Target [Functional Concept]
   795   C2986546:TARGET [Diagnostic Procedure]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]
Processing 00000000.tx.350: J. 

Phrase: "J."
Processing 00000000.tx.351: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.352: Invest. 

Phrase: "Invest."
Processing 00000000.tx.353: 93: 2286-2290, 1994[Medline]. 

Phrase: "93"

Phrase: ":"

Phrase: "2286-2290,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.354: 7.  

Phrase: "7."
Processing 00000000.tx.355: Buckley, A., J. 

Phrase: "Buckley,"

Phrase: "A.,"

Phrase: "J."
Processing 00000000.tx.356: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.357: Davidson, C. 

Phrase: "Davidson,"

Phrase: "C."
Processing 00000000.tx.358: D. 

Phrase: "D."
Processing 00000000.tx.359: Kamerath, T. 

Phrase: "Kamerath,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.360: B. 

Phrase: "B."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.361: Wolt, and S. 

Phrase: "Wolt,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.362: C. 

Phrase: "C."
Processing 00000000.tx.363: Woodward. 

Phrase: "Woodward."
Processing 00000000.tx.364: Sustained release of epidermal growth factor accelerates wound repair. 

Phrase: "Sustained release of epidermal growth factor"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C1710261:Sustained Release [Biomedical or Dental Material]
   783   C0599947:release factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0443318:Sustained [Functional Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   719 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "wound"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]
   966 E C0016204:Wind NOS [Sign or Symptom]
   966 E C0043187:Wind [Natural Phenomenon or Process]
   916 E C0021501:wounds [Qualitative Concept]
   916 E C0332797:Wounded [Functional Concept]

Phrase: "repair."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Repair, NOS [Organism Function]
  1000   C0374711:Repair [Therapeutic or Preventive Procedure]
Processing 00000000.tx.365: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.366: Natl. 

Phrase: "Natl."
Processing 00000000.tx.367: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.368: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.369: USA 82: 7340-7344, 1985[Abstract]. 

Phrase: "USA 82"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: ":"

Phrase: "7340-7344,"

Phrase: "1985"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.370: 8.  

Phrase: "8."
Processing 00000000.tx.371: Davenport, M. 

Phrase: "Davenport,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.372: L., D. 

Phrase: "L., D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475219:L/d [Quantitative Concept]
Processing 00000000.tx.373: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.374: Clemmons, M. 

Phrase: "Clemmons,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.375: V. 

Phrase: "V."
Processing 00000000.tx.376: Miles, C. 

Phrase: "Miles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0331865:Miles [Quantitative Concept]
   966 E C2347127:mile [Quantitative Concept]
   966 E C2348616:mile [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.377: Camacho Hubner, A. 

Phrase: "Camacho Hubner,"

Phrase: "A."
Processing 00000000.tx.378: J. 

Phrase: "J."
Processing 00000000.tx.379: D'Ercole, and L. 

Phrase: "D'"

Phrase: "Ercole,"

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.380: E. 

Phrase: "E."
Processing 00000000.tx.381: Underwood. 

Phrase: "Underwood."
Processing 00000000.tx.382: Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. 

Phrase: "Regulation of serum insulin-like growth factor-I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C1160191:regulation of growth [Organism Function]
           growth regulation
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "(IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "IGF binding proteins during rat pregnancy."
Meta Candidates (Total=24; Excluded=1; Pruned=0; Remaining=23)
   882   C0074825:Insulin-Like Growth-Factor-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C1149301:insulin-like growth factor binding [Molecular Function]
   818   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   818   C1753359:insulin-like growth factor [Molecular Function]
   790   C1149299:Growth Factor Binding [Molecular Function]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0032974:Pregnancy Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1623517:insulin binding [Molecular Function]
   745 E C0033618:Protein Binding [Molecular Function]
   745   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0220844:growth [Physiologic Function]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1521761:Factor [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
Processing 00000000.tx.383: Endocrinology 127: 1278-1286, 1990[Abstract]. 

Phrase: "Endocrinology 127"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "1278-1286,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.384: 9.  

Phrase: "9."
Processing 00000000.tx.385: Davies, S. 

Phrase: "Davies,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.386: C., J. 

Phrase: "C., J."
Processing 00000000.tx.387: A. 

Phrase: "A."
Processing 00000000.tx.388: Wass, R. 

Phrase: "Wass,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0043194:WAS [Disease or Syndrome]
   966   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1421478:WAS [Gene or Genome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.389: J. 

Phrase: "J."
Processing 00000000.tx.390: Ross, A. 

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "A."
Processing 00000000.tx.391: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.392: Cotterill, C. 

Phrase: "Cotterill,"

Phrase: "C."
Processing 00000000.tx.393: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.394: Buchanan, V. 

Phrase: "Buchanan,"

Phrase: "V."
Processing 00000000.tx.395: J. 

Phrase: "J."
Processing 00000000.tx.396: Coulson, and J. 

Phrase: "Coulson,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.397: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.398: Holly. 

Phrase: "Holly."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0330399:Holly [Plant]
  1000   C1256218:holly [Pharmacologic Substance]
  1000   C1527282:Holly [Plant]
Processing 00000000.tx.399: The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. 

Phrase: "The induction of a specific protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "for insulin-like growth factor binding protein-3"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
  1000   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   954   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1149301:insulin-like growth factor binding [Molecular Function]
   900   C1416453:INSULIN-LIKE 3 [Gene or Genome]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C1623517:insulin binding [Molecular Function]
   845   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1149299:Growth Factor Binding [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the circulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005775:Circulation [Physiologic Function]
  1000   C1516559:Circulation [Organism Function]

Phrase: "during severe illness."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0221423:Illness [Finding]
   789 E C0231218:Ill [Sign or Symptom]
   789 E C0332271:worse [Qualitative Concept]
   789 E C1279889:Worse [Finding]
   789 E C1457868:Worse [Qualitative Concept]
   789 E C1522166:Worst [Qualitative Concept]
Processing 00000000.tx.400: J. 

Phrase: "J."
Processing 00000000.tx.401: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.402: 130: 469-473, 1991[Abstract]. 

Phrase: "130"

Phrase: ":"

Phrase: "469-473,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.403: 10.  

Phrase: "10."
Processing 00000000.tx.404: Duckworth, W. 

Phrase: "Duckworth,"

Phrase: "W."
Processing 00000000.tx.405: C. 

Phrase: "C."
Processing 00000000.tx.406: Insulin degradation: mechanisms, products, and significance. 

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "significance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.407: Endocr. 

Phrase: "Endocr."
Processing 00000000.tx.408: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.409: 9: 319-345, 1988[Abstract]. 

Phrase: "9"

Phrase: ":"

Phrase: "319-345,"

Phrase: "1988"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.410: 11.  

Phrase: "11."
Processing 00000000.tx.411: Francis, G. 

Phrase: "Francis,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.412: L., S. 

Phrase: "L., S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439394:L/s [Quantitative Concept]
Processing 00000000.tx.413: E. 

Phrase: "E."
Processing 00000000.tx.414: Aplin, S. 

Phrase: "Aplin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.415: J. 

Phrase: "J."
Processing 00000000.tx.416: Milner, K. 

Phrase: "Milner,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.417: A. 

Phrase: "A."
Processing 00000000.tx.418: McNeil, F. 

Phrase: "McNeil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331860:McNeil [Health Care Related Organization]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.419: J. 

Phrase: "J."
Processing 00000000.tx.420: Ballard, and J. 

Phrase: "Ballard,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.421: C. 

Phrase: "C."
Processing 00000000.tx.422: Wallace. 

Phrase: "Wallace."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]
Processing 00000000.tx.423: Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II. 

Phrase: "Insulin-like growth factor"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1753359:insulin-like growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IGF)-II binding"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
  1000   C1622199:insulin-like growth factor II binding [Molecular Function]
   947   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   941   C1149301:insulin-like growth factor binding [Molecular Function]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   895   C1623517:insulin binding [Molecular Function]
   867   C1149299:Growth Factor Binding [Molecular Function]
   848   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0200396:Factor II [Laboratory Procedure]
   827   C1414504:FACTOR II [Gene or Genome]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0220844:growth [Physiologic Function]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "to IGF-binding proteins"
Meta Candidates (Total=23; Excluded=2; Pruned=0; Remaining=21)
  1000   C0074825:Insulin-Like Growth-Factor-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1149301:insulin-like growth factor binding [Molecular Function]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   876   C1623517:insulin binding [Molecular Function]
   861   C1149299:Growth Factor Binding [Molecular Function]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0220844:growth [Physiologic Function]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF receptors"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
  1000   C0140079:Insulin-Like Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   897   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   884   C0206454:Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   881 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "modified by deletion of the N-terminal hexapeptide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0205349:Modified By [Qualitative Concept]
   744   C0205088:Terminal [Temporal Concept]
   744   C0392747:Modified [Functional Concept]
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C1880274:Deletion [Activity]

Phrase: "or"

Phrase: "substitution of arginine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1555721:Substitution [Idea or Concept]
   790   C1706204:Substitution [Activity]

Phrase: "for glutamate-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in IGF-II."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.424: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.425: J. 

Phrase: "J."
Processing 00000000.tx.426: 293: 713-719, 1993[Medline]. 

Phrase: "293"

Phrase: ":"

Phrase: "713-719,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.427: 12.  

Phrase: "12."
Processing 00000000.tx.428: Francis, G. 

Phrase: "Francis,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.429: L., M. 

Phrase: "L., M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.430: Ross, F. 

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.431: J. 

Phrase: "J."
Processing 00000000.tx.432: Ballard, S. 

Phrase: "Ballard,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.433: J. 

Phrase: "J."
Processing 00000000.tx.434: Milner, C. 

Phrase: "Milner,"

Phrase: "C."
Processing 00000000.tx.435: Senn, K. 

Phrase: "Senn,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.436: A. 

Phrase: "A."
Processing 00000000.tx.437: McNeil, J. 

Phrase: "McNeil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331860:McNeil [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.438: C. 

Phrase: "C."
Processing 00000000.tx.439: Wallace, R. 

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.440: King, and J. 

Phrase: "King,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.441: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.442: Wells. 

Phrase: "Wells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]
Processing 00000000.tx.443: Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. 

Phrase: "Novel recombinant fusion protein analogues of insulin-like growth factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C2825028:Insulin Analogue [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706   C0243071:Analogue [Chemical Viewed Structurally]

Phrase: "(IGF)-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "indicate"

Phrase: "the relative importance of IGF-binding protein"

Phrase: "and"

Phrase: "receptor binding for enhanced biological potency."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0597358:Receptor Binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   726   C2986841:Binding Potential [Phenomenon or Process]
Processing 00000000.tx.444: J. 

Phrase: "J."
Processing 00000000.tx.445: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.446: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.447: 8: 213-223, 1992[Abstract]. 

Phrase: "8"

Phrase: ":"

Phrase: "213-223,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.448: 13.  

Phrase: "13."
Processing 00000000.tx.449: Galiano, R. 

Phrase: "Galiano,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.450: D., L. 

Phrase: "D."

Phrase: ","

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.451: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.452: Zhao, D. 

Phrase: "Zhao,"

Phrase: "D."
Processing 00000000.tx.453: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.454: Clemmons, S. 

Phrase: "Clemmons,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.455: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.456: Roth, X. 

Phrase: "Roth,"

Phrase: "X."
Processing 00000000.tx.457: Lin, and T. 

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.458: A. 

Phrase: "A."
Processing 00000000.tx.459: Mustoe. 

Phrase: "Mustoe."
Processing 00000000.tx.460: Interaction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes. 

Phrase: "Interaction between the insulin-like growth factor family"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the integrin receptor family in tissue repair processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015576:Family [Family Group]
   744   C1704727:Family [Conceptual Entity]
Processing 00000000.tx.461: Evidence in a rabbit ear dermal ulcer model. 

Phrase: "Evidence in a rabbit ear dermal ulcer model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.462: J. 

Phrase: "J."
Processing 00000000.tx.463: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.464: Invest. 

Phrase: "Invest."
Processing 00000000.tx.465: 98: 2462-2468, 1996[Abstract/Free FullText]. 

Phrase: "98"

Phrase: ":"

Phrase: "2462-2468,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.466: 14.  

Phrase: "14."
Processing 00000000.tx.467: Gartner, M. 

Phrase: "Gartner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.468: H., J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.469: D. 

Phrase: "D."
Processing 00000000.tx.470: Benson, and M. 

Phrase: "Benson,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.471: D. 

Phrase: "D."
Processing 00000000.tx.472: Caldwell. 

Phrase: "Caldwell."
Processing 00000000.tx.473: Insulin-like growth factors I and II expression in the healing wound. 

Phrase: "Insulin-like growth factors I"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   983   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   983   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   823   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   771   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   737 E C1753359:insulin-like growth factor [Molecular Function]

Phrase: "and"

Phrase: "II expression in the healing wound."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.474: J. 

Phrase: "J."
Processing 00000000.tx.475: Surg. 

Phrase: "Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.476: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.477: 52: 389-394, 1992[Medline]. 

Phrase: "52"

Phrase: ":"

Phrase: "389-394,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.478: 15.  

Phrase: "15."
Processing 00000000.tx.479: Goodson, W. 

Phrase: "Goodson,"

Phrase: "W."
Processing 00000000.tx.480: H., J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.481: Radolf, and T. 

Phrase: "Radolf,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.482: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.483: Hunt. 

Phrase: "Hunt."
Processing 00000000.tx.484: Wound healing and diabetes. 

Phrase: "Wound healing"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "and"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.485: In: Wound Healing and Wound Infection: Theory and Surgical Practice, edited by T. 

Phrase: "In"

Phrase: ":"

Phrase: "Wound Healing"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "and"

Phrase: "Wound Infection"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0043241:Wound Infection [Pathologic Function]
   861   C0009450:Infection, NOS [Disease or Syndrome]
   861   C0043250:Wound [Injury or Poisoning]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   789 E C0439663:Infected [Functional Concept]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
   750 E C0030657:infectivity [Qualitative Concept]

Phrase: ":"

Phrase: "Theory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871935:Theory [Idea or Concept]

Phrase: "and"

Phrase: "Surgical Practice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237607:practice [Mental Process]
   861   C3245512:practice [Intellectual Product]

Phrase: "edited by T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0868955:Edit [Occupational Activity]
Processing 00000000.tx.486: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.487: Hunt. 

Phrase: "Hunt."
Processing 00000000.tx.488: New York: Appleton- Century-Crofts, 1980, p. 

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ":"

Phrase: "Appleton- Century-Crofts,"

Phrase: "1980,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.489: 106-116. 

Phrase: "106-116."
Processing 00000000.tx.490: 16.  

Phrase: "16."
Processing 00000000.tx.491: Hamon, G. 

Phrase: "Hamon,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.492: A., T. 

Phrase: "A.,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.493: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.494: Hunt, and E. 

Phrase: "Hunt,"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.495: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.496: Spencer. 

Phrase: "Spencer."
Processing 00000000.tx.497: In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds. 

Phrase: "In vivo effects of systemic insulin-like growth factor-I"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "complexed with insulin-like growth factor binding protein-3"
Meta Candidates (Total=32; Excluded=1; Pruned=0; Remaining=31)
   919   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   919   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   891   C1167389:insulin-like growth factor binding protein complex [Cell Component]
   882   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C1149301:insulin-like growth factor binding [Molecular Function]
   818   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   818   C1753359:insulin-like growth factor [Molecular Function]
   790   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1149299:Growth Factor Binding [Molecular Function]
   784   C1416453:INSULIN-LIKE 3 [Gene or Genome]
   770   C1819317:protein complex binding [Molecular Function]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C0033618:Protein Binding [Molecular Function]
   762   C1623517:insulin binding [Molecular Function]
   745   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C1523872:protein complex [Cell Component]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0220844:growth [Physiologic Function]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1521761:Factor [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   708   C0439855:Complex [Qualitative Concept]
   708   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "on corticosteroid suppressed wounds."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021501:wounds [Qualitative Concept]
   827   C0043250:Wounds [Injury or Poisoning]
Processing 00000000.tx.498: Growth Regul. 

Phrase: "Growth Regul."
Processing 00000000.tx.499: 3: 53-56, 1993[Medline]. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "53-56,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.500: 17.  

Phrase: "17."
Processing 00000000.tx.501: Hodgkinson, S. 

Phrase: "Hodgkinson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.502: C., J. 

Phrase: "C., J."
Processing 00000000.tx.503: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.504: Napier, G. 

Phrase: "Napier,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.505: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.506: Spencer, and J. 

Phrase: "Spencer,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.507: J. 

Phrase: "J."
Processing 00000000.tx.508: Bass. 

Phrase: "Bass."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004830:Bass [Fish]
Processing 00000000.tx.509: Glycosaminoglycan binding characteristics of the insulin-like growth factor-binding proteins. 

Phrase: "Glycosaminoglycan binding characteristics of the insulin-like growth factor-binding proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1521970:Characteristics [Qualitative Concept]
Processing 00000000.tx.510: J. 

Phrase: "J."
Processing 00000000.tx.511: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.512: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.513: 13: 105-112, 1994[Abstract]. 

Phrase: "13"

Phrase: ":"

Phrase: "105-112,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.514: 18.  

Phrase: "18."
Processing 00000000.tx.515: Hodgkinson, S. 

Phrase: "Hodgkinson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.516: C., G. 

Phrase: "C., G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.517: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.518: Spencer, J. 

Phrase: "Spencer,"

Phrase: "J."
Processing 00000000.tx.519: J. 

Phrase: "J."
Processing 00000000.tx.520: Bass, S. 

Phrase: "Bass,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004830:Bass [Fish]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.521: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.522: Davis, and P. 

Phrase: "Davis,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.523: D. 

Phrase: "D."
Processing 00000000.tx.524: Gluckman. 

Phrase: "Gluckman."
Processing 00000000.tx.525: Distribution of circulating insulin-like growth factor-I (IGF-I) into tissues. 

Phrase: "Distribution of circulating insulin-like growth factor-I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "(IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "into tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.526: Endocrinology 129: 2085-2093, 1991[Abstract]. 

Phrase: "Endocrinology 129"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "2085-2093,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.527: 19.  

Phrase: "19."
Processing 00000000.tx.528: Hunt, T. 

Phrase: "Hunt,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.529: K., P. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.530: Twomey, B. 

Phrase: "Twomey,"

Phrase: "B."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.531: Zederfeldt, and J. 

Phrase: "Zederfeldt,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.532: E. 

Phrase: "E."
Processing 00000000.tx.533: Dunphy. 

Phrase: "Dunphy."
Processing 00000000.tx.534: Respiratory gas tensions and pH in healing wounds. 

Phrase: "Respiratory gas tensions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0233494:tensions [Mental or Behavioral Dysfunction]
   734   C0597393:respiratory gas [Organ or Tissue Function]

Phrase: "and"

Phrase: "pH in healing wounds."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
Processing 00000000.tx.535: Am. 

Phrase: "Am."
Processing 00000000.tx.536: J.Surg. 

Phrase: "J.Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.537: 114: 302-307, 1967[Medline]. 

Phrase: "114"

Phrase: ":"

Phrase: "302-307,"

Phrase: "1967"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.538: 20.  

Phrase: "20."
Processing 00000000.tx.539: Jones, J. 

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.540: I., and D. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.541: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.542: Clemmons. 

Phrase: "Clemmons."
Processing 00000000.tx.543: Insulin-like growth factors and their binding proteins: biological actions. 

Phrase: "Insulin-like growth factors"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
  1000   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   966 E C1753359:insulin-like growth factor [Molecular Function]
   861   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "their binding proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: ":"

Phrase: "biological actions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205460:biological [Qualitative Concept]
   861   C0441472:actions [Functional Concept]
   827 E C3266814:Action [Activity]
Processing 00000000.tx.544: Endocr. 

Phrase: "Endocr."
Processing 00000000.tx.545: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.546: 16: 3-34, 1995[Medline]. 

Phrase: "16"

Phrase: ":"

Phrase: "3-34,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.547: 21.  

Phrase: "21."
Processing 00000000.tx.548: Jyung, R. 

Phrase: "Jyung,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.549: W., J. 

Phrase: "W., J."
Processing 00000000.tx.550: A. 

Phrase: "A."
Processing 00000000.tx.551: Mustoe, W. 

Phrase: "Mustoe,"

Phrase: "W."
Processing 00000000.tx.552: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.553: Busby, and D. 

Phrase: "Busby,"

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.554: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.555: Clemmons. 

Phrase: "Clemmons."
Processing 00000000.tx.556: Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1. 

Phrase: "Increased wound-breaking strength"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   812   C0043250:Wound [Injury or Poisoning]
   812   C0237897:Strength [Quantitative Concept]
   812   C0808080:Strength [Idea or Concept]
   812   C1705922:Strength [Qualitative Concept]
   779 E C0016204:Wind NOS [Sign or Symptom]
   779 E C0043187:Wind [Natural Phenomenon or Process]
   779   C1881704:BREAK [Phenomenon or Process]
   741 E C0442821:Strong [Qualitative Concept]
   729 E C0021501:wounds [Qualitative Concept]
   729 E C0332797:Wounded [Functional Concept]

Phrase: "induced by insulin-like growth factor I"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0205263:Induced [Functional Concept]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with insulin-like growth factor binding protein-1."
Meta Candidates (Total=29; Excluded=2; Pruned=0; Remaining=27)
  1000   C0123256:Insulin-Like Growth-Factor Binding Protein 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334092:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1 [Gene or Genome]
   954   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   927   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   927   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   913   C1149301:insulin-like growth factor binding [Molecular Function]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C1623517:insulin binding [Molecular Function]
   845   C1149299:Growth Factor Binding [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.557: Surgery 115: 233-239, 1994[Medline]. 

Phrase: "Surgery 115"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038894:Surgery [Biomedical Occupation or Discipline]
   861   C0038895:surgery [Functional Concept]
   861   C0543467:Surgery [Health Care Activity]

Phrase: ":"

Phrase: "233-239,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.558: 22.  

Phrase: "22."
Processing 00000000.tx.559: Kaufman, S., B. 

Phrase: "Kaufman,"

Phrase: "S."

Phrase: ","

Phrase: "B."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.560: J. 

Phrase: "J."
Processing 00000000.tx.561: Mackay, and J. 

Phrase: "Mackay,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.562: Z. 

Phrase: "Z."
Processing 00000000.tx.563: Scott. 

Phrase: "Scott."
Processing 00000000.tx.564: Daily water and electrolyte balance in chronically hyperprolactinaemic rats. 

Phrase: "Daily water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "electrolyte balance in chronically hyperprolactinaemic rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013831:Electrolyte Balance [Organism Function]
   753   C0014653:Balance [Organism Function]
   753   C0205415:Balance [Functional Concept]
   753   C0560184:Balance [Finding]
Processing 00000000.tx.565: J. 

Phrase: "J."
Processing 00000000.tx.566: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.567: (Lond.) 

Phrase: "(Lond."

Phrase: ")"
Processing 00000000.tx.568: 321: 11-19, 1981[Abstract]. 

Phrase: "321"

Phrase: ":"

Phrase: "11-19,"

Phrase: "1981"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.569: 23.  

Phrase: "23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.570: Lalou, C., C. 

Phrase: "Lalou,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.571: Lassarre, and M. 

Phrase: "Lassarre,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.572: Binoux. 

Phrase: "Binoux."
Processing 00000000.tx.573: A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. 

Phrase: "A proteolytic fragment of insulin-like growth factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "(IGF) binding protein-3"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
  1000   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   954   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1149301:insulin-like growth factor binding [Molecular Function]
   900   C1416453:INSULIN-LIKE 3 [Gene or Genome]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C1623517:insulin binding [Molecular Function]
   845   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1149299:Growth Factor Binding [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "that"

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "IGFs"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
  1000   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   966 E C1753359:insulin-like growth factor [Molecular Function]
   861   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the mitogenic effects of IGF-I"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.574: Endocrinology 137: 3206-3212, 1996[Abstract]. 

Phrase: "Endocrinology 137"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "3206-3212,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.575: 24.  

Phrase: "24."
Processing 00000000.tx.576: Lee, C. 

Phrase: "Lee,"

Phrase: "C."
Processing 00000000.tx.577: Y., and M. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.578: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.579: Rechler. 

Phrase: "Rechler."
Processing 00000000.tx.580: A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially. 

Phrase: "A major portion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449719:Portion [Spatial Concept]

Phrase: "of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   931   C1167389:insulin-like growth factor binding protein complex [Cell Component]
   807   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C1523872:protein complex [Cell Component]
   791   C0439855:Complex [Qualitative Concept]
   791   C1704241:Complex [Chemical Viewed Structurally]
   734   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   707   C1149301:insulin-like growth factor binding [Molecular Function]

Phrase: "in adult rat serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "unoccupied, proteolytically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1548224:Unoccupied [Idea or Concept]

Phrase: "nicked"

Phrase: "IGFBP-3"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
  1000   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   954   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1149301:insulin-like growth factor binding [Molecular Function]
   900   C1416453:INSULIN-LIKE 3 [Gene or Genome]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C1623517:insulin binding [Molecular Function]
   845   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1149299:Growth Factor Binding [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "that"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "IGF-II preferentially."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0200396:Factor II [Laboratory Procedure]
   827   C1414504:FACTOR II [Gene or Genome]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0220844:growth [Physiologic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.581: Endocrinology 136: 668-678, 1995[Abstract]. 

Phrase: "Endocrinology 136"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "668-678,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.582: 25.  

Phrase: "25."
Processing 00000000.tx.583: Lewitt, M. 

Phrase: "Lewitt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.584: S., H. 

Phrase: "S."

Phrase: ","

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.585: Saunders, and R. 

Phrase: "Saunders,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.586: C. 

Phrase: "C."
Processing 00000000.tx.587: Baxter. 

Phrase: "Baxter."
Processing 00000000.tx.588: Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3. 

Phrase: "Bioavailability of insulin-like growth factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005508:Bioavailability [Quantitative Concept]
   753   C1706947:BIO-AVAILABILITY [Research Activity]
   716   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "(IGFs"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
  1000   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   966 E C1753359:insulin-like growth factor [Molecular Function]
   861   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "determined by the molecular distribution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0520511:distribution [Idea or Concept]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "of human IGF-binding protein-3."
Meta Candidates (Total=31; Excluded=2; Pruned=0; Remaining=29)
  1000   C1872103:insulin-like growth factor binding protein 3, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   960   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   960   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   923   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   890   C1149301:insulin-like growth factor binding [Molecular Function]
   883   C1416453:INSULIN-LIKE 3 [Gene or Genome]
   878   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1753359:insulin-like growth factor [Molecular Function]
   850   C1623517:insulin binding [Molecular Function]
   835   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   835   C1149299:Growth Factor Binding [Molecular Function]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0086418:Human [Human]
   793   C0220844:growth [Physiologic Function]
   793   C0243122:binding [Functional Concept]
   793   C1145667:Binding [Activity]
   793   C1167622:Binding [Molecular Function]
   793   C1521761:Factor [Functional Concept]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.589: Endocrinology 133: 1797-1802, 1993[Abstract]. 

Phrase: "Endocrinology 133"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "1797-1802,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.590: 26.  

Phrase: "26."
Processing 00000000.tx.591: Lord, A. 

Phrase: "Lord,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422581:LORD [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.592: P., S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.593: E.P. 

Phrase: "E.P."
Processing 00000000.tx.594: Bastian, L. 

Phrase: "Bastian,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.595: C. 

Phrase: "C."
Processing 00000000.tx.596: Read, P. 

Phrase: "Read"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Read [Daily or Recreational Activity]
  1000   C1705179:read [Finding]

Phrase: ","

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.597: E. 

Phrase: "E."
Processing 00000000.tx.598: Walton, and F. 

Phrase: "Walton,"

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.599: J. 

Phrase: "J."
Processing 00000000.tx.600: Ballard. 

Phrase: "Ballard."
Processing 00000000.tx.601: Differences in the association of insulin-like growth factor-I (IGF-I) and IGF-I variants with rat, sheep, pig, human and chicken plasma-binding proteins. 

Phrase: "Differences in the association of insulin-like growth factor-I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   716   C2752783:differential growth [Organism Function]
   706   C1705241:*Difference [Quantitative Concept]
   706   C1705242:Difference [Qualitative Concept]

Phrase: "(IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "IGF-I variants with rat,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205419:variants [Qualitative Concept]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "sheep,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036945:Sheep [Mammal]
  1000   C1123019:Sheep [Mammal]

Phrase: "pig,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1135183:Pig [Mammal]
  1000   C1136016:PIG [Mammal]
  1000   C1265533:Pig [Mammal]
  1000   C1270360:Pig [Mammal]

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "chicken plasma-binding proteins."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   875   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.602: J. 

Phrase: "J."
Processing 00000000.tx.603: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.604: 140: 475-482, 1994[Abstract]. 

Phrase: "140"

Phrase: ":"

Phrase: "475-482,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.605: 27.  

Phrase: "27."
Processing 00000000.tx.606: Lord, A. 

Phrase: "Lord,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422581:LORD [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.607: P., A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.608: A. 

Phrase: "A."
Processing 00000000.tx.609: Martin, F. 

Phrase: "Martin,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.610: J. 

Phrase: "J."
Processing 00000000.tx.611: Ballard, and L. 

Phrase: "Ballard,"

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.612: C. 

Phrase: "C."
Processing 00000000.tx.613: Read. 

Phrase: "Read."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Read [Daily or Recreational Activity]
  1000   C1705179:read [Finding]
Processing 00000000.tx.614: Transfer of insulin-like growth factor (IGF)-I from blood to intestine: comparison with IGFs that bind poorly to IGF-binding proteins. 

Phrase: "Transfer of insulin-like growth factor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0040673:Transfer Factor [Immunologic Factor]
   783   C1280474:Transfer factor [Finding]
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]
   716   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   716   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "(IGF)-I from blood"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0853230:blood insulin [Laboratory Procedure]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   724   C0078057:vascular factor [Amino Acid, Peptide, or Protein]

Phrase: "to intestine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]

Phrase: ":"

Phrase: "comparison with IGFs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1707455:Comparison [Activity]
   716   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "that"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "poorly to IGF-binding proteins."
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   909   C0074825:Insulin-Like Growth-Factor-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1149301:insulin-like growth factor binding [Molecular Function]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   800   C1149299:Growth Factor Binding [Molecular Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1623517:insulin binding [Molecular Function]
   750 E C0033618:Protein Binding [Molecular Function]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205169:Poorly [Qualitative Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
Processing 00000000.tx.615: J. 

Phrase: "J."
Processing 00000000.tx.616: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.617: 141: 505-515, 1994[Abstract]. 

Phrase: "141"

Phrase: ":"

Phrase: "505-515,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.618: 28.  

Phrase: "28."
Processing 00000000.tx.619: Lynch, S. 

Phrase: "Lynch,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.620: E. 

Phrase: "E."
Processing 00000000.tx.621: Interactions of growth factors in tissue repair. 

Phrase: "Interactions of growth factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "in tissue repair."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043240:Tissue repair [Organism Function]
           Repair, NOS
   861   C0374711:Repair [Therapeutic or Preventive Procedure]
Processing 00000000.tx.622: In: Clinical and Experimental Approaches to Dermal and Epidermal Repair: Normal and Chronic Wounds, edited by A. 

Phrase: "In"

Phrase: ":"

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "Experimental Approaches to Dermal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449445:Approaches [Spatial Concept]
   770   C1292724:Approaches [Functional Concept]

Phrase: "and"

Phrase: "Epidermal Repair"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043240:Repair, NOS [Organism Function]
   861   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "Normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "Chronic Wounds,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021501:wounds [Qualitative Concept]
   861   C0043250:Wounds [Injury or Poisoning]

Phrase: "edited by A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0868955:Edit [Occupational Activity]
Processing 00000000.tx.623: Barbul, M. 

Phrase: "Barbul,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.624: D. 

Phrase: "D."
Processing 00000000.tx.625: Caldwell, W. 

Phrase: "Caldwell,"

Phrase: "W."
Processing 00000000.tx.626: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.627: Eaglstein, T. 

Phrase: "Eaglstein,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.628: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.629: Hunt, D. 

Phrase: "Hunt,"

Phrase: "D."
Processing 00000000.tx.630: Marshall, E. 

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "E."
Processing 00000000.tx.631: Pines, and G. 

Phrase: "Pines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0872909:pines [Organic Chemical,Pharmacologic Substance]
  1000   C0885001:pines [Pharmacologic Substance]

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.632: Skover. 

Phrase: "Skover."
Processing 00000000.tx.633: New York: Wiley-Liss, 1991, p. 

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ":"

Phrase: "Wiley-Liss,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1508741:LISS [Laboratory Procedure]
   861   C2247545:LIS [Molecular Function]

Phrase: "1991,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.634: 341-357. 

Phrase: "341-357."
Processing 00000000.tx.635: 29.  

Phrase: "29."
Processing 00000000.tx.636: Lynch, S. 

Phrase: "Lynch,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.637: E., R. 

Phrase: "E.,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.638: B. 

Phrase: "B."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.639: Colvin, and H. 

Phrase: "Colvin,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.640: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.641: Antoniades. 

Phrase: "Antoniades."
Processing 00000000.tx.642: Growth factors in wound healing. 

Phrase: "Growth factors in wound healing."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.643: Single and synergistic effects on partial thickness porcine skin wounds. 

Phrase: "Single"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037179:Single [Population Group]
  1000   C0087136:single [Finding]
  1000   C0205171:Single [Quantitative Concept]

Phrase: "and"

Phrase: "synergistic effects on partial thickness porcine skin wounds."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C1280500:effects [Qualitative Concept]
   744   C2986495:Synergistic [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.644: J. 

Phrase: "J."
Processing 00000000.tx.645: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.646: Invest. 

Phrase: "Invest."
Processing 00000000.tx.647: 84: 640-646, 1989[Medline]. 

Phrase: "84"

Phrase: ":"

Phrase: "640-646,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.648: 30.  

Phrase: "30."
Processing 00000000.tx.649: Masure, S., and G. 

Phrase: "Masure,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.650: Opdenakker. 

Phrase: "Opdenakker."
Processing 00000000.tx.651: Cytokine-mediated proteolysis in tissue remodelling. 

Phrase: "Cytokine-mediated proteolysis in tissue remodelling."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597304:Proteolysis [Molecular Function]
Processing 00000000.tx.652: Experientia 45: 542-549, 1989[Medline]. 

Phrase: "Experientia 45"

Phrase: ":"

Phrase: "542-549,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.653: 31.  

Phrase: "31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.654: Mustoe, T. 

Phrase: "Mustoe,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.655: A., G. 

Phrase: "A.,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.656: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.657: Pierce, A. 

Phrase: "Pierce,"

Phrase: "A."
Processing 00000000.tx.658: Thomason, P. 

Phrase: "Thomason,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.659: Gramates, M. 

Phrase: "Gramates,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.660: B. 

Phrase: "B."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.661: Sporn, and T. 

Phrase: "Sporn,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.662: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.663: Deuel. 

Phrase: "Deuel."
Processing 00000000.tx.664: Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. 

Phrase: "Accelerated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:Accelerated [Functional Concept]

Phrase: "healing of incisional wounds"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0043240:healing wounds [Organism Function]
           Healing
   819   C0574776:healing wounds [Finding]
   819   C1265679:healing wounds [Anatomical Abnormality]
   770   C0205249:Healing [Functional Concept]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "induced by transforming growth factor-beta."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   882   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0205263:Induced [Functional Concept]
   753   C0220844:growth [Physiologic Function]
   753   C0330390:Beta [Plant]
   753   C0439096:Beta [Intellectual Product]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2004068:Beta [Qualitative Concept]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
Processing 00000000.tx.665: Science 237: 1333-1336, 1987[Medline]. 

Phrase: "Science 237"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "1333-1336,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.666: 32.  

Phrase: "32."
Processing 00000000.tx.667: Oh, Y., H. 

Phrase: "Oh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "Y.,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.668: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.669: Muller, H. 

Phrase: "Muller,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.670: Pham, G. 

Phrase: "Pham,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.671: Lamson, and R. 

Phrase: "Lamson,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.672: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.673: Rosenfeld. 

Phrase: "Rosenfeld."
Processing 00000000.tx.674: Non-receptor mediated, post-transcriptional regulation of insulin-like growth factor binding protein (IGFBP)-3 in Hs578T human breast cancer cells. 

Phrase: "Non-receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1518422:Non [Functional Concept]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: ","

Phrase: "post-transcriptional regulation of insulin-like growth factor binding protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   795   C1655411:regulation of protein binding [Molecular Function]
   782   C1514248:Post-Transcriptional Regulation [Genetic Function]
   777   C1160191:regulation of growth [Organism Function]
           growth regulation
   777   C1523122:regulation of binding [Molecular Function]
   760   C1158770:Transcriptional Regulation [Genetic Function]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1327622:Regulation [Biologic Function]

Phrase: "(IGFBP)-3"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
  1000   C0123707:Insulin-Like Growth Factor Binding Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1334094:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 [Gene or Genome]
   954   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1149301:insulin-like growth factor binding [Molecular Function]
   900   C1416453:INSULIN-LIKE 3 [Gene or Genome]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C1623517:insulin binding [Molecular Function]
   845   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1149299:Growth Factor Binding [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in Hs578T human breast cancer cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   921   C1512505:Human Breast Cancer Cell [Cell]
           Breast Cancer Cell
   875   C0427861:Human cells [Laboratory or Test Result]
   840   C0334227:cancer cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.675: Endocrinology 131: 3123-3125, 1992[Abstract]. 

Phrase: "Endocrinology 131"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "3123-3125,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.676: 33.  

Phrase: "33."
Processing 00000000.tx.677: Peacock, E. 

Phrase: "Peacock,"

Phrase: "E."
Processing 00000000.tx.678: E. 

Phrase: "E."
Processing 00000000.tx.679: Wound Repair. 

Phrase: "Wound Repair."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043240:Wound Repair [Organism Function]
           Repair, NOS
   861   C0374711:Repair [Therapeutic or Preventive Procedure]
Processing 00000000.tx.680: Philadelphia, PA: W. 

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ":"

Phrase: "W."
Processing 00000000.tx.681: B.

Phrase: "B."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.682: Saunders, 1984, p. 

Phrase: "Saunders,"

Phrase: "1984,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.683: 1-14. 

Phrase: "1-14."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.684: 34.  

Phrase: "34."
Processing 00000000.tx.685: Robertson, J. 

Phrase: "Robertson,"

Phrase: "J."
Processing 00000000.tx.686: G., K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.687: J. 

Phrase: "J."
Processing 00000000.tx.688: Pickering, and D. 

Phrase: "Pickering,"

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.689: A. 

Phrase: "A."
Processing 00000000.tx.690: Belford. 

Phrase: "Belford."
Processing 00000000.tx.691: Insulin-like growth factor-I (IGF-I) and IGF-binding proteins in rat wound fluid. 

Phrase: "Insulin-like growth factor-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "IGF-binding proteins in rat wound fluid."
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   862   C0074825:Insulin-Like Growth-Factor-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1149301:insulin-like growth factor binding [Molecular Function]
   806   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   806   C1753359:insulin-like growth factor [Molecular Function]
   782   C1149299:Growth Factor Binding [Molecular Function]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1623517:insulin binding [Molecular Function]
   741 E C0033618:Protein Binding [Molecular Function]
   741   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0220844:growth [Physiologic Function]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1521761:Factor [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
Processing 00000000.tx.692: Endocrinology 137: 2774-2781, 1996[Abstract]. 

Phrase: "Endocrinology 137"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "2774-2781,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.693: 35.  

Phrase: "35."
Processing 00000000.tx.694: Roth, R. 

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.695: A., M. 

Phrase: "A.,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.696: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.697: Mesirow, K. 

Phrase: "Mesirow,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.698: Yokuno, and S. 

Phrase: "Yokuno,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.699: Baba. 

Phrase: "Baba."
Processing 00000000.tx.700: Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme. 

Phrase: "Degradation of insulin-like growth factors I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]
   714   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "and"

Phrase: "II by a human insulin degrading enzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   746   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.701: Endocr. 

Phrase: "Endocr."
Processing 00000000.tx.702: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.703: 10: 101-112, 1984[Medline]. 

Phrase: "10"

Phrase: ":"

Phrase: "101-112,"

Phrase: "1984"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.704: 36.  

Phrase: "36."
Processing 00000000.tx.705: Shearer, J. 

Phrase: "Shearer,"

Phrase: "J."
Processing 00000000.tx.706: D., C. 

Phrase: "D."

Phrase: ","

Phrase: "C."
Processing 00000000.tx.707: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.708: Coulter, W. 

Phrase: "Coulter,"

Phrase: "W."
Processing 00000000.tx.709: C. 

Phrase: "C."
Processing 00000000.tx.710: Engeland, R. 

Phrase: "Engeland,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.711: A. 

Phrase: "A."
Processing 00000000.tx.712: Roth, and M. 

Phrase: "Roth,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.713: D. 

Phrase: "D."
Processing 00000000.tx.714: Caldwell. 

Phrase: "Caldwell."
Processing 00000000.tx.715: Insulin is degraded extracellularly in wounds by insulin-degrading enzyme (EC 3.4.24.56). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "extracellularly in wounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021501:wounds [Qualitative Concept]
   790   C0043250:Wounds [Injury or Poisoning]

Phrase: "by insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(EC 3.4.24.56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.716: Am. 

Phrase: "Am."
Processing 00000000.tx.717: J.

Phrase: "J."
Processing 00000000.tx.718: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.719: 273 (Endocrinol. Metab. 36): E657-E664, 1997[Abstract/Free FullText]. 

Phrase: "273"

Phrase: "(Endocrinol. Metab. 36"

Phrase: ")"

Phrase: ":"

Phrase: "E657-E664,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.720: 37.  

Phrase: "37."
Processing 00000000.tx.721: Sprugel, K. 

Phrase: "Sprugel,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.722: H., J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.723: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.724: Mcpherson, A. 

Phrase: "Mcpherson,"

Phrase: "A."
Processing 00000000.tx.725: W. 

Phrase: "W."
Processing 00000000.tx.726: Clowes, and R. 

Phrase: "Clowes,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.727: Ross. 

Phrase: "Ross."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]
Processing 00000000.tx.728: Effects of growth factors in-vivo. 

Phrase: "Effects of growth factors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "in-vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.729: I.

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.730: Cell ingrowth into porous subcutaneous chambers. 

Phrase: "Cell ingrowth into porous subcutaneous chambers."
Processing 00000000.tx.731: Am. 

Phrase: "Am."
Processing 00000000.tx.732: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.733: 129: 601-613, 1988[Abstract]. 

Phrase: "129"

Phrase: ":"

Phrase: "601-613,"

Phrase: "1988"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.734: 38.  

Phrase: "38."
Processing 00000000.tx.735: Steenfos, H. 

Phrase: "Steenfos,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.736: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.737: Growth factors and wound healing. 

Phrase: "Growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "wound healing."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.738: Scand. 

Phrase: "Scand."
Processing 00000000.tx.739: J.Plast. 

Phrase: "J.Plast."
Processing 00000000.tx.740: Reconstr. 

Phrase: "Reconstr."
Processing 00000000.tx.741: Surg. 

Phrase: "Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.742: Hand Surg. 

Phrase: "Hand Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.743: 28: 95-105, 1994[Medline]. 

Phrase: "28"

Phrase: ":"

Phrase: "95-105,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.744: 39.  

Phrase: "39."
Processing 00000000.tx.745: Suh, D. 

Phrase: "Suh,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416171:SUH [Gene or Genome]
  1000   C1422188:SUH [Gene or Genome]

Phrase: "D."
Processing 00000000.tx.746: Y., T. 

Phrase: "Y.,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.747: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.748: Hunt, and E. 

Phrase: "Hunt,"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.749: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.750: Spencer. 

Phrase: "Spencer."
Processing 00000000.tx.751: Insulin-like growth factor-I reverses the impairment of wound healing induced by corticosteroids in rats. 

Phrase: "Insulin-like growth factor-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "reverses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "the impairment of wound healing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0684336:Impairment [Pathologic Function]

Phrase: "induced by corticosteroids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0001617:Corticosteroids [Hormone,Pharmacologic Substance,Steroid]
   790   C0205263:Induced [Functional Concept]
   756 E C3536709:Corticosteroid [Pharmacologic Substance]

Phrase: "in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.752: Endocrinology 131: 2399-2403, 1992[Abstract]. 

Phrase: "Endocrinology 131"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "2399-2403,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.753: 40.  

Phrase: "40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.754: Tavakkol, A., J. 

Phrase: "Tavakkol,"

Phrase: "A.,"

Phrase: "J."
Processing 00000000.tx.755: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.756: Elder, C. 

Phrase: "Elder,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331055:Elder [Plant]
  1000   C0994408:Elder [Organic Chemical,Pharmacologic Substance]

Phrase: "C."
Processing 00000000.tx.757: E. 

Phrase: "E."
Processing 00000000.tx.758: Griffiths, K. 

Phrase: "Griffiths,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.759: D. 

Phrase: "D."
Processing 00000000.tx.760: Cooper, H. 

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.761: Talwar, G. 

Phrase: "Talwar,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.762: J. 

Phrase: "J."
Processing 00000000.tx.763: Fisher, K. 

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.764: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.765: Keane, S. 

Phrase: "Keane,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.766: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.767: Foltin, and J. 

Phrase: "Foltin,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.768: J. 

Phrase: "J."
Processing 00000000.tx.769: Voorhees. 

Phrase: "Voorhees."
Processing 00000000.tx.770: Expression of growth hormone receptor, insulin-like growth factor 1(IGF-1) and IGF-1 receptor mRNA and proteins in human skin. 

Phrase: "Expression of growth hormone receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0597360:receptor expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "insulin-like growth factor 1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IGF-1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "IGF-1 receptor mRNA"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   795   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   787   C0140080:Insulin-Like Growth Factor 1 Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   787   C1334088:insulin-like growth factor 1 receptor [Gene or Genome]
   747   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   744   C0140079:Insulin-Like Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   710   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1334133:INSULIN RECEPTOR [Gene or Genome]
   710   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "and"

Phrase: "proteins in human skin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.771: J. 

Phrase: "J."
Processing 00000000.tx.772: Invest. 

Phrase: "Invest."
Processing 00000000.tx.773: Dermatol. 

Phrase: "Dermatol."
Processing 00000000.tx.774: 99: 343-349, 1992[Abstract]. 

Phrase: "99"

Phrase: ":"

Phrase: "343-349,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.775: 41.  

Phrase: "41."
Processing 00000000.tx.776: Tomas, F. 

Phrase: "Tomas,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.777: M., S. 

Phrase: "M."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.778: E. 

Phrase: "E."
Processing 00000000.tx.779: Knowles, C. 

Phrase: "Knowles,"

Phrase: "C."
Processing 00000000.tx.780: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.781: Chandler, G. 

Phrase: "Chandler,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.782: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.783: Francis, P. 

Phrase: "Francis,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.784: C. 

Phrase: "C."
Processing 00000000.tx.785: Owens, and F. 

Phrase: "Owens,"

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.786: J. 

Phrase: "J."
Processing 00000000.tx.787: Ballard. 

Phrase: "Ballard."
Processing 00000000.tx.788: Anabolic effects of insulin-like growth factor-I (IGF-I) and an IGF-I variant in normal female rats. 

Phrase: "Anabolic effects of insulin-like growth factor-I"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C3179309:Anabolic Effects [Physiologic Function]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "(IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "an IGF-I variant in normal female rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.789: J. 

Phrase: "J."
Processing 00000000.tx.790: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.791: 137: 413-421, 1993[Abstract]. 

Phrase: "137"

Phrase: ":"

Phrase: "413-421,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.792: 42.  

Phrase: "42."
Processing 00000000.tx.793: Tsuboi, R., C. 

Phrase: "Tsuboi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "C."
Processing 00000000.tx.794: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.795: Shi, C. 

Phrase: "Shi,"

Phrase: "C."
Processing 00000000.tx.796: Sato, G. 

Phrase: "Sato,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.797: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.798: Cox, and H. 

Phrase: "Cox,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.799: Ogawa. 

Phrase: "Ogawa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]
Processing 00000000.tx.800: Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models. 

Phrase: "Co-administration of insulin-like growth factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0199782:Administration of insulin [Therapeutic or Preventive Procedure]
           administration insulin
   748   C0001554:Administration [Occupational Activity]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "(IGF)-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-binding protein-1"
Meta Candidates (Total=29; Excluded=2; Pruned=0; Remaining=27)
  1000   C0123256:Insulin-Like Growth-Factor Binding Protein 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334092:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1 [Gene or Genome]
   954   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   927   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   927   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   913   C1149301:insulin-like growth factor binding [Molecular Function]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C1623517:insulin binding [Molecular Function]
   845   C1149299:Growth Factor Binding [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "wound healing in animal models."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0043240:Wound Healing [Organism Function]
           Healing
   797 E C0574776:healing wound [Finding]
   797 E C1265679:healing wound [Anatomical Abnormality]
   760   C0043250:Wound [Injury or Poisoning]
   760   C0205249:Healing [Functional Concept]
   726 E C0016204:Wind NOS [Sign or Symptom]
   726 E C0043187:Wind [Natural Phenomenon or Process]
Processing 00000000.tx.801: J. 

Phrase: "J."
Processing 00000000.tx.802: Invest. 

Phrase: "Invest."
Processing 00000000.tx.803: Dermatol. 

Phrase: "Dermatol."
Processing 00000000.tx.804: 104: 199-203, 1995[Abstract]. 

Phrase: "104"

Phrase: ":"

Phrase: "199-203,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.805: 43.  

Phrase: "43."
Processing 00000000.tx.806: Upton, Z., H. 

Phrase: "Upton,"

Phrase: "Z.,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.807: Webb, F. 

Phrase: "Webb,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.808: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.809: Tomas, F. 

Phrase: "Tomas,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.810: J. 

Phrase: "J."
Processing 00000000.tx.811: Ballard, and G. 

Phrase: "Ballard,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.812: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.813: Francis. 

Phrase: "Francis."
Processing 00000000.tx.814: Characterization of serum-derived and recombinant rat IGF-I and their use for measuring true concentrations of IGF-I in rat plasma. 

Phrase: "Characterization of serum-derived"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "recombinant rat IGF-I"
Meta Candidates (Total=23; Excluded=2; Pruned=0; Remaining=21)
   913   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   911   C1522567:Recombinant Insulin-Like Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   884   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   833   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   829   C1533581:Recombinant Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Insulin
   818   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0021966:I- [Inorganic Chemical]
   795   C0220844:growth [Physiologic Function]
   795   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C1521761:Factor [Functional Concept]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "their use for measuring true concentrations of IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   751   C0240016:INSULIN USE [Finding]
   751   C1524063:Use of [Functional Concept]
   736   C0042153:use [Functional Concept]
   736   C0457083:Use [Functional Concept]
   736   C1947944:Use [Intellectual Product]

Phrase: "in rat plasma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
Processing 00000000.tx.815: J. 

Phrase: "J."
Processing 00000000.tx.816: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.817: 149: 379-387, 1996[Abstract]. 

Phrase: "149"

Phrase: ":"

Phrase: "379-387,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.818: Am J Physiol Endocrinol Metab 276(4):E663-E671 0002-9513/99 $5.00 Copyright  1999 the American Physiological Society

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 276"

Phrase: "(4"

Phrase: ")"

Phrase: ":"

Phrase: "E663-E671 0002-9513/99 $5.00 Copyright  1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0009993:Copyright [Intellectual Product]
   791   C1552856:copyright [Idea or Concept]

Phrase: "the American Physiological Society"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0037455:society [Organization]
   827   C0205463:Physiological [Functional Concept]
   827   C0596070:American [Population Group]
   755 E C0031842:Physiology [Biomedical Occupation or Discipline]
   755 E C0031843:physiology [Physiologic Function]

